[
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. CC(=O)Nc1cc2c(cc1O)-c1ccccc1C2",
            "b. O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1",
            "c. O=C1c2ccccc2C(=O)N1CCl",
            "d. ClCCC(Br)CBr"
        ],
        "answer": "c",
        "answer_smiles": "O=C1c2ccccc2C(=O)N1CCl",
        "domain": "Ames",
        "id": 1
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. CC(Br)C(=O)NCc1ccc(Cl)cc1",
            "b. ICCc1ccccc1",
            "c. CSSC",
            "d. CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC"
        ],
        "answer": "a",
        "answer_smiles": "CC(Br)C(=O)NCc1ccc(Cl)cc1",
        "domain": "Ames",
        "id": 2
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. O=C(/C=C/c1ccccc1[N+](=O)[O-])c1ccccc1",
            "b. CCOC(=O)CNC(=O)CBr",
            "c. C[C@H](I)[C@@H]1OC[C@@H](CO)O1",
            "d. C1CNCCN1"
        ],
        "answer": "c",
        "answer_smiles": "C[C@H](I)[C@@H]1OC[C@@H](CO)O1",
        "domain": "Ames",
        "id": 3
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. CC(=O)OCN=[N+](C)[O-]",
            "b. O=[N+]([O-])c1ccccc1-c1ccccc1",
            "c. CC(=O)OC/C=C(/C)CCC=C(C)C",
            "d. CN(C(=O)c1csc([N+](=O)[O-])c1)c1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "CN(C(=O)c1csc([N+](=O)[O-])c1)c1ccccc1",
        "domain": "Ames",
        "id": 4
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. COP(=O)(OC)Oc1ccc([N+](=O)[O-])c(C)c1",
            "b. O=Cc1cn(C2CC(O)C(CO)O2)c(=O)[nH]c1=O",
            "c. Clc1ccc(Cl)c(Cl)c1Cl",
            "d. CCc1ccccc1[N+](=O)[O-]"
        ],
        "answer": "a",
        "answer_smiles": "COP(=O)(OC)Oc1ccc([N+](=O)[O-])c(C)c1",
        "domain": "Ames",
        "id": 5
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. O=C(O)C1=CC(O)C(O)C(O)C1",
            "b. O=C(O)CCC(=O)Nc1ccc(Cl)c(Cl)c1",
            "c. CCCC(=O)C1c2cccc(O)c2C(=O)c2c(O)cccc21",
            "d. COc1cc(C)cc2c1C(=O)C=C(c1c(C)cc3c(c1OC)C(=O)C=CC3=O)C2=O"
        ],
        "answer": "c",
        "answer_smiles": "CCCC(=O)C1c2cccc(O)c2C(=O)c2c(O)cccc21",
        "domain": "Ames",
        "id": 6
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. CC(=O)Nc1ccc(S(N)(=O)=O)cc1",
            "b. C[C@@H](S)C(=O)NCC(=O)O",
            "c. CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1",
            "d. OC1C=Cc2ccc3cc4c(ccc5ccccc54)cc3c2C1O"
        ],
        "answer": "d",
        "answer_smiles": "OC1C=Cc2ccc3cc4c(ccc5ccccc54)cc3c2C1O",
        "domain": "Ames",
        "id": 7
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. O=[N+]([O-])c1ccc(Cl)c(Cl)c1Cl",
            "b. O=C/C=C\\c1ccco1",
            "c. Cc1ccsc1",
            "d. CCCCCC(=O)O"
        ],
        "answer": "a",
        "answer_smiles": "O=[N+]([O-])c1ccc(Cl)c(Cl)c1Cl",
        "domain": "Ames",
        "id": 8
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. CC(/C=C(\\C#N)c1ccc(Cl)c(Cl)c1)C(c1ccccc1)C(C#N)c1ccc(Cl)c(Cl)c1",
            "b. O=C1CCCCCN1",
            "c. CC(C)(C)c1cc(-c2ccccc2)ccc1[N+](=O)[O-]",
            "d. CCCCOCCOC(=O)COc1ccc(Cl)cc1Cl"
        ],
        "answer": "a",
        "answer_smiles": "CC(/C=C(\\C#N)c1ccc(Cl)c(Cl)c1)C(c1ccccc1)C(C#N)c1ccc(Cl)c(Cl)c1",
        "domain": "Ames",
        "id": 9
    },
    {
        "question": "Which of the following four compounds is most likely to test positive in the Ames mutagenesis assay (Colonies >=2 fold) based on the public experimental data?",
        "options": [
            "a. O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1",
            "b. CC(C)[N+](=O)[O-]",
            "c. O=CC(O)C(O)C(O)C(O)CO",
            "d. c1ccc2c(c1)Cc1ccc3ccc4ccccc4c3c1-2"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)[N+](=O)[O-]",
        "domain": "Ames",
        "id": 10
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1",
            "b. COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)CC(C)O1",
            "c. CC(=O)OCCC(SC(C)=O)=C(C)N(C=O)Cc1cnc(C)nc1N",
            "d. CC(O)C1C(=O)N2C(C(=O)O)=C(SC3Cn4cnc[n+]4C3)C(C)C12"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)OCCC(SC(C)=O)=C(C)N(C=O)Cc1cnc(C)nc1N",
        "domain": "BBB",
        "id": 11
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. Cc1cc(O)[n+]([O-])c(C2CCCCC2)c1",
            "b. O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1ccc(O)cc1",
            "c. COc1cccnc1CCCCNc1ncc(Cc2ccc(C)nc2)c(=O)[nH]1",
            "d. CC(Oc1c(Cl)cccc1Cl)C1=NCCN1"
        ],
        "answer": "d",
        "answer_smiles": "CC(Oc1c(Cl)cccc1Cl)C1=NCCN1",
        "domain": "BBB",
        "id": 12
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. O=C(NCC1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1",
            "b. CN1C(=O)C2NC=NC2N(C)C1=O",
            "c. O=C(Cc1cccs1)NC1C(=O)N2C(C(=O)O)=C(C[n+]3ccccc3)CSC12",
            "d. Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C(=O)C2NC=NC2N(C)C1=O",
        "domain": "BBB",
        "id": 13
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. COC1OC2OC3(CN4CCCCC4)C(O)CC(C2C)C13",
            "b. N=c1nc(N2CCCCC2)cc(N)n1O",
            "c. CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1",
            "d. Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1"
        ],
        "answer": "a",
        "answer_smiles": "COC1OC2OC3(CN4CCCCC4)C(O)CC(C2C)C13",
        "domain": "BBB",
        "id": 14
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. CNC(=O)CC(N)C(=O)NC(C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O)c1ccc(O)cc1",
            "b. CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C",
            "c. Cc1ccc(OCC(C)NC(=O)C(=Cc2ccco2)c2ccccc2)cc1",
            "d. CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C",
        "domain": "BBB",
        "id": 15
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I",
            "b. CON=C(C(=O)NC1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CSC12)c1ccco1",
            "c. CC(N)(Cc1ccc(O)c(O)c1)C(=O)O",
            "d. CSC(=O)C1(O)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C"
        ],
        "answer": "d",
        "answer_smiles": "CSC(=O)C1(O)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C",
        "domain": "BBB",
        "id": 16
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. COC1C(OC(N)=O)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C",
            "b. Cn1c(=O)c2c(ncn2C)n(C)c1=O",
            "c. CC1(C)SC2C(NC(=O)C(NC(=O)CNC(=N)c3ccncc3)c3ccccc3)C(=O)N2C1C(=O)O",
            "d. O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl"
        ],
        "answer": "b",
        "answer_smiles": "Cn1c(=O)c2c(ncn2C)n(C)c1=O",
        "domain": "BBB",
        "id": 17
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. Nc1nc(F)nc2c1ncn2C1OC(COP(=O)(O)O)C(O)C1O",
            "b. COc1ccc(C2C(C#N)C2S(=O)(=O)c2ccc(Cl)cc2)cc1",
            "c. CC[N+](C)(C)c1cccc(O)c1",
            "d. NC(=O)N1c2ccccc2C2CC2c2ccccc21"
        ],
        "answer": "d",
        "answer_smiles": "NC(=O)N1c2ccccc2C2CC2c2ccccc21",
        "domain": "BBB",
        "id": 18
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. OCC(O)C1OC2OC(C(Cl)(Cl)Cl)OC2C1O",
            "b. c1ccc(NC2=NCCN2)cc1",
            "c. O=C(O)C1=C(CSc2nnnn2CS(=O)(=O)O)CSC2C(NC(=O)C(O)c3ccccc3)C(=O)N12",
            "d. CC(C)CC1NC(=O)C(CCCN)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(Cc2ccccc2)NC(=O)C(CC(C)C)NC(=O)C(CCCN)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(Cc2ccccc2)NC1=O"
        ],
        "answer": "a",
        "answer_smiles": "OCC(O)C1OC2OC(C(Cl)(Cl)Cl)OC2C1O",
        "domain": "BBB",
        "id": 19
    },
    {
        "question": "Which of the following four compounds is most likely to cross the blood-brain barrier (BBB) (lgBBB>=-1) based on the public experimental data?",
        "options": [
            "a. CC1(C)SC2C(N=CN3CCCCCC3)C(=O)N2C1C(=O)O",
            "b. CC(C)CCO",
            "c. O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O",
            "d. Cc1cn(C2OC(CO)C(O)C2F)c(=O)[nH]c1=O"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)CCO",
        "domain": "BBB",
        "id": 20
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ccccc1NC(=O)Nc1ccc(CCN2CCc3ccccc3C2)cc1",
            "b. NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O",
            "c. COc1cc(C(=O)NN=Cc2ccc(OC)c(CN3CCN(c4ccc(F)cc4)CC3)c2)ccc1O",
            "d. COc1cc(C(F)(F)F)cc2nc3ccccc3c(O)c12"
        ],
        "answer": "d",
        "answer_smiles": "COc1cc(C(F)(F)F)cc2nc3ccccc3c(O)c12",
        "domain": "BCRPi",
        "id": 21
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)CCC=C1c2ccccc2CCc2ccccc21",
            "b. CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccc(OCc2ccccc2)cc1",
            "c. O=C(NN=C1CCCc2c1[nH]c1ccc([N+](=O)[O-])cc21)c1ccncc1",
            "d. Cc1cc(C)n(-c2ccc(Cl)c(C(=O)Nc3cc(C(F)(F)F)ccc3Cl)n2)n1"
        ],
        "answer": "b",
        "answer_smiles": "CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccc(OCc2ccccc2)cc1",
        "domain": "BCRPi",
        "id": 22
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(NC(=O)CCl)c1ccc(C)cc1",
            "b. CC(C)C(N)C(=O)OCC(CO)OCn1cnc2c(O)nc(N)nc21",
            "c. COc1ccc(COc2ccccc2CCc2ccccc2)cc1OC",
            "d. COCCOCCOCCOc1cc2c(cc1OC)CCN(CCc1ccc(NC(=O)c3ccc(C(=O)O)c(NC(=O)c4ccc5ccccc5n4)c3)cc1)C2"
        ],
        "answer": "d",
        "answer_smiles": "COCCOCCOCCOc1cc2c(cc1OC)CCN(CCc1ccc(NC(=O)c3ccc(C(=O)O)c(NC(=O)c4ccc5ccccc5n4)c3)cc1)C2",
        "domain": "BCRPi",
        "id": 23
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COCCc1ccc(OCC(O)CNC(C)C)cc1",
            "b. COc1c(OC)c2c(=O)cc(C)oc2c2c(OC)cc(O)cc12",
            "c. CC(=O)N1CCN(c2cc(-c3ccccc3)nc3cc(-c4ccccc4)nn23)CC1",
            "d. COc1ccc(OCC(=O)Nc2ccccc2C(=O)N2CCOCC2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)N1CCN(c2cc(-c3ccccc3)nc3cc(-c4ccccc4)nn23)CC1",
        "domain": "BCRPi",
        "id": 24
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. N#CC(=Cc1ccc(N2CCCCC2)o1)C(=O)Nc1ccc(Cl)cc1",
            "b. COc1ccc(S(=O)(=O)c2cnc3ccc(OC)cc3c2N2CCC3(CC2)OCCO3)cc1",
            "c. COc1ccc(C(=O)C=Cc2ccccc2)c(O)c1",
            "d. O=C(Nc1ccc(CCN2CCc3ccccc3C2)cc1)c1ccc([N+](=O)[O-])cc1"
        ],
        "answer": "d",
        "answer_smiles": "O=C(Nc1ccc(CCN2CCc3ccccc3C2)cc1)c1ccc([N+](=O)[O-])cc1",
        "domain": "BCRPi",
        "id": 25
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1",
            "b. CC1OC(OC2C(Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)OC(CO)C(O)C2O)C(O)C(O)C1O",
            "c. c1ccc(OCc2nc(-c3ccncc3)no2)cc1",
            "d. O=C(c1ccoc1)N1CCN(c2cc(-c3ccco3)nc3cc(-c4cccc(-c5ccco5)c4)nn23)CC1"
        ],
        "answer": "d",
        "answer_smiles": "O=C(c1ccoc1)N1CCN(c2cc(-c3ccco3)nc3cc(-c4cccc(-c5ccco5)c4)nn23)CC1",
        "domain": "BCRPi",
        "id": 26
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(C(=O)Nc2ccc(CCN3CCc4cc(OC)c(OC)cc4C3)cc2)cc1OC",
            "b. CCOc1ccc(N2C(=O)C3ON(c4ccccc4)C(c4cccs4)C3C2=O)cc1",
            "c. CCCCN1C(=O)C(=CC=C2Oc3ccccc3N2CC)SC1=S",
            "d. COc1cc2c(=O)n(CCN(C)CC#N)c3c4cc5c(cc4ncc3c2cc1OC)OCO5"
        ],
        "answer": "d",
        "answer_smiles": "COc1cc2c(=O)n(CCN(C)CC#N)c3c4cc5c(cc4ncc3c2cc1OC)OCO5",
        "domain": "BCRPi",
        "id": 27
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COCCc1ccc(OCC(O)CNC(C)C)cc1",
            "b. COc1c(OC)c2c(=O)cc(C)oc2c2c(OC)cc(O)cc12",
            "c. COc1ccc(C2CC(=O)c3c(O)cc(O)c(CC=C(C)C)c3O2)cc1O",
            "d. COc1ccc(OCC(=O)Nc2ccccc2C(=O)N2CCOCC2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc(C2CC(=O)c3c(O)cc(O)c(CC=C(C)C)c3O2)cc1O",
        "domain": "BCRPi",
        "id": 28
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3ccc(N)cc3)cc1)CC2",
            "b. COC(=Cc1ccc(O)cc1)C(=O)NCC(O)c1ccc(O)cc1",
            "c. CC1NC(=O)C2Cc3c([nH]c4ccccc34)C(C(C)C)N2C1=O",
            "d. COc1cc2c(=O)n(CCN(CC(F)(F)F)C(C)C)c3c4cc5c(cc4ncc3c2cc1OC)OCO5"
        ],
        "answer": "d",
        "answer_smiles": "COc1cc2c(=O)n(CCN(CC(F)(F)F)C(C)C)c3c4cc5c(cc4ncc3c2cc1OC)OCO5",
        "domain": "BCRPi",
        "id": 29
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the breast cancer resistance protein (BCRP) transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O",
            "b. NCCc1c[nH]cn1",
            "c. CC(N=C(NC#N)Nc1ccncc1)C(C)(C)C",
            "d. COc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1O"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1O",
        "domain": "BCRPi",
        "id": 30
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN(CC)CCOC(=O)c1ccc(N)cc1",
            "b. O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1",
            "c. NNc1nnc(NN)c2ccccc12",
            "d. CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1",
        "domain": "BSEPi",
        "id": 31
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1",
            "b. O=C(O)c1ccc(OCCn2ccnc2)cc1",
            "c. C1CCc2nnnn2CC1",
            "d. O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1",
        "domain": "BSEPi",
        "id": 32
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O",
            "b. CNC(=O)Oc1ccc2c(c1)C1(C)CCN(C)C1N2C",
            "c. O=CN(O)C(CCCc1ncccn1)CS(=O)(=O)N1CCN(c2ccc(Cl)cn2)CC1",
            "d. O=C1c2ccccc2CN2C(=O)c3ccccc3CN12"
        ],
        "answer": "c",
        "answer_smiles": "O=CN(O)C(CCCc1ncccn1)CS(=O)(=O)N1CCN(c2ccc(Cl)cn2)CC1",
        "domain": "BSEPi",
        "id": 33
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)C(=O)CN1CC2CN(CCCNc3ccc(C#N)cc3)CC(C1)O2",
            "b. Cn1cnc([N+](=O)[O-])c1Sc1[nH]cnc2ncnc1-2",
            "c. Cc1cc(=O)n(-c2ccccc2)n1C",
            "d. COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C",
        "domain": "BSEPi",
        "id": 34
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1CN(N=Cc2ccc([N+](=O)[O-])o2)C(=O)N1",
            "b. CS(=O)(=O)OCCCCOS(C)(=O)=O",
            "c. OCC(O)C(O)C(OC1OC(CO)C(O)C(O)C1O)C(O)CO",
            "d. CNCCCN1c2ccccc2CCc2ccccc21"
        ],
        "answer": "d",
        "answer_smiles": "CNCCCN1c2ccccc2CCc2ccccc21",
        "domain": "BSEPi",
        "id": 35
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(NC(=O)c2cccc3c2oc2ccccc23)cc1NC(=O)c1cccc(CN2CCN(C)CC2)c1",
            "b. CC(O)C1C(=O)N2C(C(=O)O)=C(SCCN=CN)CC12",
            "c. CN1CCC(OC(c2ccccc2)c2ccccc2)CC1",
            "d. CN(C)C(=O)Oc1ccc[n+](C)c1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccc(NC(=O)c2cccc3c2oc2ccccc23)cc1NC(=O)c1cccc(CN2CCN(C)CC2)c1",
        "domain": "BSEPi",
        "id": 36
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(CO)C(O)C(=O)NCCC(=O)O",
            "b. Cn1ccnc1S",
            "c. Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O",
            "d. Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1",
        "domain": "BSEPi",
        "id": 37
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2C1OC(COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)C(O)C1O",
            "b. CC(C)(CO)C(O)C(=O)NCCCO",
            "c. O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12",
            "d. CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2"
        ],
        "answer": "c",
        "answer_smiles": "O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12",
        "domain": "BSEPi",
        "id": 38
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1",
            "b. CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1",
            "c. COc1ccccc1O",
            "d. CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(O)=C3C(=O)c4c(O)cccc4C(C)(O)C3CC12"
        ],
        "answer": "a",
        "answer_smiles": "O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1",
        "domain": "BSEPi",
        "id": 39
    },
    {
        "question": "Which of the following four compounds is most likely to act as a BSEP (bile salt export pump) inhibitor (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(O)c1ccccc1S",
            "b. Cc1n[nH]c(C)c1Cc1sc2c(c1C(=O)N1CC(O)CO1)c(=O)n(C)c(=O)n2C(C)C",
            "c. Cc1ccc2c(c1)c(-c1ccnc3c(C(F)(F)F)cccc13)c(C)n2CC(=O)O",
            "d. CN=C(N)NC(=O)Nc1c(C)cccc1C"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc2c(c1)c(-c1ccnc3c(C(F)(F)F)cccc13)c(C)n2CC(=O)O",
        "domain": "BSEPi",
        "id": 40
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(c1nc2ccc(N3CCCC(C(=O)N4CCCC4)C3)nc2[nH]1)n1cc(Cl)cn1",
            "b. CCc1c(C)nn2c(N)c(C#N)c(NCCc3ccn(C4(CO)CC4)n3)nc12",
            "c. Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cn1",
            "d. CCCCC(CCO)Nc1nc(N)ncc1OC"
        ],
        "answer": "d",
        "answer_smiles": "CCCCC(CCO)Nc1nc(N)ncc1OC",
        "domain": "CLhepa_dog",
        "id": 41
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1ncc(C(=O)NC2C3CC4CC2CC(O)(C4)C3)c(C2CCCC2)n1",
            "b. CC(C(=O)Nc1ccc(F)cc1)C12CC(NC(=O)c3ccc(F)c(F)c3)(C1)C2",
            "c. COCc1ccc(-c2ccc3ncc(C(N)=O)c(NC(C)C4CCOCC4)c3c2)cn1",
            "d. COc1cc(Nc2nn(C3COCCC3C#N)cc2C(N)=O)ccc1Cl"
        ],
        "answer": "b",
        "answer_smiles": "CC(C(=O)Nc1ccc(F)cc1)C12CC(NC(=O)c3ccc(F)c(F)c3)(C1)C2",
        "domain": "CLhepa_dog",
        "id": 42
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cccnc1-n1ccc(-c2ccc(F)cc2)n1",
            "b. COc1nnc2ccc(N3CCC(c4ccc(OCCN5C(C)CN(C(C)=O)CC5C)cc4)CC3)nn12",
            "c. NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2C1CCOCC1",
            "d. CCOC(=O)C(C)(C)NP(=O)(OCC1OC(n2ccc(=O)[nH]c2=O)C(F)(Br)C1O)Oc1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "CCOC(=O)C(C)(C)NP(=O)(OCC1OC(n2ccc(=O)[nH]c2=O)C(F)(Br)C1O)Oc1ccccc1",
        "domain": "CLhepa_dog",
        "id": 43
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(C(C)c3ccccn3)c12",
            "b. Cc1nn(C2CCN(C(=O)C(C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1",
            "c. CC(C)(O)Cn1ncc(Nc2ncc3cc(Cl)c(C4CCN(C5COC5)CC4)cc3n2)c1Cl",
            "d. Cc1nc(C)n(CC(=O)N2CCN(c3sc(C(F)(F)F)nc3-c3cnc(OC(C)C)nc3)CC2C)n1"
        ],
        "answer": "c",
        "answer_smiles": "CC(C)(O)Cn1ncc(Nc2ncc3cc(Cl)c(C4CCN(C5COC5)CC4)cc3n2)c1Cl",
        "domain": "CLhepa_dog",
        "id": 44
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCn1c(C(C)NS(=O)(=O)c2ccc(C#N)nc2)nc2cnc(C(F)(F)F)cc21",
            "b. COc1ccccc1N1CCN(CCn2cnc3ccccc3c2=O)CC1",
            "c. Cc1ccc(NC(=O)C2(c3ccccc3C(C)C)CN(CCC(C)(C)C(=O)O)C2)c(OC(F)F)n1",
            "d. CC(C)(C)NCC(O)c1cccc(C(F)(F)F)n1"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccccc1N1CCN(CCn2cnc3ccccc3c2=O)CC1",
        "domain": "CLhepa_dog",
        "id": 45
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#Cc1cnc(Nc2cc(NCC3CNCCO3)c(C(F)(F)F)cn2)cn1",
            "b. Cc1cc(COc2nc(N)nc3ccn(Cc4ccccn4)c23)no1",
            "c. CC(C)c1nc(N2CCN(c3ncc(OCc4ccncc4C#N)cn3)C(C)C2)no1",
            "d. N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4cc5c(cn4)OCCO5)CC3)c2c1"
        ],
        "answer": "a",
        "answer_smiles": "N#Cc1cnc(Nc2cc(NCC3CNCCO3)c(C(F)(F)F)cn2)cn1",
        "domain": "CLhepa_dog",
        "id": 46
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C",
            "b. Cc1cccc(C)c1CNc1cc(C(=O)N2CCC2)cn2c(C)c(C)nc12",
            "c. Cc1nnc(-c2ccc(-c3c(F)c(F)cc4c3C(=O)N(C(C3CC3)C(C)(C)O)C4)cc2)o1",
            "d. CC1Cc2c(ccc3[nH]ncc23)C(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(C)F"
        ],
        "answer": "d",
        "answer_smiles": "CC1Cc2c(ccc3[nH]ncc23)C(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(C)F",
        "domain": "CLhepa_dog",
        "id": 47
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1",
            "b. NCc1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F",
            "c. COc1cc(C(F)(F)F)ccc1CCNCc1ccccc1O",
            "d. CC(=O)N1CCN(C2CCC(Nc3ncnn4ccc(C(C)C)c34)CC2)CC1"
        ],
        "answer": "c",
        "answer_smiles": "COc1cc(C(F)(F)F)ccc1CCNCc1ccccc1O",
        "domain": "CLhepa_dog",
        "id": 48
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1cc(C)c(-c2cn(C)cn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1",
            "b. CCCSc1nc(N2CCOCC2)ccc1C(=O)NC1C2CC3CC1CC(O)(C3)C2",
            "c. CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1",
            "d. OCC1OC(c2cc(Cc3ccc(C4CC4)cc3)c(Cl)c3c2CCO3)C(O)C(O)C1O"
        ],
        "answer": "b",
        "answer_smiles": "CCCSc1nc(N2CCOCC2)ccc1C(=O)NC1C2CC3CC1CC(O)(C3)C2",
        "domain": "CLhepa_dog",
        "id": 49
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a dog hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(C=CC(=O)O)ccc1C1c2ccc3[nH]ncc3c2CC(C)N1CC(C)(F)F",
            "b. O=c1ccc2ccc(O)cc2o1",
            "c. N#Cc1ccc2ccc(=O)n(CCN3CCC(NCc4ccc5c(n4)NC(=O)CO5)C(F)C3)c2c1",
            "d. CCCSc1nc(C)ncc1C(=O)NC1C2CC3CC1CC(O)(C3)C2"
        ],
        "answer": "b",
        "answer_smiles": "O=c1ccc2ccc(O)cc2o1",
        "domain": "CLhepa_dog",
        "id": 50
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCNC(=NS(=O)(=O)c1ccc(N)cc1)N1CC(CC)C=N1",
            "b. CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3c(CO)ccnc32)CC1",
            "c. Cc1ccc2c(c1)c(-c1ccnc3cc(Cl)ccc13)c(C)n2CC(=O)O",
            "d. C=C(Cc1nc(-c2ccc(Oc3cnc(C(F)(F)F)cn3)cc2)no1)C(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3c(CO)ccnc32)CC1",
        "domain": "CLhepa_human",
        "id": 51
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(C)CCc2c(C(C(=O)Nc3nccs3)N3Cc4c(cc(C#Cc5ccc(CN6CCC(CO)CC6)cc5)cc4C(F)F)C3=O)ncn21",
            "b. CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(Cl)nc(N)nc21",
            "c. C=CC(=O)N1CCN(c2nc(=O)n(-c3ccccc3C(C)C)c3cc(-c4ccccc4Cl)c(Cl)cc23)C(C)C1",
            "d. CC(CO)Nc1nc(SCc2cccc(Cl)c2F)nc2[nH]c(=O)sc12"
        ],
        "answer": "c",
        "answer_smiles": "C=CC(=O)N1CCN(c2nc(=O)n(-c3ccccc3C(C)C)c3cc(-c4ccccc4Cl)c(Cl)cc23)C(C)C1",
        "domain": "CLhepa_human",
        "id": 52
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(Oc1cc2cc(F)cc(F)c2nc1N)c1[nH]c(=O)ccc1-n1cccn1",
            "b. COc1ccc2c(c1)OC(c1ccc(OC)c(OC)c1)CC2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1",
            "c. Cc1cc(-c2ccc(C(=O)C3CCCCC3C(=O)Nc3cn(C)nc3C(N)=O)cc2)n[nH]1",
            "d. OCC1OC(Sc2cncc(Br)c2)C(O)C(n2cc(-c3cc(F)c(F)c(F)c3)nn2)C1O"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc2c(c1)OC(c1ccc(OC)c(OC)c1)CC2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1",
        "domain": "CLhepa_human",
        "id": 53
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(=O)N1C=Cc2nc(N3CCC(Oc4ccc(F)cc4F)CC3)c(NC(C)C)nc2C1",
            "b. COc1ccc2c(c1)CCn1c-2cc(OCC2COc3cccnc3O2)nc1=O",
            "c. c1cncc(Nc2ncnc3ccc(-c4cccc(N5CCOCC5)c4)cc23)c1",
            "d. COCCc1ccc(OCC(O)CNC(C)C)cc1"
        ],
        "answer": "c",
        "answer_smiles": "c1cncc(Nc2ncnc3ccc(-c4cccc(N5CCOCC5)c4)cc23)c1",
        "domain": "CLhepa_human",
        "id": 54
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(-c2cc3c(C(=O)O)c[nH]c3cc2Cl)cn1",
            "b. C=C(CC(=O)OC1(c2cc(Cl)ccc2Cl)CCC1)C(=O)OCC(=O)O",
            "c. CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O",
            "d. CCOc1ccc2ccc(=O)oc2c1"
        ],
        "answer": "c",
        "answer_smiles": "CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O",
        "domain": "CLhepa_human",
        "id": 55
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)Cn1c(=O)n(C)c(=O)c2c(SC(C)C)c(Cc3ccccc3C(F)(F)F)sc21",
            "b. Cc1ccc(C(=O)c2cn(CCCCCCl)c3ccccc23)c2ccccc12",
            "c. CCC(O)c1nc2cnc3[nH]ccc3c2n1C1CCCCC1",
            "d. NC(=O)CC1COc2cc(Cl)ccc2N1C(=O)c1ccc2c(c1)NC(=O)CO2"
        ],
        "answer": "b",
        "answer_smiles": "Cc1ccc(C(=O)c2cn(CCCCCCl)c3ccccc23)c2ccccc12",
        "domain": "CLhepa_human",
        "id": 56
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1ccc2c(c1)OCC(C)(CS(C)(=O)=O)N2C(=O)c1ccc2c(c1)NC(=O)CO2",
            "b. COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1",
            "c. CCS(=O)(=O)c1ccc(C(NC(C)=O)C(=O)Nc2cc(-c3cc(C#N)cc(F)c3OC)cs2)cc1",
            "d. COc1cc(-c2cn(C)c(=O)c(C)c2C)cc(OC)c1CN1CCC(N2CCN(c3ccc(NC4CCC(=O)NC4=O)cc3F)CC2)C(F)(F)C1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccc2c(c1)OCC(C)(CS(C)(=O)=O)N2C(=O)c1ccc2c(c1)NC(=O)CO2",
        "domain": "CLhepa_human",
        "id": 57
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#Cc1ccc(C2C3=C(CCC3=O)N(c3cccc(C(F)(F)F)c3)C(=O)N2C(=O)NCCCO)cc1",
            "b. CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1",
            "c. C=C(CC(=O)OC1(c2ccc(C#CC(F)(F)F)cc2)CCC1)C(=O)O",
            "d. CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO"
        ],
        "answer": "b",
        "answer_smiles": "CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1",
        "domain": "CLhepa_human",
        "id": 58
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)(C)S(=O)(=O)NC1CCC(C(=O)Nc2ccc(C(F)(F)F)cn2)CC1",
            "b. O=c1nc(Nc2ncnc3ccc(-c4cccc(N5CCOCC5)c4)cc23)c(F)c[nH]1",
            "c. Cn1c(=O)c2c(ncn2C)n(C)c1=O",
            "d. COc1cccc2c1c(NS(=O)(=O)c1ccc(Cl)s1)nn2Cc1cccc(CNC(=O)C(C)(C)O)c1"
        ],
        "answer": "b",
        "answer_smiles": "O=c1nc(Nc2ncnc3ccc(-c4cccc(N5CCOCC5)c4)cc23)c(F)c[nH]1",
        "domain": "CLhepa_human",
        "id": 59
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(Oc2ccc3[nH]nc(-c4cc(N5CCOCC5)ncn4)c3c2)CC1",
            "b. CC(C)NCC(O)COc1cccc2ccccc12",
            "c. CCNC(=NS(=O)(=O)c1c(C)nn(C)c1Cl)N1CC(CC)C=N1",
            "d. Cc1cc(C(C)Nc2ccccc2-c2nnn[nH]2)c2nc(N3CCOCC3)cc(=O)n2c1"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)NCC(O)COc1cccc2ccccc12",
        "domain": "CLhepa_human",
        "id": 60
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(Nc1ccn(-c2ccnc(F)c2)n1)C1(c2ccccc2F)CC1",
            "b. CCC(=O)c1csc(C(=O)c2c[nH]c3c(F)cccc23)n1",
            "c. C=C(CC(=O)OC1(c2ccc(Br)cn2)CCC1)C(=O)O",
            "d. CC(C)CC=C(CC(=O)NC(C)c1ccc(C(F)(F)F)cc1)C(=O)O"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)CC=C(CC(=O)NC(C)c1ccc(C(F)(F)F)cc1)C(=O)O",
        "domain": "CLhepa_mice",
        "id": 61
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCCC(C)COc1ccc(C(NC(=O)C(C)(O)c2ccccc2)C(C)(C)O)cc1",
            "b. NC1c2ccccc2OC12CCN(c1cnc3c(N4CCCc5ncccc54)n[nH]c3n1)CC2",
            "c. Cc1[nH]c(C(=O)Nc2nc3c(N4CCOCC4)cc(C(=O)O)cc3s2)c(Cl)c1Cl",
            "d. CC(=O)N1CCC2C1CCN2C1CCCC(NC(=O)c2cc3c(F)ccc(C)c3[nH]2)C1"
        ],
        "answer": "a",
        "answer_smiles": "CCCC(C)COc1ccc(C(NC(=O)C(C)(O)c2ccccc2)C(C)(C)O)cc1",
        "domain": "CLhepa_mice",
        "id": 62
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)NCC(C(=O)N1CCN(c2ncnc3c2C(C)SC3)CC1)c1ccc(Cl)cc1",
            "b. O=C(O)Cc1nn(Cc2cn3cc(OCC4CC4)c(Cl)cc3n2)c2ccccc2c1=O",
            "c. CCOc1ccc(NC(=S)N(CCO)Cc2cc3cc(C)cc(C)c3[nH]c2=O)cc1",
            "d. CNC1CCN(c2ccc(C(=O)Nc3cc(F)c4nc(C)cn4c3)c(F)c2)C1"
        ],
        "answer": "c",
        "answer_smiles": "CCOc1ccc(NC(=S)N(CCO)Cc2cc3cc(C)cc(C)c3[nH]c2=O)cc1",
        "domain": "CLhepa_mice",
        "id": 63
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(N2C(=O)N(c3c(C)csc3Cl)Cc3cnc(Nc4ccc(C5CCN(C)CC5)cc4OC)nc32)nc1",
            "b. Cn1nccc1CNc1nc(N)nc2nc(-c3cc[nH]n3)ccc12",
            "c. O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(cc(C#Cc3ccc(CN4CCC(CO)CC4)cc3)cc2C(F)F)C1=O",
            "d. Cc1noc(-c2csc(C(=O)c3c[nH]c4ccccc34)n2)n1"
        ],
        "answer": "c",
        "answer_smiles": "O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(cc(C#Cc3ccc(CN4CCC(CO)CC4)cc3)cc2C(F)F)C1=O",
        "domain": "CLhepa_mice",
        "id": 64
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCCC(C)COc1ccc(C(NC(=O)C(CC#N)c2ccccc2)C(C)(C)O)cc1",
            "b. CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(NCC4CC4)nc3n(C)c2=O)c1F",
            "c. O=c1cc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12",
            "d. CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1"
        ],
        "answer": "a",
        "answer_smiles": "CCCC(C)COc1ccc(C(NC(=O)C(CC#N)c2ccccc2)C(C)(C)O)cc1",
        "domain": "CLhepa_mice",
        "id": 65
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(C(=O)NC(=N)Nc2ccc(C)c(NC(=O)c3ccc(CCc4ccccc4)cc3)c2)cc(OC)c1OC",
            "b. Oc1n[nH]c2cc(Cl)ccc12",
            "c. Nc1nnc(-c2csc(C(=O)c3c[nH]c4ccccc34)n2)s1",
            "d. OCC1OC(Sc2cncc(Br)c2)C(O)C(n2cc(-c3cc(F)c(F)c(F)c3)nn2)C1O"
        ],
        "answer": "a",
        "answer_smiles": "COc1cc(C(=O)NC(=N)Nc2ccc(C)c(NC(=O)c3ccc(CCc4ccccc4)cc3)c2)cc(OC)c1OC",
        "domain": "CLhepa_mice",
        "id": 66
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=C(Cc1nc(-c2ccc(Oc3nccn3C)cc2)no1)C(=O)O",
            "b. C=C(CC(=O)OC1(c2ccc(C(F)(F)C(F)(F)F)cc2)CCC1)C(=O)O",
            "c. C=C(CC(=O)OC1(c2ccc(C)c(Cl)c2)CCC1)C(=O)OCC(=O)O",
            "d. CC(C)n1nc(-c2cnc(N)nc2-c2ccccc2)ccc1=O"
        ],
        "answer": "c",
        "answer_smiles": "C=C(CC(=O)OC1(c2ccc(C)c(Cl)c2)CCC1)C(=O)OCC(=O)O",
        "domain": "CLhepa_mice",
        "id": 67
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(NC1(C23CC(C(=O)O)(C2)C3)CC1)c1cccc2ccn(Cc3ccc(C(F)(F)F)cc3)c12",
            "b. C=C(Cc1nc(-c2c(F)cc(Oc3ncccc3F)cc2F)no1)C(=O)O",
            "c. CC(C(=O)O)n1nc(Cn2cc3cc(OCC4CC4)c(Cl)cc3n2)c2ccccc2c1=O",
            "d. COC(=O)c1csc(C(=O)c2c[nH]c3ccc(Cl)cc23)n1"
        ],
        "answer": "b",
        "answer_smiles": "C=C(Cc1nc(-c2c(F)cc(Oc3ncccc3F)cc2F)no1)C(=O)O",
        "domain": "CLhepa_mice",
        "id": 68
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN1CCCC(Nc2nnc(-c3ccc(C(F)(F)F)cc3O)n3ccnc23)C1",
            "b. CC(C)(c1ccc(OCc2ccnc(C#N)n2)cc1)c1cc(Cl)c(OCCCl)c(C#N)c1",
            "c. C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC(N(C)C)C1",
            "d. CC1(c2c[nH]c(=O)c(=O)[nH]2)COc2cc(Cl)ccc2S1"
        ],
        "answer": "c",
        "answer_smiles": "C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC(N(C)C)C1",
        "domain": "CLhepa_mice",
        "id": 69
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COCc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccccn3)cc2)cc1",
            "b. C=C(CC(=O)NC(C)c1ccc(S(F)(F)(F)(F)F)cc1)C(=O)O",
            "c. O=C(O)C1CCN(c2ccc3c(=O)c4c(Cl)ccc(Cl)c4oc3c2)C1",
            "d. Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2"
        ],
        "answer": "a",
        "answer_smiles": "COCc1ccc(-c2ccc(NC(=O)C(C)(C)Oc3ccccn3)cc2)cc1",
        "domain": "CLhepa_mice",
        "id": 70
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F",
            "b. CC1Cc2c([nH]c3ccccc23)C(c2c(F)cc(NC3CN(CCCF)C3)cc2F)N1CC(F)(F)CO",
            "c. CC1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12",
            "d. C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)c(F)c3)c3c(N)ncnc3n2C)cc1"
        ],
        "answer": "c",
        "answer_smiles": "CC1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12",
        "domain": "CLhepa_monkey",
        "id": 71
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1",
            "b. CC(O)c1nc2cnc3[nH]ccc3c2n1C1CCC(NCC(F)(F)F)CC1",
            "c. CC1OC(=O)C2(N)CC(F)(F)C(C)C(C=Cc3ccc(-c4ccccc4C#N)cn3)C12",
            "d. CNS(=O)(=O)Nc1cccc(Cc2c(CN(C)C)c3cc(F)c(OC(=O)N(C)C)cc3oc2=O)c1F"
        ],
        "answer": "a",
        "answer_smiles": "CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1",
        "domain": "CLhepa_monkey",
        "id": 72
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1CC(CN2CCC(N3CCOCC3)CC2)CN(c2ccc(C#N)c3nccnc23)C1",
            "b. CN(C)Cc1c(Cc2cccc(N[S+]([O-])C(C)(C)C)c2F)c(=O)oc2cc(OC(=O)N(C)C)ccc12",
            "c. COCCOCCOCCOc1ccc(CC(NC(=O)OC2COC3OCCC23)C(O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)cc1",
            "d. COc1cc(C(=O)N2CCOCC2)c(F)cc1Nc1ncc(C(F)(F)F)c(NC2CC2)n1"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)Cc1c(Cc2cccc(N[S+]([O-])C(C)(C)C)c2F)c(=O)oc2cc(OC(=O)N(C)C)ccc12",
        "domain": "CLhepa_monkey",
        "id": 73
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1cccc(-c2ccc(C=CC3C(C)C(F)(F)CC4(O)C(=O)OC(C)C34)nc2)c1C#N",
            "b. CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1",
            "c. CCOc1ccc2ccc(=O)oc2c1",
            "d. O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1"
        ],
        "answer": "c",
        "answer_smiles": "CCOc1ccc2ccc(=O)oc2c1",
        "domain": "CLhepa_monkey",
        "id": 74
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CNS(=O)(=O)Nc1cccc(Cc2c(CN3CCNCC3)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1Cl",
            "b. CCS(=O)(=O)N1CC(Oc2cncc(N3C(=O)c4ccc(Cl)cc4C3(C)C)c2)C1",
            "c. c1ccc(-c2nnc(OC3C4CC5CC3CN(C5)C4)s2)cc1",
            "d. NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cccnc1-n1ccc(-c2ccc(F)cc2)n1"
        ],
        "answer": "d",
        "answer_smiles": "NC(=O)C(=O)C(Cc1ccccc1)NC(=O)c1cccnc1-n1ccc(-c2ccc(F)cc2)n1",
        "domain": "CLhepa_monkey",
        "id": 75
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(-c2ccc3c(n2)C(C)N(c2cnn(CC(F)(F)F)c2)C3=O)cnc1OC",
            "b. CC(O)c1nc2cnc3[nH]ccc3c2n1C1CCCOC1",
            "c. COC(=O)Nc1cc(C(F)(F)F)c(-c2nc(N3CCOCC3)c3cc(CN4CCN(S(C)(=O)=O)CC4)cn3n2)cn1",
            "d. Clc1ccc2c(c1)CC1(Cc3nnc(C4CCC(Oc5ccccn5)CC4)n3-2)OCCO1"
        ],
        "answer": "d",
        "answer_smiles": "Clc1ccc2c(c1)CC1(Cc3nnc(C4CCC(Oc5ccccn5)CC4)n3-2)OCCO1",
        "domain": "CLhepa_monkey",
        "id": 76
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN(C(=O)c1cc2c(cn1)nc(N)c1cncn12)C1COc2cc(C(F)(F)F)ccc21",
            "b. Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1",
            "c. Cc1cc(C(=O)O)nc(N2CC3CC(c4ccccc4C(F)(F)F)CC3C2)n1",
            "d. CN1C(=O)C(CCCCN)NC(=O)C(CCCN)NCc2cccnc2Sc2cccc(-c3ccc(C(=O)O)cc3)c2CNC(=O)C1Cc1c[nH]c2ccccc12"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1",
        "domain": "CLhepa_monkey",
        "id": 77
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F",
            "b. CC1Cc2c([nH]c3ccccc23)C(c2c(F)cc(NC3CN(CCCF)C3)cc2F)N1CC(F)(F)CO",
            "c. CNS(=O)(=O)Nc1cccc(Cc2c(CN3CC(F)(F)C3)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1F",
            "d. CCC1(F)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5CC(CS(C)(=O)=O)C5C)c4cn3)n2)CCC1O"
        ],
        "answer": "d",
        "answer_smiles": "CCC1(F)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5CC(CS(C)(=O)=O)C5C)c4cn3)n2)CCC1O",
        "domain": "CLhepa_monkey",
        "id": 78
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CNS(=O)(=O)Nc1cccc(Cc2c(CN(C)C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1F",
            "b. CNS(=O)(=O)Nc1ccnc(Cc2c(CN(C)C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1F",
            "c. CN(C(=O)c1cc2c(cn1)nc(N)c1cncn12)C1CC(F)(F)c2cc(C(F)(F)F)ccc21",
            "d. CC(O)c1nc2cnc3[nH]ccc3c2n1C1CCC(CCC#N)CC1"
        ],
        "answer": "a",
        "answer_smiles": "CNS(=O)(=O)Nc1cccc(Cc2c(CN(C)C)c3ccc(OC(=O)N(C)C)cc3oc2=O)c1F",
        "domain": "CLhepa_monkey",
        "id": 79
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a monkey hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(Oc4nccc(C)n4)cc3)c3c(N)ncnc3n2C)cc1",
            "b. COC1C(O)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5CC(CS(C)(=O)=O)C5C)c4cn3)n2)CC1F",
            "c. CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1",
            "d. O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccc(F)cc1"
        ],
        "answer": "b",
        "answer_smiles": "COC1C(O)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5CC(CS(C)(=O)=O)C5C)c4cn3)n2)CC1F",
        "domain": "CLhepa_monkey",
        "id": 80
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23",
            "b. COc1cnc(C(=O)Nc2ccc(F)c(C3(C)CCC(F)(CF)C(N)=N3)c2)cn1",
            "c. O=c1[nH]c(=O)n(Cc2ccccc2)cc1-c1cc(F)cc(F)c1",
            "d. CCCSc1nc(N2CCC(CC(=O)O)CC2)ccc1C(=O)NC1CCCCC1"
        ],
        "answer": "c",
        "answer_smiles": "O=c1[nH]c(=O)n(Cc2ccccc2)cc1-c1cc(F)cc(F)c1",
        "domain": "CLhepa_rat",
        "id": 81
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN1CCN(Nc2ncc(-c3ccc4c(Nc5cnccn5)ccnc4c3)cn2)CC1",
            "b. COCC(C(=O)Nc1cccc2c(-c3nc(Nc4ccc5scnc5c4)ncc3F)c[nH]c12)N1CCN(C)CC1",
            "c. NC1CCCN(c2ccccc2C=C2SC(=O)NC2=O)C1",
            "d. CCCOc1ccc(CCC(N)(CO)CO)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CCCOc1ccc(CCC(N)(CO)CO)cc1",
        "domain": "CLhepa_rat",
        "id": 82
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN(C)C(=O)CNCCc1cccc(OCCCC(F)(F)F)c1",
            "b. Cc1nc(-c2cccc(C(F)(F)F)c2)sc1C(=O)NC1CN(S(=O)(=O)c2ccccc2)CC1C(=O)NC1CCCNC1",
            "c. CC(F)(F)C1CN(c2ccc3nccc(C(=O)NCC(=O)N4CSCC4C#N)c3c2)C1",
            "d. O=C(O)c1cccc(C(=O)O)c1"
        ],
        "answer": "a",
        "answer_smiles": "CN(C)C(=O)CNCCc1cccc(OCCCC(F)(F)F)c1",
        "domain": "CLhepa_rat",
        "id": 83
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#CC1CSCN1C(=O)CNC(=O)c1ccnc2ccc(N3CCCC(F)(F)C3)cc12",
            "b. CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1",
            "c. CCOc1nc2ccc(OCCC3CCN(c4ccc(C)nn4)CC3)cc2o1",
            "d. O=C(NC1C2CC3CC1CC(O)(C3)C2)c1cnn2cccnc12"
        ],
        "answer": "a",
        "answer_smiles": "N#CC1CSCN1C(=O)CNC(=O)c1ccnc2ccc(N3CCCC(F)(F)C3)cc12",
        "domain": "CLhepa_rat",
        "id": 84
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. c1nc(OC2CCC(N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1",
            "b. CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N1CCC(N)C1",
            "c. COCc1ccc(-c2cc3c(NC(C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1",
            "d. CNC(=O)c1nc(C)n2ccc(Nc3nccc(-n4cc(NC5CCOCC5N)c(C)n4)n3)cc12"
        ],
        "answer": "a",
        "answer_smiles": "c1nc(OC2CCC(N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1",
        "domain": "CLhepa_rat",
        "id": 85
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cn1cc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cn1",
            "b. CNc1nc(Nc2cnn(C3COC3)c2C)ncc1C(F)(F)F",
            "c. CC1Cc2c(ccc3[nH]ncc23)C(C)(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(F)F",
            "d. CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C5CCOCC5)c4)ccnc3[nH]2)CC1"
        ],
        "answer": "c",
        "answer_smiles": "CC1Cc2c(ccc3[nH]ncc23)C(C)(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(F)F",
        "domain": "CLhepa_rat",
        "id": 86
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(c2ccc(C#N)cc2F)Oc2cccc(C3CCN(Cc4nc5ccc(-c6nnn[nH]6)cc5n4CC4CCO4)CC3)c2O1",
            "b. O=C(NCC(O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F",
            "c. O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2C1c1ccc(Cl)cc1",
            "d. CN(CCNc1ncc(-c2ccc3c(Nc4cnccn4)ccnc3c2)cn1)C(=O)OC(C)(C)C"
        ],
        "answer": "d",
        "answer_smiles": "CN(CCNc1ncc(-c2ccc3c(Nc4cnccn4)ccnc3c2)cn1)C(=O)OC(C)(C)C",
        "domain": "CLhepa_rat",
        "id": 87
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCOC(=O)c1c(-c2ccccc2)nc2ccc(C)cn12",
            "b. CCC1(OC)CCN(c2ccc3nccc(C(=O)NCC(=O)N4CSCC4C#N)c3c2)CC1",
            "c. CC(C1CC1)N1Cc2cc(-c3cnc(N)nc3)cc(Cl)c2C1=O",
            "d. CC(=O)N1CCN(C2CCC(Nc3nc(Nc4cnn(C)c4)nc4ccc(C#N)cc34)CC2)CC1"
        ],
        "answer": "a",
        "answer_smiles": "CCOC(=O)c1c(-c2ccccc2)nc2ccc(C)cn12",
        "domain": "CLhepa_rat",
        "id": 88
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cn1nc(-c2cnc(N)c(-c3cn[nH]c3)n2)nc1C1(c2ccccc2)CC1",
            "b. COc1c(CC(F)(F)F)cc(-n2ccc(=O)[nH]c2=O)c2ncc(-c3ccc(NS(C)(=O)=O)cc3)cc12",
            "c. COc1ccc(C(Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)C(C)NC(=O)C2CC2)cn1",
            "d. Nc1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)[nH]c2n1"
        ],
        "answer": "d",
        "answer_smiles": "Nc1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)[nH]c2n1",
        "domain": "CLhepa_rat",
        "id": 89
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat hepatocyte assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1",
            "b. N#CC1CSCN1C(=O)CNC(=O)c1ccnc2ccc(-c3cnn(C4CC4)c3)cc12",
            "c. C=CC(=O)N1CCC(n2cc(-c3ccncc3)c(-c3cccc(NC(=O)c4ncc(C5CC5)o4)c3)n2)C1",
            "d. COCC1CN(c2ccc3nccc(C(=O)NCC(=O)N4CSCC4C#N)c3c2)CCO1"
        ],
        "answer": "c",
        "answer_smiles": "C=CC(=O)N1CCC(n2cc(-c3ccncc3)c(-c3cccc(NC(=O)c4ncc(C5CC5)o4)c3)n2)C1",
        "domain": "CLhepa_rat",
        "id": 90
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=c1ccc2ccc(F)c3c2n1CC3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1",
            "b. O=C(NCc1ccc(Cl)cc1)c1cn(N2CCOCC2)c2ccc(CN3CCOCC3)cc2c1=O",
            "c. N#Cc1cccc(S(=O)(=O)c2cnc3cc(F)ccc3c2-c2ccc(Cl)cc2)c1",
            "d. CC1Cc2c(ccc3[nH]ncc23)C(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(F)F"
        ],
        "answer": "a",
        "answer_smiles": "O=c1ccc2ccc(F)c3c2n1CC3CN1CCC(NCc2cc3c(nn2)OCCO3)CC1",
        "domain": "CLinvivo_dog",
        "id": 91
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1cc(F)ccc1C1CC(N2CCN3C(=O)CCC3C2)CCN1C(=O)N(C)C(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1",
            "b. COc1ccccc1CCC1CCc2cc(C3CCC(N)(CO)C3)ccc2C1",
            "c. CSC1(C(=O)Nc2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)CCN(CC(=O)N2CC=C(c3ccc(-c4ncccn4)cc3)CC2)C1",
            "d. CC(=NO)c1nc(C(O)C(O)C(O)CO)c[nH]1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1cc(F)ccc1C1CC(N2CCN3C(=O)CCC3C2)CCN1C(=O)N(C)C(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1",
        "domain": "CLinvivo_dog",
        "id": 92
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(C)OCCn2c1nc(C(=O)NCc1ccc(F)cc1)c(O)c2=O",
            "b. COc1cc(N2CCN(C(=O)Cn3nc(C(F)(F)F)c(Cl)c3C)CC2)ccc1Cl",
            "c. CCc1nc(OC)c(NC(=O)N2CCN(c3cc(C)cc(C)c3)CC2)cc1C(=O)NC(C)C(=O)Nc1cc(CO)cc(Nc2c3ccccc3nc3ccccc23)c1",
            "d. C#CC(CC(=O)O)NC(=O)CCC(=O)Nc1ccc(C(=N)N)cc1"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc(N2CCN(C(=O)Cn3nc(C(F)(F)F)c(Cl)c3C)CC2)ccc1Cl",
        "domain": "CLinvivo_dog",
        "id": 93
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#CC1(NC(=O)C2CCCCC2C(=O)N2CCc3[nH]c4ccc(F)cc4c3C2)CC1",
            "b. Cc1oc(-c2ccccc2)nc1CCCc1ccc(CC(C(=O)O)n2nccn2)cc1",
            "c. N#Cc1cccc(S(=O)(=O)Nc2ccc(F)c(C#Cc3cnc4[nH]nc(O)c4c3)c2F)c1",
            "d. CN1C(=O)c2c3c(c(O)c(=O)n2C12CCC1CC12CO)C(=O)N(Cc1ccc(F)c(Cl)c1)CC3"
        ],
        "answer": "a",
        "answer_smiles": "N#CC1(NC(=O)C2CCCCC2C(=O)N2CCc3[nH]c4ccc(F)cc4c3C2)CC1",
        "domain": "CLinvivo_dog",
        "id": 94
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(O)c1cccc(-c2cccc(NCCNCC(O)c3cccc(Cl)c3)c2)c1",
            "b. COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
            "c. O=C1OC(Cn2ccnn2)CN1c1ccc(-c2ccc(C3=NOC(CN4CCOCC4)C3)nc2)c(F)c1",
            "d. CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)c1nnc2ncc(OCC3CC3)cn12"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
        "domain": "CLinvivo_dog",
        "id": 95
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1oc(-c2ccccc2)nc1CCCc1ccc(CC(C(=O)O)n2nccn2)cc1",
            "b. CCON=Cc1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1",
            "c. CS(=O)(=O)Nc1ccc(F)c(C(O)CN)c1",
            "d. CC1COC(c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1"
        ],
        "answer": "b",
        "answer_smiles": "CCON=Cc1ccc(OCCC2CCN(c3ccc(C)nn3)CC2)cc1",
        "domain": "CLinvivo_dog",
        "id": 96
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1",
            "b. CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1",
            "c. O=C(Nc1ccc(CC2CCC(C(O)c3cccnc3)N2)cc1)C1CCc2scnc21",
            "d. Cl[Pt]Cl"
        ],
        "answer": "c",
        "answer_smiles": "O=C(Nc1ccc(CC2CCC(C(O)c3cccnc3)N2)cc1)C1CCc2scnc21",
        "domain": "CLinvivo_dog",
        "id": 97
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(NS(=O)(=O)c1ccc(-c2c(C#N)c3cc(F)c(OC(F)F)cc3n2C2CCC2)nc1)C(F)(F)F",
            "b. CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1",
            "c. COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1",
            "d. CC(Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1",
        "domain": "CLinvivo_dog",
        "id": 98
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCn1c(C(C)NS(=O)(=O)c2ccc(C#N)nc2)nc2cnc(C3CC3)cc21",
            "b. CC(=O)Nc1ccc(O)cc1",
            "c. CC1=CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2(C)CCOC2)c1O",
            "d. CC1c2nnn(-c3ncc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl"
        ],
        "answer": "b",
        "answer_smiles": "CC(=O)Nc1ccc(O)cc1",
        "domain": "CLinvivo_dog",
        "id": 99
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in dogs, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(c1ccc(F)cc1)N1CCc2nc(COc3ccccc3)oc2C1",
            "b. CCn1c(C(C)NS(=O)(=O)c2ccc(C#N)nc2)nc2cnc(C3CC3)cc21",
            "c. CCCN1CC(c2ccc(N)nc2)OCC1C",
            "d. CC1c2nnn(-c3ncc(F)cn3)c2CCN1C(=O)c1cccc(C(F)(F)F)c1Cl"
        ],
        "answer": "a",
        "answer_smiles": "O=C(c1ccc(F)cc1)N1CCc2nc(COc3ccccc3)oc2C1",
        "domain": "CLinvivo_dog",
        "id": 100
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1C(=O)OC2CC34C5OC(=O)C3(OC3OC(=O)C(O)C34C(C(C)(C)C)C5O)C21O",
            "b. OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F",
            "c. NC(=S)NN=Cc1ncccc1N",
            "d. CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O"
        ],
        "answer": "d",
        "answer_smiles": "CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CN(C)C(C)C(O)C1(C)O",
        "domain": "CLinvivo_human",
        "id": 101
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=CC1CC1(NC(=O)C1CC(Oc2cc(-c3nc(C(C)C)cs3)nc3c(C)c(OC)ccc23)CN1C(=O)C(Nc1cccc(C(F)(F)F)c1)C(C)(C)C)C(=O)NS(=O)(=O)C1(C)CC1",
            "b. CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C",
            "c. O=c1[nH]cnc2c1ncn2C1CCC(CO)O1",
            "d. Cn1nnc2c(C(N)=O)ncn2c1=O"
        ],
        "answer": "c",
        "answer_smiles": "O=c1[nH]cnc2c1ncn2C1CCC(CO)O1",
        "domain": "CLinvivo_human",
        "id": 102
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)Oc1ccc(C(=O)NC(CNC(=O)CN(C)C)Cc2ccc(-c3cn4cccc(C(C)O)c4n3)cc2)cc1Cl",
            "b. COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C",
            "c. CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1",
            "d. NCCCNc1ccc2c(CNCCO)nn3c4c(O)ccc(O)c4c(=O)c1c23"
        ],
        "answer": "d",
        "answer_smiles": "NCCCNc1ccc2c(CNCCO)nn3c4c(O)ccc(O)c4c(=O)c1c23",
        "domain": "CLinvivo_human",
        "id": 103
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(C)CC1C(=O)NC(=CCCCCSCC(N)C(=O)O)C(=O)O",
            "b. CNC(=O)c1cnn(-c2nc(N)c3ncn(C4OC(CO)C(O)C4O)c3n2)c1",
            "c. CC(=N)N1CCC(SC2=C(C(=O)O)N3C(=O)C(C(C)O)C3C2)C1",
            "d. Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1"
        ],
        "answer": "b",
        "answer_smiles": "CNC(=O)c1cnn(-c2nc(N)c3ncn(C4OC(CO)C(O)C4O)c3n2)c1",
        "domain": "CLinvivo_human",
        "id": 104
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1",
            "b. NC(=O)c1ccc2c(c1O)C13CCN(CC4CC4)C(C2)C1(O)CCC(=O)C3",
            "c. *NC(CCC(=O)O)C(=O)NC(CCC(=O)OC(C(=O)OC1CC2(O)C(OC(=O)c3ccccc3)C3C4(OC(C)=O)COC4CC(O)C3(C)C(=O)C(OC(C)=O)C(=C1C)C2(C)C)C(NC(=O)c1ccccc1)c1ccccc1)C(=O)NC(CCC(=O)O)C(=O)O",
            "d. CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "NC(=O)c1ccc2c(c1O)C13CCN(CC4CC4)C(C2)C1(O)CCC(=O)C3",
        "domain": "CLinvivo_human",
        "id": 105
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=CCC1C(=O)C(C)(C)C(O)CC(=O)OC(c2ccc3sc(C)nc3c2)CC2OC2(C)CCCC(C)C1O",
            "b. COCC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I",
            "c. CON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CSC12)c1csc(N)n1",
            "d. BBBBBBBC1B2BBC21C(=O)OCC(OC(=O)C12BBB1C2BBBBBBB)C1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C(COC(=O)C12BBB1C2BBBBBBB)OC(=O)C12BBB1C2BBBBBBB"
        ],
        "answer": "a",
        "answer_smiles": "C=CCC1C(=O)C(C)(C)C(O)CC(=O)OC(c2ccc3sc(C)nc3c2)CC2OC2(C)CCCC(C)C1O",
        "domain": "CLinvivo_human",
        "id": 106
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1CNC(C2CC2)C(=O)N(C)C(C)C(=O)NC(Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1",
            "b. Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1",
            "c. CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(N)C(O)C(C)O2)C1)C(=O)c1ccccc1C3=O",
            "d. CC1C(=O)OC2C(O)C34C5CC(C(C)(C)C)C36C(OC(=O)C6O)OC4(C(=O)O5)C12O"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(N)C(O)C(C)O2)C1)C(=O)c1ccccc1C3=O",
        "domain": "CLinvivo_human",
        "id": 107
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC",
            "b. CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2",
            "c. CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(N)CC(=O)O)C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CO)C(N)=O",
            "d. Cc1cc(NC(=O)C(=O)c2cc(Cc3ccc(C#N)cc3)n3ccccc23)sn1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2",
        "domain": "CLinvivo_human",
        "id": 108
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1ccn(CC(CO)OCP(=O)(O)O)c(=O)n1",
            "b. CC(C)C(CCC(C)C1CCC2C3C(O)CC4CC(NCCCNCCCCN)CCC4(C)C3CCC12C)OS(=O)(=O)O",
            "c. N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCCC1",
            "d. CC(=N)N1CCC(SC2=C(C(=O)O)N3C(=O)C(C(C)O)C3C2)C1"
        ],
        "answer": "c",
        "answer_smiles": "N#CC1CCC(C#N)N1C(=O)CNC1(CO)CCCC1",
        "domain": "CLinvivo_human",
        "id": 109
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in humans, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=NN(CCCl)C(=O)NCCCl",
            "b. CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2C1OC(COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)C(O)C1O",
            "c. COCC1OC(OC2OCC3OC4(OCC(OC(=O)c5c(C)cc(O)cc5O)C5OCOC54)OC3C2O)C(OC)C(O)C1OC1OC(C)C(OC)C(OC2OC(C)C3OC4(CC(O)C(OC5CC(OC6CC(C)([N+](=O)[O-])C(OC)C(C)O6)C(OC(=O)c6c(C)c(Cl)c(O)c(Cl)c6OC)C(C)O5)C(C)O4)OC3(C)C2O)C1O",
            "d. Cn1nnc(-c2ccc(-c3ccc(N4CC(CO)OC4=O)cc3F)cn2)n1"
        ],
        "answer": "b",
        "answer_smiles": "CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2C1OC(COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)C(O)C1O",
        "domain": "CLinvivo_human",
        "id": 110
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COCCOC1CCC(Nc2cc(=O)n(C)c3c(C)cc(-c4cncs4)cc23)CC1",
            "b. Nc1n[nH]c(N2CCC(NS(=O)(=O)Cc3ccc(Br)cc3)CC2)n1",
            "c. Fc1cccc(C2Cc3[nH]nc(-c4nnn[nH]4)c3C2)c1",
            "d. CCCCCCCCCCNC1(C)CC(OC2C(Oc3c4cc5cc3Oc3ccc(cc3Cl)C(O)C3NC(=O)C(NC(=O)C5NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)c5ccc(c(Cl)c5)O4)c4ccc(O)c(c4)-c4c(O)cc(O)cc4C(C(=O)NCCCNC(=O)C(O)C(O)C(OC4OC(CO)C(O)C(O)C4O)C(O)CO)NC3=O)OC(CO)C(O)C2O)OC(C)C1O"
        ],
        "answer": "c",
        "answer_smiles": "Fc1cccc(C2Cc3[nH]nc(-c4nnn[nH]4)c3C2)c1",
        "domain": "CLinvivo_mice",
        "id": 111
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(NC(=O)C1CNCC1c1ccc(C(F)(F)F)cc1)c1ccc(N(C)C)cc1",
            "b. CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2",
            "c. Cc1ccc(C(C)NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc2ccccn12",
            "d. COc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)c(CO)c2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2",
        "domain": "CLinvivo_mice",
        "id": 112
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(O)CCc1cc(F)c(OCc2c(C(F)(F)F)ccn2-c2ccc(Cl)cc2)c(F)c1",
            "b. CCCCCCCCNC(=O)Oc1cc(O)c2c(c1)C(C(=O)NC1C3CC4CC(C3)CC1C4)NC(=O)C1NC(=O)C(NC(=O)C3NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)c4ccc(c(Cl)c4)Oc4cc3cc(c4OC3OC(CO)C(O)C(O)C3OC3CC(C)(N)C(O)C(C)O3)Oc3ccc(cc3Cl)C1O)c1ccc(O)c-2c1",
            "c. CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F",
            "d. Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncc(-c2cnn(C)c2)c1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncc(-c2cnn(C)c2)c1",
        "domain": "CLinvivo_mice",
        "id": 113
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C#Cc1cnc2nc(O)n(C(CC)CC)c2n1",
            "b. c1cncc(OCC2CNCCN2c2nc3ncccc3o2)c1",
            "c. CC1C(NC(=O)C(=NOCc2cc(=O)c(O)cn2O)c2cccs2)C(=O)N1S(=O)(=O)O",
            "d. CCCCCCCCCCCCCCCCNCCCNCCCNCCCCNCCCN"
        ],
        "answer": "b",
        "answer_smiles": "c1cncc(OCC2CNCCN2c2nc3ncccc3o2)c1",
        "domain": "CLinvivo_mice",
        "id": 114
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)CC(NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(CCCNC(=N)N)NC(=O)C1CCCN1C(=O)C(N)CCCNC(=N)N)C(C)O)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)O)C(C)O)C(C)O",
            "b. Cc1cc2nc(-c3nccs3)n(-c3ccc4c(N)nc(N)nc4c3)c2cc1C",
            "c. N#CC1CC1c1c(Cl)ccc2nc(Cn3nc(C(F)(F)F)cc3Cl)cc(=O)n12",
            "d. NC(CCO)c1cccc(-c2cccc(COc3ccccc3CC(=O)O)c2)c1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc2nc(-c3nccs3)n(-c3ccc4c(N)nc(N)nc4c3)c2cc1C",
        "domain": "CLinvivo_mice",
        "id": 115
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCc1nnc(-c2ccc(-c3ccccc3)nc2)n1-c1cccc(C#N)c1C",
            "b. Nc1nc(C(=NOC2(C(=O)O)CC2)C(=O)NC2C(=O)N(S(=O)(=O)O)C2CN2CCOC2=O)cs1",
            "c. CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(C=CC[n+]3ccc(-c4cc(C(=O)NC#N)[nH]n4)cc3)CSC12)c1csc(N)n1",
            "d. CC(Nc1cc(=O)n(C(C)C)c(=O)[nH]1)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "CCc1nnc(-c2ccc(-c3ccccc3)nc2)n1-c1cccc(C#N)c1C",
        "domain": "CLinvivo_mice",
        "id": 116
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CS(=O)(=O)c1ccc2c(c1)CCN2c1ncnc2c(C3CCN(c4ncc(Cl)cn4)CC3)coc12",
            "b. CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1",
            "c. CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1",
            "d. Nc1ncnc2c1C(=O)N(c1ccc(-c3ccccc3F)cc1)CCO2"
        ],
        "answer": "b",
        "answer_smiles": "CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1",
        "domain": "CLinvivo_mice",
        "id": 117
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC",
            "b. OC(CNC1CCCCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21",
            "c. CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CN(CCCNc2ccnc3ccccc23)C(C)C(O)C1(C)O",
            "d. N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1"
        ],
        "answer": "a",
        "answer_smiles": "COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC",
        "domain": "CLinvivo_mice",
        "id": 118
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12",
            "b. N#Cc1ccc(C=Cc2nc3ccccc3c(=O)n2-c2cccc(C(=O)O)c2)cc1",
            "c. CC(=O)NCC1CN(c2ccc(N3CC[Si](C)(C)CC3)c(F)c2)C(=O)O1",
            "d. CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(N4CC4)C(OS(C)(=O)=O)C(C)O2)C1)C(=O)c1ccccc1C3=O"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)NCC1CN(c2ccc(N3CC[Si](C)(C)CC3)c(F)c2)C(=O)O1",
        "domain": "CLinvivo_mice",
        "id": 119
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in mice, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=c1[nH]c(=O)n(Cc2cccc3ccccc23)nc1O",
            "b. CC(C)CC(NC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(CCCNC(=N)N)NC(=O)C1CCCN1C(=O)C(N)CCCNC(=N)N)C(C)O)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)O)C(C)O)C(C)O",
            "c. CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1",
            "d. NC(CCO)c1cccc(-c2cccc(COc3ccccc3CC(=O)O)c2)c1"
        ],
        "answer": "c",
        "answer_smiles": "CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1",
        "domain": "CLinvivo_mice",
        "id": 120
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1",
            "b. CCN=C(NCC)NCCCCC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCCNC(=NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(N)=O",
            "c. CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3",
            "d. Cc1cc(Oc2cncc(F)c2)cc(C(=O)Nc2ccc(F)cn2)n1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1cc(Oc2cncc(F)c2)cc(C(=O)Nc2ccc(F)cn2)n1",
        "domain": "CLinvivo_monkey",
        "id": 121
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(c1cccc(F)c1)N1CCc2oc(-c3ccc(F)cn3)nc2C1",
            "b. Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1",
            "c. CN1Cc2cc(N3CCOCC3)ccc2C(c2ccc3sccc3c2)C1",
            "d. Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1"
        ],
        "answer": "c",
        "answer_smiles": "CN1Cc2cc(N3CCOCC3)ccc2C(c2ccc3sccc3c2)C1",
        "domain": "CLinvivo_monkey",
        "id": 122
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1ccn(C2OC(CO)(CCl)C(O)C2F)c(=O)n1",
            "b. CC[N+](C)(CC=CC1=C(C(=O)[O-])N2C(=O)C(NC(=O)C(=NOCF)c3nsc(N)n3)C2SC1)CC(N)=O",
            "c. Cc1ccc(Oc2ccc3nc(COc4cccc(C(=O)O)c4)n(C)c3c2)cc1",
            "d. Nc1ncc(-c2ccc(C(=O)N3CCNCC3)cc2)nc1-c1ccc(C(F)(F)F)cc1"
        ],
        "answer": "a",
        "answer_smiles": "Nc1ccn(C2OC(CO)(CCl)C(O)C2F)c(=O)n1",
        "domain": "CLinvivo_monkey",
        "id": 123
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCC(O)C1CC1",
            "b. Fc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1",
            "c. Cn1c(COc2cccc(C(=O)O)c2)nc2ccc(Oc3ccc(Cl)c(F)c3)cc21",
            "d. Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O"
        ],
        "answer": "d",
        "answer_smiles": "Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O",
        "domain": "CLinvivo_monkey",
        "id": 124
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(O)CC1Cc2ccc(OCCCNc3ccccn3)cc2Cc2ccccc21",
            "b. O=C(O)CCNC(=O)c1ccc(Cn2nc(-c3cc(Cl)cc(Cl)c3)cc2-c2ccc(OC(F)(F)F)cc2)cc1",
            "c. COc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1",
            "d. CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3ncn4CCCNC)CSC12)c1nsc(N)n1"
        ],
        "answer": "a",
        "answer_smiles": "O=C(O)CC1Cc2ccc(OCCCNc3ccccn3)cc2Cc2ccccc21",
        "domain": "CLinvivo_monkey",
        "id": 125
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(C(CC(=O)O)N2CCN(CCCc3ccc4c(n3)NCCC4)C2=O)cn1",
            "b. CC(C)C1NC(=O)C(Cc2cccs2)NC(=O)C(Cc2ccc(Cl)cc2)NC(=O)CCCSCC(C(=O)N2CCCC2C(=O)NCCCCNC(=N)N)NC(=O)C(CC(N)=O)NC1=O",
            "c. CCC(C)C(NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(N)CO)C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)O)C(C)C)C(C)C",
            "d. CC(c1ccc(F)cc1CCCC(=O)O)N(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1"
        ],
        "answer": "c",
        "answer_smiles": "CCC(C)C(NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(N)CO)C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)O)C(C)C)C(C)C",
        "domain": "CLinvivo_monkey",
        "id": 126
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(=N)N1CCCN(c2ccc(N(Cc3ccc4ccc(C(=N)N)cc4c3)S(=O)(=O)CC(=O)O)cc2)CC1",
            "b. CCCCCCCCCCNCCNC1(C)CC(OC2C(Oc3c4cc5cc3Oc3ccc(cc3Cl)C(O)C3NC(=O)C(NC(=O)C5NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)c5ccc(c(Cl)c5)O4)c4ccc(O)c(c4)-c4c(cc(O)c(CNCP(=O)(O)O)c4O)C(C(=O)O)NC3=O)OC(CO)C(O)C2O)OC(C)C1O",
            "c. CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(C(C)O)NC(=O)C(C(O)C(O)c5ccc(O)cc5)NC(=O)C5CC(O)CN5C(=O)C(C(C)O)NC4=O)cc3)cc2)cc1",
            "d. CNC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1"
        ],
        "answer": "d",
        "answer_smiles": "CNC(=O)N1CCc2c(c(N3CCCc4cc(-c5cnn(C)c5)c(C(F)F)cc43)nn2C2CCOCC2)C1",
        "domain": "CLinvivo_monkey",
        "id": 127
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12",
            "b. CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1",
            "c. COc1ccc(Cl)cc1-c1cc(=O)[nH]c(=S)n1CC(N)=O",
            "d. O=C(CCS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2Cc3cnc(CO)n3C2=O)CC1"
        ],
        "answer": "b",
        "answer_smiles": "CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1",
        "domain": "CLinvivo_monkey",
        "id": 128
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC1(C)Cc2c(c(C(=O)Nc3ccc(C(F)(F)F)cc3)cc3nc(Nc4c(F)cccc4Cl)[nH]c23)O1",
            "b. O=C(NN1C(=O)C2C3C=CC(C4CC34)C2C1=O)c1ccc(C(F)(F)F)cc1",
            "c. COc1c(N2CCC(C(C)NCC3=C(C(=O)O)N4C(=O)C(NC(=O)COc5ccccc5)C4SC3)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12",
            "d. CCOc1cc(Cc2cnc(N)nc2N)cc(OCC)c1-n1cccc1"
        ],
        "answer": "d",
        "answer_smiles": "CCOc1cc(Cc2cnc(N)nc2N)cc(OCC)c1-n1cccc1",
        "domain": "CLinvivo_monkey",
        "id": 129
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in monkeys, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O",
            "b. O=C(O)C1CN(Cc2ccc(-c3nc4cc(Cc5ccccc5F)ccc4s3)c(F)c2)C1",
            "c. COc1ccc(C(NC(=O)c2cnc(-c3cccnn3)nc2O)c2ccc(OC)cc2)cc1",
            "d. N=C(N)c1ccc(N2CCN(C3CCN(CC(=O)O)CC3)CC2=O)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O",
        "domain": "CLinvivo_monkey",
        "id": 130
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)(C)CCC1(C)C(=O)C(C2=NS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)=C(O)c2ccccc21",
            "b. NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N",
            "c. O=C(O)c1cc(F)c2nc(N3C4CCC3CC(OCc3c(-c5ccccc5OC(F)F)noc3C3CC3)C4)sc2c1",
            "d. Cn1cc(NC(=O)c2cnn3ccc(N4CC(N)CC(F)(F)C4)nc23)c(C(F)F)n1"
        ],
        "answer": "d",
        "answer_smiles": "Cn1cc(NC(=O)c2cnn3ccc(N4CC(N)CC(F)(F)C4)nc23)c(C(F)F)n1",
        "domain": "CLinvivo_rat",
        "id": 131
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1ccccc1Nc1nc2ccc(CC(=O)N3CC(F)CC3COC3CCC(C(=O)O)CC3)cc2o1",
            "b. CC1CCC(C)N1CCCOc1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1",
            "c. O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1",
            "d. O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12"
        ],
        "answer": "b",
        "answer_smiles": "CC1CCC(C)N1CCCOc1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1",
        "domain": "CLinvivo_rat",
        "id": 132
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)(N)C(NC(=O)c1ccc(C#CC#CC2CC2CO)cc1)C(=O)NO",
            "b. CCOC(=O)C1=C(c2ccc(-n3c(C)nc4cnccc43)cc2)NC(C)=C(C(=O)Nc2ccccn2)C1c1ccccc1Cl",
            "c. CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F",
            "d. COC(=O)N1CC(F)CC1c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C"
        ],
        "answer": "d",
        "answer_smiles": "COC(=O)N1CC(F)CC1c1nc(C(=O)NCc2ccc(F)c(Cl)c2)c(O)c(=O)n1C",
        "domain": "CLinvivo_rat",
        "id": 133
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C(N)=O)C(N)c1nc2cc(C(C)(C)C)ccc2[nH]1",
            "b. CC(=O)NCC1CC(c2ccc(N3CCOCC3)c(F)c2)=NO1",
            "c. CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(Cc1ccccc1)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)CC)C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C(=O)NC(CC(=O)O)C(=O)O)C(C)O)C(C)CC)C(C)O)C(C)CC",
            "d. Cc1cc(C(=O)NS(=O)(=O)c2ccccc2S(N)(=O)=O)ccc1C#CC1CCC1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C(N)=O)C(N)c1nc2cc(C(C)(C)C)ccc2[nH]1",
        "domain": "CLinvivo_rat",
        "id": 134
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1c(C(=O)NCC(O)(CN(CCO)C(=O)c2c(F)cccc2F)C(F)(F)F)cnn1-c1ccc(F)cc1",
            "b. CN(c1ncnc2[nH]ccc12)C1CC(NS(=O)(=O)CC2COC2)C1",
            "c. CCOC(Cc1ccc(OCC=CC#Cc2ccc(C#CC=CCOc3ccc(CC(OCC)C(=O)O)cc3)cc2)cc1)C(=O)O",
            "d. CCOc1cc(-c2nncn2C)ccc1Nc1ncc2cc(C)nc(NC(C)C(C)(C)C)c2n1"
        ],
        "answer": "b",
        "answer_smiles": "CN(c1ncnc2[nH]ccc12)C1CC(NS(=O)(=O)CC2COC2)C1",
        "domain": "CLinvivo_rat",
        "id": 135
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1ccc(Br)cc1C(=O)O)c(=O)n2C",
            "b. Cn1cc(-c2cc(F)c(CN3Cc4ccc5nccn5c4C3=O)c(F)c2)cn1",
            "c. O=C(NCc1ccc(Cl)cc1)c1cn(N2CCOCC2)c2ccc(CN3CCOCC3)cc2c1=O",
            "d. COc1ccc(C2Sc3cc(Cl)ccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1"
        ],
        "answer": "c",
        "answer_smiles": "O=C(NCc1ccc(Cl)cc1)c1cn(N2CCOCC2)c2ccc(CN3CCOCC3)cc2c1=O",
        "domain": "CLinvivo_rat",
        "id": 136
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Oc1ccc2nc(CN3CCC(Cc4ccccc4F)CC3)[nH]c2c1",
            "b. O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)c(F)cc1F)N1CCN(c2ccccn2)CC1",
            "c. CN1CCN(c2ccc(N3CC(CO)OC3=O)cc2F)C=N1",
            "d. Cc1ncn(-c2ccc(Nc3nccc(-c4cccc(N5CCOCC5)c4)n3)cc2)n1"
        ],
        "answer": "b",
        "answer_smiles": "O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)c(F)cc1F)N1CCN(c2ccccn2)CC1",
        "domain": "CLinvivo_rat",
        "id": 137
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Oc1cccc(-c2cc(-c3ccccc3)c3oc4ccccc4c3n2)c1",
            "b. CCc1ccc(C2Oc3cc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc(F)c3-c3cc4cc(-c5cnc(C6CCCN6C(=O)C(NC(=O)OC)C(C)C)[nH]5)ccc4n32)s1",
            "c. Nc1[nH]ncc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl",
            "d. CCOCC(CC(C)C)NC(=O)C1CNCC(N2CC(=O)N(c3ccccc3Cl)CC2(C)C)C1"
        ],
        "answer": "d",
        "answer_smiles": "CCOCC(CC(C)C)NC(=O)C1CNCC(N2CC(=O)N(c3ccccc3Cl)CC2(C)C)C1",
        "domain": "CLinvivo_rat",
        "id": 138
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(O)C1CCC(c2cc3cccnc3c(-c3cccc(OC(F)(F)F)c3)n2)CC1",
            "b. O=P1(NCCCl)OCCCN1CCCl",
            "c. CC1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)nc1",
            "d. N#CC1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12"
        ],
        "answer": "c",
        "answer_smiles": "CC1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)nc1",
        "domain": "CLinvivo_rat",
        "id": 139
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in vivo in rats, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CN(Cc1cccc(-c2cnc(N3CCN(c4ccc(C(=O)O)cc4Cl)CC3)nc2)c1)C(=O)CN",
            "b. CNC(=O)c1ccc(-c2ccc(C(C)(F)CNS(=O)(=O)C(C)C)cc2)cc1",
            "c. Cc1ccc(CN2CCC(N3CCC(c4ccc(OP(=O)(O)O)cc4)C(F)C3)C2=O)cc1",
            "d. N=C(N)c1ccc2[nH]c(-c3cc(CC(=O)O)cc(-c4cccc([N+](=O)[O-])c4)c3O)cc2c1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc(CN2CCC(N3CCC(c4ccc(OP(=O)(O)O)cc4)C(F)C3)C2=O)cc1",
        "domain": "CLinvivo_rat",
        "id": 140
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCOc1ccc(/C=C/C(=O)NCCc2nc3ccccc3[nH]2)cc1",
            "b. Cc1ccc2[nH]c(C)c(/C=N/Nc3nc4ccccc4s3)c2c1",
            "c. Cc1ccccc1CNc1ncnc2c1ncn2C1OC(CO)C(O)C1O",
            "d. COC(=O)[C@@]1(Cc2ccc(OC)cc2)[C@H]2c3cc(C(=O)N(C)C)n(CCc4ccc(O)c(OC)c4)c3C[C@H]2CN1C(=O)c1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1ccc2[nH]c(C)c(/C=N/Nc3nc4ccccc4s3)c2c1",
        "domain": "CYP1A2I",
        "id": 141
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. N#CC1=C(N)N(c2ccccc2F)C2=C(CCCC2)C1(C(F)(F)F)C(F)(F)F",
            "b. CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21",
            "c. N#Cc1ccc(CN2CCCC3(CCN(C(=O)c4csnn4)CC3)C2)cc1",
            "d. C/C(CCN1CCCCc2nc(C)c(C)cc21)=N\\O[C@@H](C)CN1CCCc2nc(C)c(C)cc21"
        ],
        "answer": "b",
        "answer_smiles": "CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21",
        "domain": "CYP1A2I",
        "id": 142
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)[C@@]1(Cc2ccccc2)[C@@H]2c3cc(C(=O)N(C)C)n(Cc4cc(F)c(F)c(F)c4)c3C[C@H]2CN1C(=O)c1ccccc1",
            "b. CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1",
            "c. O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO",
            "d. CC(C)C[C@@H](CC(=O)N[C@@H](CCCN)CC(=O)N[C@@H]1CCNC[C@H]1C(=O)N[C@H](CC(=O)N[C@@H](CCC(=O)O)CC(=O)O)Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CNCC[C@H]1N"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1",
        "domain": "CYP1A2I",
        "id": 143
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H]1[C@H](C)CC[C@@]2(C(=O)O)CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@@H](O)C(C)(C)[C@@H]5CC[C@@]43C)[C@@H]12",
            "b. CCc1ccc(N(C(=O)CNC(=O)c2cccs2)C(C(=O)NC(C)(C)C)c2cc(OC)c(OC)c(OC)c2)cc1",
            "c. CN(C)c1ccc(-c2nccc(NCCN3CCOCC3)n2)cc1",
            "d. CC(C)=C1C(=O)C(c2ccccc2)=C2CN3C(=O)N(CCc4ccccc4)C(=O)[C@]3(Cc3ccccc3)[C@H]21"
        ],
        "answer": "c",
        "answer_smiles": "CN(C)c1ccc(-c2nccc(NCCN3CCOCC3)n2)cc1",
        "domain": "CYP1A2I",
        "id": 144
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CS(=O)(=O)N1CCC2(CC1)CN(C(=O)Nc1cccc(F)c1)C2",
            "b. Cc1cc(C)c(-c2cc([C@H](C)O/N=C\\[C@@H](C)[C@H](OCc3ccccc3)C(C)C)on2)c(C)c1",
            "c. CCOC(=O)c1cc(-c2ccccc2)sc1NC(=O)C(C)(C)C",
            "d. COc1ccc2cc1Oc1ccc(cc1)C[C@@H]1c3c(cc(OC)c4c3Oc3cc5c(cc3O4)CCN[C@H]5C2)CCN1C"
        ],
        "answer": "a",
        "answer_smiles": "CS(=O)(=O)N1CCC2(CC1)CN(C(=O)Nc1cccc(F)c1)C2",
        "domain": "CYP1A2I",
        "id": 145
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=c1c[n+](CCCC[n+]2cc(=O)o[nH]2)[nH]o1",
            "b. COC(=O)NC/C=C\\c1nc(CC/C=C\\C(=O)O[C@H]2C[C@H]3CC(=O)O[C@@H](/C=C\\CC(C)C)C[C@@H]4CC[C@H](C)[C@H](C[C@@H](OC)C[C@H](C2)O3)O4)co1",
            "c. O=C(Nc1ccc(-c2cn3ccccc3n2)cc1)c1cc(Br)ccc1O",
            "d. CCCc1nnc(SCC(=O)N2C(C)CCCC2C)n1CCCOC"
        ],
        "answer": "c",
        "answer_smiles": "O=C(Nc1ccc(-c2cn3ccccc3n2)cc1)c1cc(Br)ccc1O",
        "domain": "CYP1A2I",
        "id": 146
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1OCC(CO)(CO)N=C1NNc1ccc(Cl)c(Cl)c1",
            "b. O=C(O)c1cc(C(=O)O)cc(N2C(=O)c3ccccc3C2=O)c1",
            "c. N#CCCn1c(=O)c(CCc2ccccc2)nc2cnc(Nc3ccccc3)nc21",
            "d. COC(=O)[C@@]1(Cc2ccc(OC)cc2)[C@@H]2c3cc(C(=O)N4CCCC4)n(Cc4cc(F)c(F)c(F)c4)c3C[C@H]2CN1C(=O)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "O=C1OCC(CO)(CO)N=C1NNc1ccc(Cl)c(Cl)c1",
        "domain": "CYP1A2I",
        "id": 147
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(OC)c([C@H](O)[C@H](C)N)c1",
            "b. CN(C)CCOC(c1ccccc1)c1ccccc1",
            "c. CC[C@@H](c1ccccc1)n1c(=O)n2n(c1=O)[C@H]1[C@H](O)[C@H]3O[C@@H]3/C(=N/OCC(C)C)[C@@H]1CC2",
            "d. Cc1ccccc1N=C(N)Nc1ccccc1C"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)CCOC(c1ccccc1)c1ccccc1",
        "domain": "CYP1A2I",
        "id": 148
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=c1cnc2cnc(N3CCOCC3)nc2n1CCc1ccccc1",
            "b. COC(=O)[C@@]1(Cc2ccc(F)cc2)[C@H]2c3cc(C(=O)N4CCCC4)n(Cc4ccc(C)c(F)c4F)c3C[C@H]2CN1C(=O)c1ccccc1",
            "c. O=C(O)CNC1=NC2(CCCC2)Cc2ccccc21",
            "d. O=C(NC(=S)Nc1ccc(C(=O)N2CCOCC2)cc1)c1ccc([N+](=O)[O-])cc1"
        ],
        "answer": "a",
        "answer_smiles": "O=c1cnc2cnc(N3CCOCC3)nc2n1CCc1ccccc1",
        "domain": "CYP1A2I",
        "id": 149
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the cytochrome P450 1A2 (CYP1A2) enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOc1cc(C)c(S(=O)(=O)Nc2ccc3c[nH]nc3c2)cc1C",
            "b. O=C1CCCCCC1C1(O)C(=O)Nc2ccc(Br)cc21",
            "c. COC(=O)N1CCC2(CCCN(c3ccncc3)C2)CC1",
            "d. C[N+]1([O-])[C@H]2CC[C@H]1CC(OC(=O)[C@@H](CO)c1ccccc1)C2"
        ],
        "answer": "a",
        "answer_smiles": "CCOc1cc(C)c(S(=O)(=O)Nc2ccc3c[nH]nc3c2)cc1C",
        "domain": "CYP1A2I",
        "id": 150
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cccc(N2CCN(CC(=O)Nc3ccc(-n4cnnn4)cc3)CC2)c1C",
            "b. C[C@@H](C(=O)Nc1ccc2ccccc2c1)[C@@H]1C[C@@]1(C)[C@@H](NC(=O)OCc1ccccc1)c1ccccc1",
            "c. O=C(Nc1cccc(F)c1)N1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2",
            "d. O=C1CNCCCN2CCN(CCCNCC(=O)Nc3ccc(cc3)S(=O)(=O)c3ccc(cc3)NC(=O)CNCCCN3CCN(CCCNCC(=O)Nc4ccc(cc4)S(=O)(=O)c4ccc(cc4)N1)CC3)CC2"
        ],
        "answer": "b",
        "answer_smiles": "C[C@@H](C(=O)Nc1ccc2ccccc2c1)[C@@H]1C[C@@]1(C)[C@@H](NC(=O)OCc1ccccc1)c1ccccc1",
        "domain": "CYP2C19I",
        "id": 151
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(CCc1ccccn1)Cc1ccc(Cl)cc1Cl",
            "b. C[N+]1(C)[C@@H]2C[C@H](OC(=O)[C@@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@H]12",
            "c. N=C(N)Nc1nc2cc([N+](=O)[O-])ccc2[nH]1",
            "d. Cn1cccc1C(=O)N1CCC2(CCCN(Cc3ccc(C#N)cc3)C2)CC1"
        ],
        "answer": "a",
        "answer_smiles": "CN(CCc1ccccn1)Cc1ccc(Cl)cc1Cl",
        "domain": "CYP2C19I",
        "id": 152
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCNc1ncc2nc(-c3cn(C)c4ccccc34)c(=O)n(C[C@H]3CCCO3)c2n1",
            "b. O[C@H](CN1CC1)[C@@H](O)CN1CC1",
            "c. C/C(=N\\NC(=O)c1[nH]c2c([N+](=O)[O-])cc(C)cc2c1-c1ccccc1)c1cccnc1",
            "d. CC(C)(C)N1C(=O)[C@H]2[C@@H]3[C@H](O)C=CC(=O)[C@H]3CC[C@H]2C1=O"
        ],
        "answer": "c",
        "answer_smiles": "C/C(=N\\NC(=O)c1[nH]c2c([N+](=O)[O-])cc(C)cc2c1-c1ccccc1)c1cccnc1",
        "domain": "CYP2C19I",
        "id": 153
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COCC1C2CC[C@H]3C(OCc4ccc(OC)cc4)OC[C@]4(C)[C@H]3C2=C(CN4C(=O)OC(C)(C)C)[C@H](C)C1COC",
            "b. COc1cc(C=C(C#N)C#N)cc(O)c1O",
            "c. CN(C)c1ncc2ncc(=O)n(C[C@H]3CCCO3)c2n1",
            "d. CCCC(=O)Nc1c2c(nn1-c1ccc(C)cc1C)CSC2"
        ],
        "answer": "d",
        "answer_smiles": "CCCC(=O)Nc1c2c(nn1-c1ccc(C)cc1C)CSC2",
        "domain": "CYP2C19I",
        "id": 154
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN1C(=O)[C@H]2[C@H]3[C@H](O)[C@H](O)C/C(=N/OC[C@@H]4O[C@H](c5ccccc5)C=C[C@@H]4Oc4ccc(OC)cc4)[C@@H]3CC[C@@H]2C1=O",
            "b. COCC(=O)N1CCC2(CC1)CN(Cc1ccc(C#N)cc1)C2",
            "c. O=C(c1cnccn1)N1CCC2(CC1)CCN(c1ncccn1)CC2",
            "d. COc1ccc(C(=O)N2CCC3(CCCN(Cc4ccncc4)C3)CC2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CCN1C(=O)[C@H]2[C@H]3[C@H](O)[C@H](O)C/C(=N/OC[C@@H]4O[C@H](c5ccccc5)C=C[C@@H]4Oc4ccc(OC)cc4)[C@@H]3CC[C@@H]2C1=O",
        "domain": "CYP2C19I",
        "id": 155
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H](CCC[C@@H]1SC[C@H]2NC(=O)N[C@H]12)C(=O)O",
            "b. O=C(CNC(=O)/C(=C\\c1ccccc1)NC(=O)c1ccc(Br)cc1)OCc1ccccc1",
            "c. CO[C@H]1COC(=O)[C@H](C)NC(=O)[C@@H](C)COC(=O)C/C=C\\[C@@H]1C",
            "d. CCC(C)NS(=O)(=O)c1ccc(OCC(=O)NCC2CCCO2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "O=C(CNC(=O)/C(=C\\c1ccccc1)NC(=O)c1ccc(Br)cc1)OCc1ccccc1",
        "domain": "CYP2C19I",
        "id": 156
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccccc1CN1CCCC2(CCN(C(=O)c3ccco3)CC2)C1",
            "b. CN(C)c1nc(-c2ccc3c(c2)OCO3)nc2ccccc12",
            "c. N[C@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O",
            "d. CCOC(=O)N/N=C1/C[C@@H](O)[C@@H](O)[C@@H]2[C@@H]3C(=O)N(Cc4ccc5c(c4)OCO5)C(=O)[C@H]3CC[C@H]12"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)c1nc(-c2ccc3c(c2)OCO3)nc2ccccc12",
        "domain": "CYP2C19I",
        "id": 157
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)CN1CCC2(CC1)CCN(C(=O)Oc1ccccc1)CC2",
            "b. COc1ccc(Oc2ncc3nc(CCc4ccccc4)c(=O)n(C[C@H]4CCCO4)c3n2)cc1",
            "c. O=C(Nc1ccc(Nc2ccc3c(c2)C(=O)c2ccccc2C3=O)c2c1C(=O)c1ccccc1C2=O)c1ccccc1",
            "d. C/C=C\\C1=C(CO)[C@H](O)[C@H]2O[C@H]2[C@@H]1O"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(Oc2ncc3nc(CCc4ccccc4)c(=O)n(C[C@H]4CCCO4)c3n2)cc1",
        "domain": "CYP2C19I",
        "id": 158
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N",
            "b. CC(C)C[C@@H](CC(=O)N[C@H](CC(=O)N[C@@H]1CCNC[C@H]1C(=O)N[C@H](CC(=O)N[C@@H](CCC(=O)O)CC(=O)O)Cc1c[nH]c2ccccc12)C(C)C)NC(=O)[C@@H]1CNCC[C@H]1N",
            "c. CCCCCCCCCCCCCCCCCCc1ccc(C(=O)/C=C\\C(=O)O)cc1",
            "d. O=C(Nc1nc2c(s1)CN(Cc1ccccc1)CC2)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1"
        ],
        "answer": "d",
        "answer_smiles": "O=C(Nc1nc2c(s1)CN(Cc1ccccc1)CC2)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1",
        "domain": "CYP2C19I",
        "id": 159
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2C19 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)O",
            "b. CO[C@@H]1/C=C\\CC(=O)N[C@@H](C)C(=O)OC[C@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](C)/C=C\\CC(=O)OC[C@H]1C",
            "c. O=C(O)CN(CC(=O)O)c1ccccc1",
            "d. CC1(C)O[C@@H]2C[C@H]3[C@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@H]4[C@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1"
        ],
        "answer": "a",
        "answer_smiles": "COCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)O",
        "domain": "CYP2C19I",
        "id": 160
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(C(C(=O)NC2CCCCC2)N(C(=O)c2sc(C)nc2C)c2ccc(C(C)=O)cc2)cc1",
            "b. COc1cccc(Cn2c(=O)c(C)nc3cnc(N4CCOCC4)nc32)c1",
            "c. O=C(O)Cc1cccnc1",
            "d. C/C(CCN1CCCCc2nc(C)c(C)cc21)=N\\O[C@@H](C)c1cn([C@@H]2COC[C@@H]2O)nn1"
        ],
        "answer": "b",
        "answer_smiles": "COc1cccc(Cn2c(=O)c(C)nc3cnc(N4CCOCC4)nc32)c1",
        "domain": "CYP2C9I",
        "id": 161
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C/C(CCN1CCc2nc(-c3ccccc3)c(-c3ccccc3)cc2C1)=N\\OC[C@@H](C)[C@H](OCc1ccccc1)C(C)C",
            "b. C[C@H]1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CC[C@@]1(C(=O)O)c1ccccc1",
            "c. COc1cccc2oc(-c3ccc(O)cc3)cc(=O)c12",
            "d. CCC(CC)C(=O)c1c[nH]c(C(=O)NCCCN2CCOCC2)c1"
        ],
        "answer": "c",
        "answer_smiles": "COc1cccc2oc(-c3ccc(O)cc3)cc(=O)c12",
        "domain": "CYP2C9I",
        "id": 162
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21",
            "b. CN1Cc2ccccc2[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21",
            "c. CCOc1cc(/C=N/O)cc(Cl)c1OC",
            "d. COc1cccc(Cn2c(=O)c(C)nc3cnc(N4CCN(C)CC4)nc32)c1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)n1c(N2CCN(C(=O)Nc3ccccc3)CC2)nc2ccccc21",
        "domain": "CYP2C9I",
        "id": 163
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ccc(S(=O)(=O)NCc2nccs2)cc1",
            "b. COc1ccc(CNc2ncnc3ccc(-c4ccccc4C#N)cc23)c(OC)c1",
            "c. CN1CCN(CC(=O)N2c3ccccc3Sc3cc4ccccc4cc32)CC1",
            "d. CC(=O)N1CCC[C@@]2(CCN(C(=O)Nc3cccc(C#N)c3)C2)C1"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(CNc2ncnc3ccc(-c4ccccc4C#N)cc23)c(OC)c1",
        "domain": "CYP2C9I",
        "id": 164
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1c2ccccc2-c2ccc(N=[N+]([O-])c3ccc4c(c3)C(=O)c3ccccc3-4)cc21",
            "b. CCOC(=O)C(NC(C)=O)C(OC(C)=O)c1cccc(N(CCO)CCO)c1",
            "c. C=CC[C@@H]1C=C[C@@H](O/N=C\\[C@@H](NS(=O)(=O)c2ccc(C)cc2)[C@H](C)/C=C\\CC(=O)OC)[C@@H](CO)O1",
            "d. CCOC(=O)Cn1nc(C)n(-c2ccc(C(C)(C)C)cc2)c1=O"
        ],
        "answer": "d",
        "answer_smiles": "CCOC(=O)Cn1nc(C)n(-c2ccc(C(C)(C)C)cc2)c1=O",
        "domain": "CYP2C9I",
        "id": 165
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NNc1nncn1N",
            "b. COc1ccc(OCC(O)COc2ccc(C(=O)O)cc2)cc1",
            "c. NC1(C(=O)O)CC(C(=O)O)C1",
            "d. Cc1nc(C(=O)Nc2cccc(Cl)c2Cl)nn1-c1cc(OC(C)C)c(Cl)cc1Cl"
        ],
        "answer": "d",
        "answer_smiles": "Cc1nc(C(=O)Nc2cccc(Cl)c2Cl)nn1-c1cc(OC(C)C)c(Cl)cc1Cl",
        "domain": "CYP2C9I",
        "id": 166
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN1C(=O)[C@H]2[C@H]3[C@H](O)[C@H](O)C/C(=N/O[C@@H]4O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]4OC(C)=O)[C@@H]3CC[C@@H]2C1=O",
            "b. Cn1cccc1C(=O)N1CCC[C@@]2(CCN(Cc3ccc(C#N)cc3)C2)C1",
            "c. CCOC(=O)c1c(NC(=O)Cn2cc([N+](=O)[O-])cn2)sc2c1CCC2",
            "d. COc1ccc(C2C(C(=O)c3ccccc3)=C(O)C(=O)N2CC(C)O)c(OC)c1"
        ],
        "answer": "c",
        "answer_smiles": "CCOC(=O)c1c(NC(=O)Cn2cc([N+](=O)[O-])cn2)sc2c1CCC2",
        "domain": "CYP2C9I",
        "id": 167
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cn1cccc1C(=O)N1CCC[C@@]2(CCN(C(=O)Nc3cccc(F)c3)C2)C1",
            "b. O=c1c(Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12",
            "c. CCN1C(=O)C2[C@H]3[C@H](O)[C@H](O)C/C(=N/OC[C@@H](O)[C@H]4O[C@H]5OC(C)(C)O[C@H]5[C@@H]4O)[C@@H]3CC[C@@H]2C1=O",
            "d. CCCCc1cc2ccccc2c(OCCN(C)C)n1"
        ],
        "answer": "b",
        "answer_smiles": "O=c1c(Cc2c(O)oc3ccccc3c2=O)c(O)oc2ccccc12",
        "domain": "CYP2C9I",
        "id": 168
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)[C@@H](N)CCCN=C(N)N[N+](=O)[O-]",
            "b. Cc1cccc(N/C(S)=N/C2CC3CCCC(C2)N3Cc2cccs2)c1",
            "c. O=C(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)N1CCC2(CCCN(c3ccccn3)C2)CC1",
            "d. CNC(=O)COC(=O)c1cc2c(C)nn(-c3ccc(F)cc3)c2s1"
        ],
        "answer": "d",
        "answer_smiles": "CNC(=O)COC(=O)c1cc2c(C)nn(-c3ccc(F)cc3)c2s1",
        "domain": "CYP2C9I",
        "id": 169
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the CYP450 2C9 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOC(=O)CCN1C(=O)C2[C@H]3[C@H](O)[C@H](O)C/C(=N/OC/C=C(\\C)CCC=C(C)C)[C@@H]3CC[C@@H]2C1=O",
            "b. COc1ccc2nc(C)cc(SCC(=O)Nc3c(C)cc(C)cc3C)c2c1",
            "c. COc1ccc(O[C@H]2C=C[C@@H](c3ccccc3)O[C@H]2COC(=O)CC/C(C)=N/O[C@@H]2O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)cc1",
            "d. C[C@](Cc1ccc(O)c(O)c1)(NN)C(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc2nc(C)cc(SCC(=O)Nc3c(C)cc(C)cc3C)c2c1",
        "domain": "CYP2C9I",
        "id": 170
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O",
            "b. COc1ccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
            "c. Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1",
            "d. CCN(CC)CCC[C@H](C)Nc1ccnc2cc(Cl)ccc12"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(CCN(C)CCC[C@@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
        "domain": "CYP2C9S",
        "id": 171
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)CCCN1c2ccccc2Sc2ccccc21",
            "b. CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O",
            "c. O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1",
            "d. CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CN(C)CCCN1c2ccccc2Sc2ccccc21",
        "domain": "CYP2C9S",
        "id": 172
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(OC1C[C@@H]2CC3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12",
            "b. CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O",
            "c. CNC(=O)Oc1cc(C)c(SC)c(C)c1",
            "d. CC(=O)Nc1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "O=C(OC1C[C@@H]2CC3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12",
        "domain": "CYP2C9S",
        "id": 173
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
            "b. Cc1cccc(C)c1NC(=O)[C@H](C)N",
            "c. C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C",
            "d. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21"
        ],
        "answer": "c",
        "answer_smiles": "C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C",
        "domain": "CYP2C9S",
        "id": 174
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1C(CC[S@@H+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1",
            "b. CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1",
            "c. COc1ccccc1OC[C@@H](O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1",
            "d. CCCCc1ncc(/C=C(/Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1"
        ],
        "answer": "a",
        "answer_smiles": "O=C1C(CC[S@@H+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1",
        "domain": "CYP2C9S",
        "id": 175
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1",
            "b. CC(C)(Oc1ccc([C@@H]2CC2(Cl)Cl)cc1)C(=O)O",
            "c. COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O",
            "d. C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O"
        ],
        "answer": "d",
        "answer_smiles": "C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O",
        "domain": "CYP2C9S",
        "id": 176
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O",
            "b. OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1",
            "c. CCC1(c2ccccc2)C(=O)NC(=O)NC1=O",
            "d. C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1"
        ],
        "answer": "c",
        "answer_smiles": "CCC1(c2ccccc2)C(=O)NC(=O)NC1=O",
        "domain": "CYP2C9S",
        "id": 177
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1",
            "b. COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1",
            "c. CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1",
            "d. CN(C)CCC=C1c2ccccc2C=Cc2ccccc21"
        ],
        "answer": "a",
        "answer_smiles": "OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1",
        "domain": "CYP2C9S",
        "id": 178
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. FC(F)O[C@@H](Cl)C(F)(F)F",
            "b. Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C",
            "c. C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4",
            "d. FCOC(C(F)(F)F)C(F)(F)F"
        ],
        "answer": "b",
        "answer_smiles": "Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C",
        "domain": "CYP2C9S",
        "id": 179
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for CYP450 2C9 (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H](CN1c2ccccc2Sc2ccccc21)N(C)C",
            "b. CN[C@@]1(c2ccccc2Cl)CCCCC1=O",
            "c. CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N\\N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C",
            "d. CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1"
        ],
        "answer": "b",
        "answer_smiles": "CN[C@@]1(c2ccccc2Cl)CCCCC1=O",
        "domain": "CYP2C9S",
        "id": 180
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN1[C@@H]2CC(OC(=O)[C@@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@H]12",
            "b. COCC(=O)N1CCC2(CCCN(Cc3ccccc3)C2)CC1",
            "c. c1nc(NCCc2cnc[nH]2)c2[nH]cnc2n1",
            "d. CC(C)(C)NS(=O)(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)nc3ccccc23)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)(C)NS(=O)(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)nc3ccccc23)cc1",
        "domain": "CYP2D6I",
        "id": 181
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[N+](C)(C)c1cc2c(nn1)Nc1ccccc1S2",
            "b. Oc1cc(CN2COc3ccccc32)c(O)cc1CNC1CCCCC1",
            "c. COCC(=O)N1CCC2(CCCN(C(=O)Nc3ccc(OC)cc3)C2)CC1",
            "d. COc1ccccc1CN1CC2(CCN(C(=O)c3cnccn3)CC2)C1"
        ],
        "answer": "a",
        "answer_smiles": "C[N+](C)(C)c1cc2c(nn1)Nc1ccccc1S2",
        "domain": "CYP2D6I",
        "id": 182
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@]12CC[C@@H]3[C@H](CCC4=CC(=O)CC[C@]43C)[C@@H]1CC[C@@H]2C(=O)Cn1cnc2c(=S)nc[nH]c21",
            "b. CC1(C)CC(=O)C(CCCN2C(=O)c3ccccc3C2=O)C(=O)C1",
            "c. COc1cccc([C@H]2Oc3ccc(OC)cc3/C(=N\\OCC[C@@H]3C=C[C@H](OC(C)=O)[C@H](COC(C)=O)O3)[C@@H]2O)c1",
            "d. Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)Nc1ccc2c(c1)OCO2"
        ],
        "answer": "d",
        "answer_smiles": "Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)Nc1ccc2c(c1)OCO2",
        "domain": "CYP2D6I",
        "id": 183
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)C1C(c2ccccc2)C2C(=O)c3c(OC)cc(OC)cc3O[C@@]12c1ccc(OC)cc1",
            "b. Fc1ccc(CSc2ncnc3sc4c(c23)CCCC4)cc1",
            "c. COc1ccc(NS(=O)(=O)c2ccc(I)cc2)cc1N1CCN(C)CC1",
            "d. c1cncc(-c2nccc(NCc3cccs3)n2)c1"
        ],
        "answer": "d",
        "answer_smiles": "c1cncc(-c2nccc(NCc3cccs3)n2)c1",
        "domain": "CYP2D6I",
        "id": 184
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H](N)Cc1cnc[nH]1",
            "b. Cc1ncn(-c2ccccc2O)c1C",
            "c. C=C1CC[C@@H](O)C/C1=C/C=C1\\CCC[C@]2(C)[C@@H]1CC[C@H]2[C@@H](C)CCCC(C)C",
            "d. CCC(c1nnnn1CC1CCCO1)N(CCN1CCOCC1)Cc1cc2cc(C)ccc2nc1O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1ncn(-c2ccccc2O)c1C",
        "domain": "CYP2D6I",
        "id": 185
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(Nc1ccccc1)OCc1cc(-c2ccc(Cl)cc2)on1",
            "b. Cc1ccccc1Oc1ncnc2oc(-c3ccccc3)cc12",
            "c. COCCn1c(=O)c(-c2ccccc2)nc2cncnc21",
            "d. Cc1cccc(NC(=S)NC(=O)c2cc(-c3ccccc3)nc3ccccc23)c1"
        ],
        "answer": "a",
        "answer_smiles": "O=C(Nc1ccccc1)OCc1cc(-c2ccc(Cl)cc2)on1",
        "domain": "CYP2D6I",
        "id": 186
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1",
            "b. Cc1nc(C(=O)Nc2ccc(Cl)cc2Cl)nn1-c1cc(OC(C)C)c(Cl)cc1Cl",
            "c. COc1ccc2[nH]cc(CCNc3nc(-c4ccccc4OC)nc4ccccc34)c2c1",
            "d. COc1cc2c(cc1OC)[C@@]13CCN4C=C5CCO[C@H]6CC(=O)N2[C@@H]1C6[C@H]5C[C@H]43"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc2[nH]cc(CCNc3nc(-c4ccccc4OC)nc4ccccc34)c2c1",
        "domain": "CYP2D6I",
        "id": 187
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O",
            "b. O=C(CNC(=O)c1ccco1)OCc1c(F)cccc1Cl",
            "c. O=C(CN(Cc1ccccc1Cl)C(=O)c1ccc(CN2CCOCC2)o1)NCC1CCCO1",
            "d. COCCn1c(=O)c(-c2cn(C)c3ccccc23)nc2cnc(N3CCNCC3)nc21"
        ],
        "answer": "c",
        "answer_smiles": "O=C(CN(Cc1ccccc1Cl)C(=O)c1ccc(CN2CCOCC2)o1)NCC1CCCO1",
        "domain": "CYP2D6I",
        "id": 188
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(NCC1CCC(C(=O)O)CC1)OCc1ccccc1",
            "b. CC1CN(C(=S)NC(=O)c2ccc([N+](=O)[O-])cc2)CC(C)O1",
            "c. Cc1ccc(OCC(O)Cn2c3ccccc3c3ccccc32)cc1",
            "d. Nc1ncnc2c1ncn2C[C@@H](O)C(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc(OCC(O)Cn2c3ccccc3c3ccccc32)cc1",
        "domain": "CYP2D6I",
        "id": 189
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the CYP450 2D6 enzyme (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(N2CCN(C(=O)CSc3nnc4c5cc(C)ccc5n(C)c4n3)CC2)cc1",
            "b. CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
            "c. COc1ccc(N2C(=O)CC(SC(=N)N/N=C(\\C)c3cccs3)C2=O)cc1",
            "d. CC(=O)NCc1c(Cl)cccc1-n1cccc1"
        ],
        "answer": "b",
        "answer_smiles": "CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
        "domain": "CYP2D6I",
        "id": 190
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl",
            "b. Clc1ccc(CO[C@@H](Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1",
            "c. C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1",
            "d. CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1"
        ],
        "answer": "c",
        "answer_smiles": "C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1",
        "domain": "CYP2D6S",
        "id": 191
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(O)c1ccc(OCCn2ccnc2)cc1",
            "b. C=CCc1ccccc1OC[C@@H](O)CNC(C)C",
            "c. COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC",
            "d. NC(=O)C[S@H+]([O-])C(c1ccccc1)c1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "C=CCc1ccccc1OC[C@@H](O)CNC(C)C",
        "domain": "CYP2D6S",
        "id": 192
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12",
            "b. CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21",
            "c. CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1",
            "d. CCCOCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCOCCC)C1c1cccc([N+](=O)[O-])c1"
        ],
        "answer": "b",
        "answer_smiles": "CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21",
        "domain": "CYP2D6S",
        "id": 193
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O",
            "b. O=NN(CCCl)C(=O)NC1CCCCC1",
            "c. Cn1c(=O)c2[nH]cnc2n(C)c1=O",
            "d. Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2"
        ],
        "answer": "c",
        "answer_smiles": "Cn1c(=O)c2[nH]cnc2n(C)c1=O",
        "domain": "CYP2D6S",
        "id": 194
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C",
            "b. COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13",
            "c. CCC[C@H]1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O",
            "d. CC1=C(C)C(=O)C([C@@H](CCCCCC(=O)O)c2ccccc2)=C(C)C1=O"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C",
        "domain": "CYP2D6S",
        "id": 195
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1",
            "b. CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O",
            "c. CC(C)/N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1",
            "d. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21"
        ],
        "answer": "a",
        "answer_smiles": "O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1",
        "domain": "CYP2D6S",
        "id": 196
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO",
            "b. CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N\\N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C",
            "c. O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21",
            "d. CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O"
        ],
        "answer": "d",
        "answer_smiles": "CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O",
        "domain": "CYP2D6S",
        "id": 197
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccccc1[C@H](OCCN(C)C)c1ccccc1",
            "b. COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO",
            "c. COc1ccccc1OC[C@@H](O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1",
            "d. Cn1c(=O)[nH]c2ncn(C)c2c1=O"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccccc1[C@H](OCCN(C)C)c1ccccc1",
        "domain": "CYP2D6S",
        "id": 198
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NNc1nnc(NN)c2ccccc12",
            "b. CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1",
            "c. COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1",
            "d. Nc1nc2ccc(OC(F)(F)F)cc2s1"
        ],
        "answer": "c",
        "answer_smiles": "COCCc1ccc(OC[C@@H](O)CNC(C)C)cc1",
        "domain": "CYP2D6S",
        "id": 199
    },
    {
        "question": "Which of the following four compounds is most likely to be a substrate of the CYP450 2D6 enzyme (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1",
            "b. Clc1ccc([C@@H](Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1",
            "c. NC(=O)N1c2ccccc2CC(=O)c2ccccc21",
            "d. C[C@H](CN1c2ccccc2Sc2ccccc21)N(C)C"
        ],
        "answer": "d",
        "answer_smiles": "C[C@H](CN1c2ccccc2Sc2ccccc21)N(C)C",
        "domain": "CYP2D6S",
        "id": 200
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. N#Cc1ccc(CN2CC3(CCN(C(=O)c4cnccn4)CC3)C2)cc1",
            "b. CCOc1ccc(NC(=O)c2ccc(Br)o2)c([N+](=O)[O-])c1",
            "c. O=C(/C=C/c1ccc(F)cc1)NCCC1=CCCCC1",
            "d. C[C@@H](C(=O)Nc1ccc2ccccc2c1)[C@@H]1C[C@@]1(C)[C@@H](NS(=O)(=O)c1ccccc1)c1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "C[C@@H](C(=O)Nc1ccc2ccccc2c1)[C@@H]1C[C@@]1(C)[C@@H](NS(=O)(=O)c1ccccc1)c1ccccc1",
        "domain": "CYP3A4I",
        "id": 201
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc(/C=C\\c2ccc(OC)cc2OC)cc(OC)c1",
            "b. C#CCOCCCC(=O)O",
            "c. CCCCCCN(C(=O)CCCCCN1C(=O)NC(c2ccc(-c3ccccc3)cc2)C(C(=O)OCc2ccccc2)=C1C)C(C(=O)NCCCC)c1cccc(C(=O)OC)c1",
            "d. C[C@H]1CC[C@@]2(NC1)O[C@@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@@]5(C)[C@@H]4CC[C@]3(C)[C@@H]1[C@@H]2C"
        ],
        "answer": "a",
        "answer_smiles": "COc1cc(/C=C\\c2ccc(OC)cc2OC)cc(OC)c1",
        "domain": "CYP3A4I",
        "id": 202
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. N#CCCn1c(=O)c(-c2cccc(C#N)c2)nc2cnc(N3CCOCC3)nc21",
            "b. CN1CCN(c2nc(-c3ccc(N(C)C)cc3)nc3ccccc23)CC1",
            "c. CSCC[C@@H]1NC(=O)C/C=C\\[C@@H](C)COC(=O)[C@@H](CCSC)NC(=O)C/C=C\\[C@@H](C)COC1=O",
            "d. CCCn1c(C)nc2c(NCCN(C(C)C)C(C)C)nc(C)nc21"
        ],
        "answer": "b",
        "answer_smiles": "CN1CCN(c2nc(-c3ccc(N(C)C)cc3)nc3ccccc23)CC1",
        "domain": "CYP3A4I",
        "id": 203
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN1CC[C@@H]2CN3CCc4cccc(c43)[C@H]2C1",
            "b. COc1ccccc1-c1nc(NCCN2CCOCC2)c2ccccc2n1",
            "c. NC(Cc1ccccc1)(C(=O)O)C(=O)O",
            "d. CCn1c(N)c(C(=O)NCc2cccnc2)sc1=S"
        ],
        "answer": "d",
        "answer_smiles": "CCn1c(N)c(C(=O)NCc2cccnc2)sc1=S",
        "domain": "CYP3A4I",
        "id": 204
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccccc1NC(=O)CN1CCN(c2ccccc2F)CC1",
            "b. CC1CCCC(n2c(=S)[nH]c3ccccc3c2=O)C1C",
            "c. N#CCCn1nnc2ccccc21",
            "d. Oc1c[n+](CC[n+]2cc(O)on2)no1"
        ],
        "answer": "b",
        "answer_smiles": "CC1CCCC(n2c(=S)[nH]c3ccccc3c2=O)C1C",
        "domain": "CYP3A4I",
        "id": 205
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1c(C(C)C)oc2cc3oc(=O)ccc3cc12",
            "b. CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1",
            "c. CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C(=O)/C(=C\\NN2CCN(C)CC2)C(=C4O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C",
            "d. O=c1cc(-c2ccccc2O)oc2c(O)c(O)ccc12"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1",
        "domain": "CYP3A4I",
        "id": 206
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)c1ccccc1O",
            "b. O=C(NNc1nc2ccccc2s1)C1CC1",
            "c. COc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)nc3ccccc23)c(OC)c1",
            "d. COc1ccc(C(=O)N2CCC3(CCN(Cc4nccs4)CC3)CC2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc(CNc2nc(-c3ccc4c(c3)OCO4)nc3ccccc23)c(OC)c1",
        "domain": "CYP3A4I",
        "id": 207
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2F)c([N+](=O)[O-])c1",
            "b. Nc1ncnc2[nH]c(N3CCN(CCO)CC3)nc12",
            "c. c1ccc([C@H]2CNCc3ccccc32)cc1",
            "d. O=C(O)c1cccc(N2CCCC2=O)c1"
        ],
        "answer": "d",
        "answer_smiles": "O=C(O)c1cccc(N2CCCC2=O)c1",
        "domain": "CYP3A4I",
        "id": 208
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. c1ccc(CN2CCCC3(CCNCC3)C2)cc1",
            "b. COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC",
            "c. Cc1ccc(S(=O)(=O)O[C@H]2C[C@@H](C(C)(C)C)CC[C@@H]2c2ccccc2)cc1",
            "d. O=C(O)c1cc(Cl)cc(Cc2cc(Cl)cc(C(=O)O)c2O)c1O"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC",
        "domain": "CYP3A4I",
        "id": 209
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of the enzyme CYP450 3A4 (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H](Br)C(=O)N[C@H](CO)C(=O)O",
            "b. O=C(CN1CCN(S(=O)(=O)c2ccccc2)CC1)NC(=O)NCc1ccccc1",
            "c. CCS(=O)(=O)Nc1ccc(C2=NN(C(=O)c3ccco3)C(c3ccc(C)cc3)C2)cc1",
            "d. CC1(C)O[C@H]2[C@@H](c3n[nH]c4c(O)nc(O)nc34)OC[C@H]2O1"
        ],
        "answer": "c",
        "answer_smiles": "CCS(=O)(=O)Nc1ccc(C2=NN(C(=O)c3ccco3)C(c3ccc(C)cc3)C2)cc1",
        "domain": "CYP3A4I",
        "id": 210
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. NC(=O)c1cn(Cc2c(F)cccc2F)nn1",
            "b. Cc1c(N(C(=O)c2cc(-c3cc(F)ccc3C(=O)N3Cc4ccccc4C[C@H]3CN3CCOCC3)n(C)c2C)c2ccc(O)cc2)cc(C#N)n1C",
            "c. CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(=O)[nH]n3C)CS[C@H]12)c1csc(N)n1",
            "d. COC(=O)[C@H]1OC(SCc2nnn(-c3ccc(S(N)(=O)=O)cc3)c2I)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O"
        ],
        "answer": "a",
        "answer_smiles": "NC(=O)c1cn(Cc2c(F)cccc2F)nn1",
        "domain": "Caco2",
        "id": 211
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1",
            "b. COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)/C=C/c3cc(OC)c(OC)c(OC)c3)cc1)CC2",
            "c. COc1ccc(N(C)c2cnc(SCc3c(F)cccc3F)n2-c2ccc(F)cc2)cc1OC",
            "d. COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(C(C)(C)CO)cc2)CC3)cc1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1",
        "domain": "Caco2",
        "id": 212
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. c1ccc([C@H]2CN3CCSC3=N2)cc1",
            "b. COCc1ccc2c(C(C(=O)NS(=O)(=O)c3ccc(C)cc3OC)c3ccc4c(c3)OCO4)cn(C)c2c1",
            "c. CC1=NC(C)(c2cccc(-c3cccnc3)c2)N=C1N",
            "d. C=Cc1cc(C(NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)Nc2cccc(C(=O)NS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)ccc1Oc1cc(OC)nc(-c2ccccc2)n1"
        ],
        "answer": "c",
        "answer_smiles": "CC1=NC(C)(c2cccc(-c3cccnc3)c2)N=C1N",
        "domain": "Caco2",
        "id": 213
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. CC(=O)N1CCN(c2cccc(-c3cc(-c4ncco4)c4c(N)ncnn34)c2)C(=O)C1(C)C",
            "b. O=C1C[C@@H](c2ccc(C[C@H](Nc3nc4ccccc4s3)c3nc4ccccc4[nH]3)cc2F)S(=O)(=O)N1",
            "c. CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccn1)c1ccccc1",
            "d. CS(=O)(=O)NCc1cccc(-c2cc(=O)n(CC3CN4CCC3CC4)c3ccccc23)c1"
        ],
        "answer": "a",
        "answer_smiles": "CC(=O)N1CCN(c2cccc(-c3cc(-c4ncco4)c4c(N)ncnn34)c2)C(=O)C1(C)C",
        "domain": "Caco2",
        "id": 214
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. O=C(c1ccc(OC2CC(N3CCCCC3)C2)cc1)N1CCC(O)CC1",
            "b. COc1ccc2c(NCC(C)(C)c3ccccc3)noc2c1",
            "c. COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C",
            "d. O=C(O)CN1CCN(C(COCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ccccc2)CC1"
        ],
        "answer": "c",
        "answer_smiles": "COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C",
        "domain": "Caco2",
        "id": 215
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. N#Cc1ccc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)nc1",
            "b. CC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN[C@H]1CC(C)(C)Cn2nc(CC(C)(C)C)cc21",
            "c. CC(=O)Nc1ccc(Nc2nc3c(-c4ccc(C(=O)O)cc4)cccn3n2)cc1",
            "d. Cc1nc(-c2c(C3CCCC3)c3ccc(C(=O)NC(C)(C)C(=O)Nc4ccc(C=CC(=O)O)cc4)cc3n2C)cs1"
        ],
        "answer": "a",
        "answer_smiles": "N#Cc1ccc(OC[C@@H]2CCCN2C(=O)C[C@H](N)Cc2cc(F)c(F)cc2F)nc1",
        "domain": "Caco2",
        "id": 216
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. CC(C)c1cccnc1[C@@H]1CCC[C@H](c2nc3cccc(N4CCN(C)CC4)n3c2Cl)N1C",
            "b. CC[C@H]1C[C@@H](n2c(=O)nc(-c3cnn(C)c3)c3oc4c(C#N)cc(-c5cn(C)cn5)cc4c32)CCO1",
            "c. CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1",
            "d. C=CCNC(=O)C(=O)C(CCCC)NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC(C(=O)O)C(C)(C)C)C(C)(C)C)C2(C)C"
        ],
        "answer": "c",
        "answer_smiles": "CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1",
        "domain": "Caco2",
        "id": 217
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. CCCCCCCCCC[C@H](N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(N)=O",
            "b. COC(=O)/C=C/c1cncc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2Cl)C(=O)c2ccccc2)c1",
            "c. Cc1cc(Nc2nc3c(-c4ccc(C(=O)N(C)C)cc4)cccn3n2)ccc1C(=O)NC1CC1",
            "d. Oc1cccc(-c2ccc(-c3cccc(O)c3)cc2)c1"
        ],
        "answer": "d",
        "answer_smiles": "Oc1cccc(-c2ccc(-c3cccc(O)c3)cc2)c1",
        "domain": "Caco2",
        "id": 218
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C",
            "b. Cc1ncc(C(=O)Nc2ccc(-c3cccc(S(=O)(=O)C4CC4)c3)cn2)cn1",
            "c. CC(C)(F)[C@H](F)CNC(=O)c1cnc(-c2cnc3cc(C#N)cnn23)cc1Nc1cnn(CC(F)F)c1",
            "d. CCC1(C)NC(=O)c2cc(S(=O)(=O)Nc3ccccc3Cl)ccc2NC1=O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1ncc(C(=O)Nc2ccc(-c3cccc(S(=O)(=O)C4CC4)c3)cn2)cn1",
        "domain": "Caco2",
        "id": 219
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high Caco2 cell permeability (Papp>=10x10-6cm/s) based on the public experimental data?",
        "options": [
            "a. CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C",
            "b. O=C(N[C@@H](Cc1ccc(F)c(Br)c1)C(=O)O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nsnc12",
            "c. CC(=O)Nc1ccc(Nc2nc3c(-c4ccc(C(=O)NCCOc5ccccc5)cc4)cccn3n2)cc1",
            "d. C[C@@H]1O[C@@H](/C=C/c2ccccc2)OC[C@H]1NC(=O)Cc1ccccc1"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)Nc1ccc(Nc2nc3c(-c4ccc(C(=O)NCCOc5ccccc5)cc4)cccn3n2)cc1",
        "domain": "Caco2",
        "id": 220
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. CCN(CC)CCCNC(=O)Cn1ncc(-c2ccccc2)c1-c1ccccc1",
            "b. CCCCCC[C@H]1C(=O)O[C@H](C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C",
            "c. c1cncc(C2=NCCC2)c1",
            "d. CN1CC[C@@]2(C)c3cc(O)ccc3N(C)[C@H]12"
        ],
        "answer": "a",
        "answer_smiles": "CCN(CC)CCCNC(=O)Cn1ncc(-c2ccccc2)c1-c1ccccc1",
        "domain": "Carc",
        "id": 221
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. CNCCC=C1c2ccccc2C=Cc2ccccc21",
            "b. CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)C3C[C@@H]12",
            "c. O=c1cc(-c2ccc(O)cc2)oc2c(C3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc(O)c12",
            "d. O=S(=O)(O)c1cc(S(=O)(=O)O)c2c(N=Nc3ccc(S(=O)(=O)O)c4ccccc34)c(O)ccc2c1"
        ],
        "answer": "d",
        "answer_smiles": "O=S(=O)(O)c1cc(S(=O)(=O)O)c2c(N=Nc3ccc(S(=O)(=O)O)c4ccccc34)c(O)ccc2c1",
        "domain": "Carc",
        "id": 222
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. Nc1nc2c(ncn2[C@H]2CC(O)[C@@H](CO)O2)c(=S)[nH]1",
            "b. C=C[C@@]12CN(C)[C@H]3[C@H]1[C@@]1(C(=O)Nc4ccccc41)C1CC2[C@@H]3CO1",
            "c. COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2",
            "d. CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1"
        ],
        "answer": "a",
        "answer_smiles": "Nc1nc2c(ncn2[C@H]2CC(O)[C@@H](CO)O2)c(=S)[nH]1",
        "domain": "Carc",
        "id": 223
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. Cc1cc(C)c(N=Nc2c(O)c(S(=O)(=O)O)cc3cc(S(=O)(=O)O)ccc23)cc1C",
            "b. O=c1cccc2n1C[C@@H]1CNC[C@H]2C1",
            "c. CC1=CC(=O)C2=C(C)C[C@H](O)[C@@H]3[C@H](OC(=O)[C@H]3C)[C@@H]12",
            "d. COc1cc2ccc(=O)oc2cc1O"
        ],
        "answer": "a",
        "answer_smiles": "Cc1cc(C)c(N=Nc2c(O)c(S(=O)(=O)O)cc3cc(S(=O)(=O)O)ccc23)cc1C",
        "domain": "Carc",
        "id": 224
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. CNCCc1ccccn1",
            "b. CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O",
            "c. O=S(=O)(O)c1ccc(N=Nc2c(O)ccc3cc(S(=O)(=O)O)ccc23)cc1",
            "d. CC(=O)N[C@@H](CC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "O=S(=O)(O)c1ccc(N=Nc2c(O)ccc3cc(S(=O)(=O)O)ccc23)cc1",
        "domain": "Carc",
        "id": 225
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. NCCNc1cccc2ccccc12",
            "b. C/C=C1/C[C@@H](C)[C@](O)(CO)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23",
            "c. C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccccc12",
            "d. CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12"
        ],
        "answer": "a",
        "answer_smiles": "NCCNc1cccc2ccccc12",
        "domain": "Carc",
        "id": 226
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. COc1ccn(C)c(=O)c1C#N",
            "b. COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC",
            "c. COc1cc(-c2ccc(N=Nc3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(OC)c2)ccc1N=Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O",
            "d. CC[C@@H](C)C(=O)O[C@H]1[C@H](O)[C@H]2[C@@H](CN3C[C@@H](C)CC[C@H]3[C@@]2(C)O)C2C[C@]34O[C@@]5(O)[C@@H](OC(=O)[C@](C)(O)CC)CC[C@@]3(C)[C@@H]5[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]4[C@@]21O"
        ],
        "answer": "c",
        "answer_smiles": "COc1cc(-c2ccc(N=Nc3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(OC)c2)ccc1N=Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O",
        "domain": "Carc",
        "id": 227
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. CN(C)Cc1c[nH]c2ccccc12",
            "b. C=C1[C@@H](O)[C@]23C[C@@H]1[C@@H](O)C[C@H]2[C@@]12C4[C@@H]3C[C@@H]1[C@@](C)(CC[C@@H]2O)CN4CC",
            "c. CN1C2CCC1CC(O)C2",
            "d. O=C(O)C1=NN(c2ccc(S(=O)(=O)O)cc2)C(=O)C1N=Nc1ccc(S(=O)(=O)O)cc1"
        ],
        "answer": "d",
        "answer_smiles": "O=C(O)C1=NN(c2ccc(S(=O)(=O)O)cc2)C(=O)C1N=Nc1ccc(S(=O)(=O)O)cc1",
        "domain": "Carc",
        "id": 228
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. CC(=O)Nc1cc2ccccc2oc1=O",
            "b. CCCCNN",
            "c. O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12",
            "d. C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C"
        ],
        "answer": "b",
        "answer_smiles": "CCCCNN",
        "domain": "Carc",
        "id": 229
    },
    {
        "question": "Which of the following four compounds is the most likely to be carcinogenic based on the public experimental data?",
        "options": [
            "a. O=S(=O)(O)c1ccc2c(N=Nc3ccc(S(=O)(=O)O)c4ccccc34)c(O)c(S(=O)(=O)O)cc2c1",
            "b. C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12",
            "c. C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C",
            "d. COc1ccc(C[C@](C)(N)C(=O)O)cc1OC"
        ],
        "answer": "a",
        "answer_smiles": "O=S(=O)(O)c1ccc2c(N=Nc3ccc(S(=O)(=O)O)c4ccccc34)c(O)c(S(=O)(=O)O)cc2c1",
        "domain": "Carc",
        "id": 230
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NC(=O)c1nc([N+](=O)[O-])cn1Cc1cccc(OC(F)(F)F)c1",
            "b. C/C=C(\\C)C(=O)O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3[C@H](O[C@@H](CCCCC)CCCCCCC(=O)CCC(=O)OC[C@@H](O2)[C@H]1OC(=O)/C=C/c1ccccc1)O[C@H](C)[C@H](OC(C)=O)[C@@H]3O",
            "c. Cc1ccccc1C(=O)ON=C(Cn1cc([N+](=O)[O-])nc1C)c1ccc(Br)cc1",
            "d. C[C@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](NC(=O)[C@@H](O)CCN)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O"
        ],
        "answer": "b",
        "answer_smiles": "C/C=C(\\C)C(=O)O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3[C@H](O[C@@H](CCCCC)CCCCCCC(=O)CCC(=O)OC[C@@H](O2)[C@H]1OC(=O)/C=C/c1ccccc1)O[C@H](C)[C@H](OC(C)=O)[C@@H]3O",
        "domain": "CytotoxHEK293",
        "id": 231
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCNCC(O)COc1cc(O)c2c(=O)c3ccccc3oc2c1",
            "b. CCCCCCC12CC1(C(=O)OCC)C(=O)Nc1ccc(Cl)cc12",
            "c. COc1ccc([C@H]2CC(=O)N(c3cccc(O)c3)C2)cc1OC1CCCC1",
            "d. CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1"
        ],
        "answer": "d",
        "answer_smiles": "CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1",
        "domain": "CytotoxHEK293",
        "id": 232
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCNc1nc(N)nc2c1CCN(C(=O)c1ccccc1)C2",
            "b. Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2)cc1",
            "c. CCOC(=O)CN1CCN(CCCOc2c3c(c(-c4ccc5c(c4)OCO5)c4cc(OC)c(OC)cc24)C(=O)OC3)CC1",
            "d. CCCC[C@@H](CO)Nc1nc(N)ncc1OCCCc1ccc2c(c1)OCO2"
        ],
        "answer": "c",
        "answer_smiles": "CCOC(=O)CN1CCN(CCCOc2c3c(c(-c4ccc5c(c4)OCO5)c4cc(OC)c(OC)cc24)C(=O)OC3)CC1",
        "domain": "CytotoxHEK293",
        "id": 233
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C)C(OC(=O)CCCC/C(=N/NC(=O)CCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2c[nH]c3ccccc23)[C@@H](C)O)C(=O)O)C1=O)c1ccccc1)c1ccccc1)OC)N(C)C(=O)C(C)NC(=O)C(C(C)C)N(C)C",
            "b. CCC[C@@H](CCO)Nc1nc(N)nc2ccc(F)cc12",
            "c. CNCCCN1c2ccccc2CCc2ccccc21",
            "d. CCOC(=O)C12CC1(Cc1ccccc1)c1cc(Cl)ccc1NC2=O"
        ],
        "answer": "a",
        "answer_smiles": "CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C)C(OC(=O)CCCC/C(=N/NC(=O)CCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2c[nH]c3ccccc23)[C@@H](C)O)C(=O)O)C1=O)c1ccccc1)c1ccccc1)OC)N(C)C(=O)C(C)NC(=O)C(C(C)C)N(C)C",
        "domain": "CytotoxHEK293",
        "id": 234
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OCCOCCOC(=O)CCCC=CCCC=CCCCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C",
            "b. COc1ccc(OC)c(N(CC(=O)Nc2ccc(Cl)cc2)S(=O)(=O)c2ccc(C)cc2)c1",
            "c. O=C(NCCN1CCCC1)c1ccc2oc(C(=O)c3cc(O)c(O)c(O)c3)cc2c1",
            "d. O=C1Nc2ccc(Br)cc2C12N(c1ccccc1)N=C(c1ccccc1)N2c1ccc(Cl)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OCCOCCOC(=O)CCCC=CCCC=CCCCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C",
        "domain": "CytotoxHEK293",
        "id": 235
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1(C)CC[C@]2(C(=O)NCCCNC(=O)c3cc(C(=O)NCCCNC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)cc(C(=O)NCCCNC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)c3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1",
            "b. CC1(C)[C@@H]2CC[C@@]1([C@@H](O)CN1CCN(c3ccccc3F)CC1)C(=O)C2",
            "c. C=C(C)[C@@H]1CC[C@]2(C(=O)NCCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12",
            "d. O=C1CCCC=CC[C@H]2C=C(I)C(=O)C2=CC[C@H](CCCCC(F)(F)F)OC(=O)CCCC=CC[C@H]2C=C(I)C(=O)C2=CC[C@H](CCCCC(F)(F)F)O1"
        ],
        "answer": "d",
        "answer_smiles": "O=C1CCCC=CC[C@H]2C=C(I)C(=O)C2=CC[C@H](CCCCC(F)(F)F)OC(=O)CCCC=CC[C@H]2C=C(I)C(=O)C2=CC[C@H](CCCCC(F)(F)F)O1",
        "domain": "CytotoxHEK293",
        "id": 236
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCc1ccc(-c2cn([C@]3(CO)O[C@@H](n4ccc(N)nc4=O)[C@@H](F)[C@@H]3O)nn2)cc1",
            "b. C=C(C)[C@@H]1CC[C@]2(C(=O)NCCN)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12",
            "c. COc1ccc(NC(=O)N2CCCCN3[C@H](CN(C)C)[C@H](c4ccc(C#Cc5ccccc5)cc4)[C@@H]3C2)cc1",
            "d. C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F"
        ],
        "answer": "d",
        "answer_smiles": "C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F",
        "domain": "CytotoxHEK293",
        "id": 237
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1",
            "b. CCc1nc(C)nc(NC(CC)c2ccc(Oc3ccc(F)cc3)cc2)c1Br",
            "c. O=P([O-])(O)C(O)(C[n+]1cc[nH]c1)P(=O)(O)O",
            "d. NS(=O)(=O)c1ccc(N2N=C3c4ccccc4OCC3C2c2ccc(Cl)cc2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1",
        "domain": "CytotoxHEK293",
        "id": 238
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCNc1nc(N)nc2c1CN(C(=O)c1cc(C)on1)CC2",
            "b. CCCCNc1nc(N)nc(C)c1Oc1ccccc1",
            "c. Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1",
            "d. CCc1ncnc(NC(CC)c2ccc([N+](=O)[O-])cc2)c1Cl"
        ],
        "answer": "c",
        "answer_smiles": "Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1",
        "domain": "CytotoxHEK293",
        "id": 239
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity toward HEK293 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(Nc1nc(N)nc2ccn(Cc3ccccn3)c12)c1ccccn1",
            "b. COc1ccccc1/C=C/C=N/N1C(=S)NC2C1N(C)C(=O)N2c1ccccc1",
            "c. Cc1cccc(NC(=O)CCSc2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)c1",
            "d. O=C1C2=C3C(=O)c4ccccc4N3C(CO)CN2c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccccc1/C=C/C=N/N1C(=S)NC2C1N(C)C(=O)N2c1ccccc1",
        "domain": "CytotoxHEK293",
        "id": 240
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3cc(-c4ccccc4)n[nH]3)CC2)cc1",
            "b. C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1",
            "c. Cc1nocc1C(=O)N1CCN2C(=O)c3ncccc3CC12C1CCCCC1",
            "d. COc1ccc(C(=O)NCC(=O)N/N=C(\\C)c2csc3c(N)cccc23)cc1OC"
        ],
        "answer": "b",
        "answer_smiles": "C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1",
        "domain": "CytotoxHepG2",
        "id": 241
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1nc2c(S(=O)(=O)c3ccc(Cl)cc3)c(N)c3ccccc3c2s1",
            "b. CC[C@@H](C)CO/N=C/[C@@]12C[C@@H]3[C@H](C)CC[C@H]3[C@@]3(C=O)C[C@H]1C=C(C(C)C)[C@]32C(=O)O",
            "c. CCc1ccc(S(=O)(=O)Cc2nc(C)sc2[N+](=O)[O-])cc1",
            "d. CC(C)S(=O)(=O)c1cn(Cc2nc3cc(Cl)ccc3n2CCCS(C)(=O)=O)c2ccccc12"
        ],
        "answer": "a",
        "answer_smiles": "Cc1nc2c(S(=O)(=O)c3ccc(Cl)cc3)c(N)c3ccccc3c2s1",
        "domain": "CytotoxHepG2",
        "id": 242
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1OCCc2c(CO)cccc21",
            "b. CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1n1cc([N+](=O)[O-])c2ccc(NCc3ccccc3)cc21",
            "c. C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)nc(N)[nH]c21",
            "d. COC(=O)[C@@H]1C(C=NCCN=CC2=Cc3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@@H]2C(=O)OC)OCO4)=Cc2cc3c(cc2[C@H]1c1cc(OC)c(OC)c(OC)c1)OCO3"
        ],
        "answer": "c",
        "answer_smiles": "C=C1[C@H](CO)[C@@H](O)C[C@@H]1n1cnc2c(=O)nc(N)[nH]c21",
        "domain": "CytotoxHepG2",
        "id": 243
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NCC(O)CNc1cc(N2CCC(c3ccccc3)CC2)nc2ccccc12",
            "b. COC(=O)C=Cc1cc(OC)c(OCCOC(=O)[C@]2(C)CC[C@]3(C)CC[C@]4(C)C5=CC=C6C(=CC(=O)C(O)=C6C)[C@]5(C)CC[C@@]4(C)[C@@H]3C2)c(OC)c1",
            "c. CO[C@@H](C)[C@@H](C(=O)N1CCOCC1)N(c1cc(C#CC(C)(C)C)sc1C(=O)O)C(=O)[C@H]1CC[C@H](C)CC1",
            "d. CC(C)CCn1c(Cn2c(=O)n(C(C)C)c3ccccc32)nc2cccc(CO)c21"
        ],
        "answer": "b",
        "answer_smiles": "COC(=O)C=Cc1cc(OC)c(OCCOC(=O)[C@]2(C)CC[C@]3(C)CC[C@]4(C)C5=CC=C6C(=CC(=O)C(O)=C6C)[C@]5(C)CC[C@@]4(C)[C@@H]3C2)c(OC)c1",
        "domain": "CytotoxHepG2",
        "id": 244
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=c1[nH]cc(F)c(=O)[nH]1",
            "b. Cc1cc(NC(=O)[C@H]2CCN(S(=O)(=O)N[C@H](C)CO)C2)ccc1F",
            "c. O=C1OCCc2c(/C=C/c3ccccc3)cccc21",
            "d. Cc1ccccc1C(=O)NC(=S)Nc1cccc(F)c1"
        ],
        "answer": "a",
        "answer_smiles": "O=c1[nH]cc(F)c(=O)[nH]1",
        "domain": "CytotoxHepG2",
        "id": 245
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(C(=O)Nc2c[nH]c3ccc(-c4csc5c(F)cccc45)nc3c2=O)cc1OC",
            "b. Fc1cnc(N2CCOCC2)nc1N1CCc2ccccc21",
            "c. COc1ccc2nc3cc(Cl)ccc3c(NCCCCNC(C)=O)c2c1",
            "d. COc1cc(C(=O)NCC(O)(c2ccc(OC)c(-c3ccc(F)c(Br)c3)n2)C(F)(F)F)ccc1OCC(N)=O"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc2nc3cc(Cl)ccc3c(NCCCCNC(C)=O)c2c1",
        "domain": "CytotoxHepG2",
        "id": 246
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1c(C(=O)C(=O)NC2(C)CC(F)(F)C2)c(F)c(C(=O)Nc2ccc(F)c(C#N)c2)n1C",
            "b. Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1",
            "c. C[C@@H]1CC[C@@H](C(=O)N(CC(=O)N2CCOCC2)c2cc(C#CC(C)(C)C)sc2C(=O)O)CC1O",
            "d. COc1cc(C(=O)NCC(=O)c2cn(C(C)C)cc(-c3csc4c(F)cccc34)c2=O)ccc1OCCO"
        ],
        "answer": "b",
        "answer_smiles": "Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1",
        "domain": "CytotoxHepG2",
        "id": 247
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCc1cc(NC(=O)c2cccc(S(=O)(=O)NC(C)C)c2)ccc1F",
            "b. CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)/C=C(\\C)C(C)C)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)C=Cc4cc(F)cc(F)c4)CC3=CC[C@]12O",
            "c. COc1ccc(/C=C/C(=O)O/N=C/c2ccccn2)cc1OC",
            "d. OC[C@H]1O[C@@H](n2c3ccc(Cl)cc3c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O"
        ],
        "answer": "d",
        "answer_smiles": "OC[C@H]1O[C@@H](n2c3ccc(Cl)cc3c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O",
        "domain": "CytotoxHepG2",
        "id": 248
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCN(CCCC)c1nc(N/N=C/c2ccc3c(c2)OCO3)nc(Nc2ccc([N+](=O)[O-])cc2)n1",
            "b. COc1cc(C(=O)NCC(O)(CO)c2cc3c(c(-c4ccc(F)c(Cl)c4)n2)OCC3(C)C)cc2cccnc12",
            "c. COc1cc(C(=O)NCC(=O)c2ccc(OC)c(-c3ccc(F)c(Cl)c3)n2)ccc1OCCF",
            "d. CC1=C(NC(=O)CCC(=O)O)C(=O)C(C(C)(C)CC(=O)O[C@@H]2[C@@]3(C(C)C)O[C@H]3[C@@H]3O[C@]34[C@]23O[C@H]3C[C@H]2C3=C(CC[C@@]24C)C(=O)OC3)=C(C)C1=O"
        ],
        "answer": "d",
        "answer_smiles": "CC1=C(NC(=O)CCC(=O)O)C(=O)C(C(C)(C)CC(=O)O[C@@H]2[C@@]3(C(C)C)O[C@H]3[C@@H]3O[C@]34[C@]23O[C@H]3C[C@H]2C3=C(CC[C@@]24C)C(=O)OC3)=C(C)C1=O",
        "domain": "CytotoxHepG2",
        "id": 249
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against HepG2 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1nnc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2C)o1",
            "b. CCCNc1ccc2c([N+](=O)[O-])cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)c2c1",
            "c. CCCCCCCCCCCCCCCCCCCCOCCCOP(=O)(O)COC1(Cn2cnc3cnc(N)nc32)CC1",
            "d. Cc1ccc(NC(=O)c2ccc([N+](=O)[O-])o2)c(C)c1"
        ],
        "answer": "c",
        "answer_smiles": "CCCCCCCCCCCCCCCCCCCCOCCCOP(=O)(O)COC1(Cn2cnc3cnc(N)nc32)CC1",
        "domain": "CytotoxHepG2",
        "id": 250
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccccc1/C=C/CNc1ccc(-c2cnco2)c(OC)c1",
            "b. CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(c1c(O)n3nccc3n(Cc3ccccc3)c1=O)N2",
            "c. COC(=O)NC(C(=O)N1CCCC1c1[nH]c(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)c2c1CCCC2)C1CCOC1",
            "d. COc1cc(C(=O)NC(c2cccs2)c2cc(Cl)c3cccnc3c2O)cc(OC)c1OC"
        ],
        "answer": "c",
        "answer_smiles": "COC(=O)NC(C(=O)N1CCCC1c1[nH]c(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)c2c1CCCC2)C1CCOC1",
        "domain": "CytotoxHuh7",
        "id": 251
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@H]3[C@@H]4CC[C@@H](C4)[C@H]3N(Cc3ccc(F)cc3)C1=O)N2",
            "b. CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)C3(CC3)CN(Cc3ccc(F)cc3)C1=O)N2",
            "c. Cc1ccn(C(=O)NCCNC(=O)Nc2ccc(Cc3ccc(NC(=O)NCCNC(=O)n4ccc(C)n4)cc3)cc2)n1",
            "d. COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(N[C@@H](C(=O)OCc2ccccc2)c2ccccc2)Oc2cccc3ccccc23)[C@@H](O)[C@@]1(C)O"
        ],
        "answer": "b",
        "answer_smiles": "CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)C3(CC3)CN(Cc3ccc(F)cc3)C1=O)N2",
        "domain": "CytotoxHuh7",
        "id": 252
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(Cc1ccccc1)NCCCCNc1ccnc2cc(Cl)ccc12",
            "b. C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C1CCCCC1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)COCC=Cc1cc3c(nccc3cc1OC)O2)C(=O)NS(=O)(=O)C1CC1",
            "c. O=C(O)C(O)=CC(=O)c1ccc(OCc2ccccc2)cc1",
            "d. O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3cccnc3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1cccnc1"
        ],
        "answer": "b",
        "answer_smiles": "C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C1CCCCC1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)COCC=Cc1cc3c(nccc3cc1OC)O2)C(=O)NS(=O)(=O)C1CC1",
        "domain": "CytotoxHuh7",
        "id": 253
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=c1ccn([C@H]2C[C@@H](O)[C@@H](CO)O2)c(=O)[nH]1",
            "b. COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5=C(C(=O)N(NC(=O)OC)C(C)C)CCCC5)[nH]4)cc3)cc2)[nH]1)C(C)C",
            "c. CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C(Br)(Br)[C@@H]1O)Oc1ccccc1",
            "d. C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c2ncnc(N)c12"
        ],
        "answer": "b",
        "answer_smiles": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5=C(C(=O)N(NC(=O)OC)C(C)C)CCCC5)[nH]4)cc3)cc2)[nH]1)C(C)C",
        "domain": "CytotoxHuh7",
        "id": 254
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(-c2cc(-c3ccccc3)c(C#N)c(SCC(O)C[S+]([O-])Cc3ccccc3)n2)cc1",
            "b. Nc1ncnc2c1c(-c1ccc3ccccc3c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F",
            "c. CSCCN1CCc2ccc3[nH]cc(-c4cccc(Cl)c4)c3c2C1",
            "d. CCCN(C)c1nn(CCC(C)C)c(=O)c(C2=NS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)c1O"
        ],
        "answer": "d",
        "answer_smiles": "CCCN(C)c1nn(CCC(C)C)c(=O)c(C2=NS(=O)(=O)c3cc(NS(C)(=O)=O)ccc3N2)c1O",
        "domain": "CytotoxHuh7",
        "id": 255
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)C1CCCCN1S(=O)(=O)c1ccc(C)cc1",
            "b. CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@H]3CCC[C@H]3N(Cc3ccc(F)c(Cl)c3)C1=O)N2",
            "c. C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](O)c1ccnc2ccc(OC)cc12",
            "d. CCN1CCN(c2cc(C)c3cc(NC(=O)/C=C/c4cccc(Cl)c4)ccc3n2)CC1"
        ],
        "answer": "b",
        "answer_smiles": "CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@H]3CCC[C@H]3N(Cc3ccc(F)c(Cl)c3)C1=O)N2",
        "domain": "CytotoxHuh7",
        "id": 256
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(NCc1cccs1)c1cc2nc(-c3ccco3)cc(C(F)(F)Cl)n2n1",
            "b. COc1ccc(C[n+]2cc(-c3ccc(Cl)cc3)n3ccccc32)cc1",
            "c. CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C",
            "d. COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5c4)ccc3c2)[nH]1)C(C)C"
        ],
        "answer": "d",
        "answer_smiles": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5c4)ccc3c2)[nH]1)C(C)C",
        "domain": "CytotoxHuh7",
        "id": 257
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ccc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CC6(CN5C(=O)[C@H](NC(=O)OC)C(C)C)OCC(C)(C)CO6)[nH]4)cc3)cc2)[nH]1)C(C)C",
            "b. COc1ccc(-c2ccc3nc(N)nc(N4CCOCC4)c3c2)cc1OC",
            "c. COc1cc(OC)c2c(=O)cc(-c3ccc(OCc4cn(-c5ccc(F)cc5Cl)nn4)c(OCc4cn(-c5ccc(F)cc5Cl)nn4)c3)oc2c1",
            "d. NC(=O)c1cn([C@@H]2C[C@H](CO)C[C@H]2O)nn1"
        ],
        "answer": "a",
        "answer_smiles": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ccc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CC6(CN5C(=O)[C@H](NC(=O)OC)C(C)C)OCC(C)(C)CO6)[nH]4)cc3)cc2)[nH]1)C(C)C",
        "domain": "CytotoxHuh7",
        "id": 258
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCCC5C(=O)N(NC(=O)OC)C(C)C)[nH]4)cc3F)cc2)[nH]1)C(C)C",
            "b. CC(C)(C)C#Cc1cc(N(C(=O)c2ccc(Cl)cc2F)C2CCC(O)CC2)c(C(=O)O)s1",
            "c. CCOc1ccc(Nc2nc(N3CCCCC3)nc(N3CCCCC3)n2)cc1",
            "d. CC(=O)N(C1=C(N2CCCC2)C(=O)c2ccccc2C1=O)c1ccc(F)cc1"
        ],
        "answer": "a",
        "answer_smiles": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCCC5C(=O)N(NC(=O)OC)C(C)C)[nH]4)cc3F)cc2)[nH]1)C(C)C",
        "domain": "CytotoxHuh7",
        "id": 259
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxic effects on Huh7 liver cancer cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(Nc2ncnc3c2c(-c2ccccc2)c(-c2ccccc2)n3-c2cccc(Cl)c2)cc1",
            "b. COc1ccc(C2C(C(=O)Nc3cccc(Cl)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1",
            "c. COc1ccc(Cl)cc1S(=O)(=O)N1CCCC2=C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]21",
            "d. COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5C6CCC(C6)C5C(=O)N[C@H](C)c5cccnc5)[nH]4)cc3)cc2)[nH]1)[C@@H](C)OC"
        ],
        "answer": "d",
        "answer_smiles": "COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5C6CCC(C6)C5C(=O)N[C@H](C)c5cccnc5)[nH]4)cc3)cc2)[nH]1)[C@@H](C)OC",
        "domain": "CytotoxHuh7",
        "id": 260
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5C=CCCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C",
            "b. CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1",
            "c. COc1ccc([C@@H]2c3[nH]c4ccccc4c3C[C@@H]3C(=O)N([C@@H]4CCN(Cc5ccccc5)C4)CC(=O)N23)cc1O",
            "d. N=C(N)NCCc1ccc(OCc2ccc(COc3ccc(CCNC(=N)N)cc3)cc2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1",
        "domain": "CytotoxMRC5",
        "id": 261
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)OC(=O)NNC(=O)c1ccc([N+](=O)[O-])o1",
            "b. C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@H]([C@@H]2CCC[C@H]2C(=O)O)CC=CC=C(C#N)[C@H](O)[C@@H](C)C1",
            "c. O=C1N=C(NS(=O)(=O)c2cccc3ccccc23)SC1=Cc1ccc(C(=O)O)cc1",
            "d. COc1ccc2cc1Oc1ccc(cc1)CCc1cccc(O)c1-c1ccc(cc1O)CC2"
        ],
        "answer": "b",
        "answer_smiles": "C[C@@H]1C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O[C@H]([C@@H]2CCC[C@H]2C(=O)O)CC=CC=C(C#N)[C@H](O)[C@@H](C)C1",
        "domain": "CytotoxMRC5",
        "id": 262
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C1CCC2[C@](C)(C(=O)NCC(=O)O)CCC[C@]2(C)[C@H]1CC[C@@H](C)CC(=O)OC",
            "b. CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1",
            "c. [C]C([C])=[C][C]c1c([O])c([C][C]=C([C])[C])c2oc(-c3cc([O])c([O])cc3[O])c([C][C]=C([C])[C])c(=O)c2c1[O]",
            "d. CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(NC4CCC(O)CC4)c3)c2C1"
        ],
        "answer": "b",
        "answer_smiles": "CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1",
        "domain": "CytotoxMRC5",
        "id": 263
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1c(C)c2cccnc2c2ncccc12.N[C@H]1CCCC[C@@H]1N.[Cl-].[Cl-].[Pt+2]",
            "b. Clc1ccc2c(NCCCN3CCN(CCCN(Cc4ccnc5ccccc45)Cc4ccnc5ccccc45)CC3)ccnc2c1",
            "c. COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)CN)c1ccccc1-2",
            "d. OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O"
        ],
        "answer": "a",
        "answer_smiles": "Cc1c(C)c2cccnc2c2ncccc12.N[C@H]1CCCC[C@@H]1N.[Cl-].[Cl-].[Pt+2]",
        "domain": "CytotoxMRC5",
        "id": 264
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cccc2c1C(O)C13C=CC4=C(C(=O)CC(C)(O)C4)C1(O3)C2=O",
            "b. Nc1ncnc2c1c(-c1cccc3ccccc13)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",
            "c. Clc1ccc2c(NCCCN3CCN(CCCNCCc4ccccc4)CC3)ccnc2c1",
            "d. Cc1cccc(/C(=N\\NC(=S)N(C)C)c2ccccc2)n1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1cccc(/C(=N\\NC(=S)N(C)C)c2ccccc2)n1",
        "domain": "CytotoxMRC5",
        "id": 265
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1nc(N)nc(NCCCOC(=O)CCc2ccc(S(=O)(=O)n3c(C4(O)C=CC(=O)C=C4)cc4ccccc43)cc2)n1",
            "b. CCOC(=O)[C@H](C)NP(=O)(OC[C@@]1(C)O[C@@H](n2ccc3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O)Oc1ccccc1",
            "c. O=C(Nc1ccccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccc1",
            "d. CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(C)C)[C@@H](C)CC"
        ],
        "answer": "a",
        "answer_smiles": "Nc1nc(N)nc(NCCCOC(=O)CCc2ccc(S(=O)(=O)n3c(C4(O)C=CC(=O)C=C4)cc4ccccc43)cc2)n1",
        "domain": "CytotoxMRC5",
        "id": 266
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(O)c1ccc(-c2cc(Cl)c3c(c2)CC(CNC(=O)/C=C/c2cccnc2)O3)s1",
            "b. Cc1cc(Br)cc(C)c1Nc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(C)cc(Br)cc3C)n2)nc(Nc2ccc(C#N)cc2)n1",
            "c. COc1cc(OC)c2c(c1)OC(c1ccc(OC)c(OC)c1)C(O)C2",
            "d. COc1cc(-n2c(-c3ccc(C)cc3)csc2=S)cc(OC)c1OC"
        ],
        "answer": "a",
        "answer_smiles": "CC(O)c1ccc(-c2cc(Cl)c3c(c2)CC(CNC(=O)/C=C/c2cccnc2)O3)s1",
        "domain": "CytotoxMRC5",
        "id": 267
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ncnc2c1c(-c1c[nH]cn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",
            "b. O=C(CN1CCCCC1)Nc1cc(COC(=O)NCCCN2CCNCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1",
            "c. Cl[Au](Cl)Cl.Cl[Au](Cl)Cl.c1cc(-c2ccncc2)ccn1",
            "d. CC(C)(C)OC(=O)[C@H](CC1CCCCC1)NCCCN[C@@H](CC1CCCCC1)C(=O)OC(C)(C)C.Cl.Cl.I[Pt]I"
        ],
        "answer": "a",
        "answer_smiles": "Nc1ncnc2c1c(-c1c[nH]cn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",
        "domain": "CytotoxMRC5",
        "id": 268
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)CCCO/N=C1\\c2ccccc2-c2nc3c(CN(C)C)cccc3nc21",
            "b. Cc1cc(-c2ccccc2)cc(C)c1OCCCc1cc(COCCOCCOCCOCCNC(=O)Nc2ccc(Cc3ccc(NC(=O)NCCOCCOCCOCCOCc4cc(CCCOc5c(C)cc(-c6ccccc6)cc5C)on4)cc3)cc2)no1",
            "c. CC[C@H]1CN(C)[C@H]2Cc3c([nH]c4ccccc34)C(=O)C[C@@H]1[C@@H]2C(=O)OC",
            "d. CO[C@@H]1CN(c2ccc(C#CC3(O)CN4CCC3CC4)c(Cc3ccccc3)n2)C[C@H]1O"
        ],
        "answer": "a",
        "answer_smiles": "CN(C)CCCO/N=C1\\c2ccccc2-c2nc3c(CN(C)C)cccc3nc21",
        "domain": "CytotoxMRC5",
        "id": 269
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit cytotoxicity against MRC5 cells (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C1C(=O)[C@]2(C)C(=O)O[C@@]34C[C@H](C)C(C(=O)O)=C[C@@H]3CCC[C@H](C)C[C@@H](C)[C@H]1O[C@H]24",
            "b. CCCCCCCCCCCCCCCC(=O)O[Pt](Cl)(Cl)OC(=O)CCCC(=O)OCn1cc(F)c(=O)[nH]c1=O.N.N",
            "c. Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",
            "d. CN1O[C@H](n2cc3ccoc3nc2=O)C[C@@H]1CO"
        ],
        "answer": "a",
        "answer_smiles": "C=C1C(=O)[C@]2(C)C(=O)O[C@@]34C[C@H](C)C(C(=O)O)=C[C@@H]3CCC[C@H](C)C[C@@H](C)[C@H]1O[C@H]24",
        "domain": "CytotoxMRC5",
        "id": 270
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(C)C(=O)O[C@@H]1[C@H]2[C@@H](OC(C)=O)[C@@H](C)C[C@]2(O)C(=O)[C@@](C)(OC(C)=O)[C@@H]2[C@@H]3[C@H](C[C@@H](OC(C)=O)[C@@]12COC(C)=O)C3(C)C",
            "b. CCCCCCCCCCC#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]c1=O",
            "c. Cc1cn([C@@H]2C[C@H]3CCCN3O2)c(=O)[nH]c1=O",
            "d. O=C(CN1CCN(c2ccccc2)CC1)Nc1ccc(-c2nc3cc(C(F)(F)F)ccc3n2C23CC4CC(CC(C4)C2)C3)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CCCCCCCCCCC#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]c1=O",
        "domain": "CytotoxVero",
        "id": 271
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccn2c(NC3CCCC3)c(-c3ccccn3)nc2c1",
            "b. CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](NC(=O)[C@@H](N)CSCc2ccccc2)[C@H]1O",
            "c. CC(C(/C=N/NC(=S)NCc1ccccc1)=N\\NC(=S)NCc1ccccc1)N1C(=O)c2ccccc2C1=O",
            "d. CC(=O)OC[C@H]1O[C@@H](n2cc(C(F)CBr)c(=O)[nH]c2=O)C[C@@H]1OC(C)=O"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)c1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](NC(=O)[C@@H](N)CSCc2ccccc2)[C@H]1O",
        "domain": "CytotoxVero",
        "id": 272
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cccc(CC[C@H]2C[C@H]3CCC[C@H]4C[C@@H](C)NC(=N2)N34)c1",
            "b. COc1cc(-c2c(O)ccn(C3OC(CO)C(O)C3O)c2=O)cc(OC)c1OC",
            "c. COc1ccc(-n2c(SC(C)C(=O)Nc3ncc(C)cc3Cl)nc3ccccc32)cc1",
            "d. N[C@@H]1CCCC[C@@H]1NC(=S)NC12CC3CC(CC(C3)C1)C2"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc(-n2c(SC(C)C(=O)Nc3ncc(C)cc3Cl)nc3ccccc32)cc1",
        "domain": "CytotoxVero",
        "id": 273
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cc(C)n(Cc2ccc(NC(=O)c3nn(C)cc3[N+](=O)[O-])cc2)n1",
            "b. CC(C)c1ccc(C=NNC(=O)/C=C/c2ccc(C(C)(C)C)cc2)cc1",
            "c. Cc1cc2c(cc1C)[n+]([O-])c(/C=N/NC(=O)c1ccncc1)c(C)[n+]2[O-]",
            "d. CC(/C=N/NC(=O)c1[nH]nc2c1CCC2)=C\\c1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "CC(/C=N/NC(=O)c1[nH]nc2c1CCC2)=C\\c1ccccc1",
        "domain": "CytotoxVero",
        "id": 274
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=[N+]([O-])c1ccc(-c2cc(CNS(=O)(=O)c3ccc(F)cc3)on2)cc1",
            "b. Cc1ccc([C@H](COC(=O)/C=C/c2ccccc2)OC(=O)/C=C/c2ccccc2)cc1",
            "c. CCCOc1ccc(NC(=O)/C=C/c2cnc(-c3ccccc3)s2)cc1",
            "d. O=C(c1ccc(F)cc1)c1c(C(F)(F)F)[n+]([O-])c2cc(F)c(F)cc2[n+]1[O-]"
        ],
        "answer": "d",
        "answer_smiles": "O=C(c1ccc(F)cc1)c1c(C(F)(F)F)[n+]([O-])c2cc(F)c(F)cc2[n+]1[O-]",
        "domain": "CytotoxVero",
        "id": 275
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. c1cnc2cc3[nH]cnc3cc2c1",
            "b. COc1cc(NC(C(=O)c2c[nH]c3c(C)cc(OC(F)(F)F)cc23)c2ccc(F)cc2OCCO)cc(S(C)(=O)=O)c1",
            "c. O=S(=O)(c1cccc(NC(=S)N2CCN(c3cccc(Cl)c3)CC2)c1)C(F)F",
            "d. CN(C)C(=O)c1ccc(COc2ccccc2Br)o1"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc(NC(C(=O)c2c[nH]c3c(C)cc(OC(F)(F)F)cc23)c2ccc(F)cc2OCCO)cc(S(C)(=O)=O)c1",
        "domain": "CytotoxVero",
        "id": 276
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C=COC(=O)NC1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(SC)c(=O)cc21",
            "b. Cn1c2ccccc2c2ccccc21",
            "c. Cn1cnc([N+](=O)[O-])c1S(=O)(=O)c1cccc(Cl)c1",
            "d. Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2"
        ],
        "answer": "a",
        "answer_smiles": "C=COC(=O)NC1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(SC)c(=O)cc21",
        "domain": "CytotoxVero",
        "id": 277
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(-c2nc3cc(/C(C)=N\\NC(N)=S)ccc3n2C2CCCCC2)c(OC)c1",
            "b. COc1cc([C@H](COC(=O)/C=C/c2ccccc2)OC(=O)/C=C/c2ccccc2)cc(OC)c1OC",
            "c. CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4",
            "d. Clc1nc(Cl)c2ncn([C@@H]3C[C@H]4CC[C@@H]3C4)c2n1"
        ],
        "answer": "c",
        "answer_smiles": "CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4",
        "domain": "CytotoxVero",
        "id": 278
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCN(CCC)S(=O)(=O)c1ccc(NC(=O)c2cc(C(F)(F)F)nn2C)cc1",
            "b. OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCCCCCCC1CCCO1",
            "c. COc1ccccc1C1CC(c2c(O)nc3ccc(Cl)cc3c2-c2ccccc2)=NN1S(C)(=O)=O",
            "d. CCCCCC[C@@H](CCC[C@H](OC(C)=O)[C@H]1CC[C@H]([C@H]2CC[C@H]([C@@H](CCCCCCCCCCCCC3=C[C@H](C)OC3=O)OC(C)=O)O2)O1)O[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O"
        ],
        "answer": "d",
        "answer_smiles": "CCCCCC[C@@H](CCC[C@H](OC(C)=O)[C@H]1CC[C@H]([C@H]2CC[C@H]([C@@H](CCCCCCCCCCCCC3=C[C@H](C)OC3=O)OC(C)=O)O2)O1)O[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O",
        "domain": "CytotoxVero",
        "id": 279
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit Vero cytotoxicity (CC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc(NC(=O)CCCN2C(=O)/C(=C\\c3ccco3)SC2=S)cc1",
            "b. CO[C@H]1C2=CO[C@@]3(O)[C@H](O)CO[C@H]4O[C@@H]([C@@H]2[C@]43O)[C@]2(C)CC[C@@]3(C)CCC(C(C)C)=C3[C@H]2[C@H]1O",
            "c. CC(=O)C1=C(O)C(=O)N(c2cc(C(C)(C)C)on2)C1c1ccc(C(C)C)cc1",
            "d. CC1(C)[C@H](O)C[C@H](O)[C@]2(C)[C@H]3CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]3(C)C(=O)C[C@@H]12"
        ],
        "answer": "b",
        "answer_smiles": "CO[C@H]1C2=CO[C@@]3(O)[C@H](O)CO[C@H]4O[C@@H]([C@@H]2[C@]43O)[C@]2(C)CC[C@@]3(C)CCC(C(C)C)=C3[C@H]2[C@H]1O",
        "domain": "CytotoxVero",
        "id": 280
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341",
            "b. O=C1CCC(=O)N1c1ccc(Cl)c(Cl)c1",
            "c. CN=C(NC)NCc1ccccc1",
            "d. COc1ccc2[nH]cc(CCNC(C)=O)c2c1"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc2[nH]cc(CCNC(C)=O)c2c1",
        "domain": "DILT",
        "id": 281
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341",
            "b. CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2",
            "c. CC(=O)C(=O)O",
            "d. CCN1C(=O)NC(c2ccccc2)C1=O"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2",
        "domain": "DILT",
        "id": 282
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. CCCOC(=O)Cn1cc(I)c(=O)c(I)c1",
            "b. CC1(CO)CN(c2ccccc2)NC1=O",
            "c. C=Cc1ccccc1S(=O)(=O)O",
            "d. COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OCCO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C"
        ],
        "answer": "b",
        "answer_smiles": "CC1(CO)CN(c2ccccc2)NC1=O",
        "domain": "DILT",
        "id": 283
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. Cc1ccccc1OCC(O)CO",
            "b. C1CCNC1",
            "c. NC(=O)C1CCCN1C(=O)C(Cc1c[nH]cn1)NC(=O)C1CCC(=O)N1",
            "d. N#Cc1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "N#Cc1ccccc1",
        "domain": "DILT",
        "id": 284
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CC#N)C2SC1",
            "b. CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccccc3)C2SC1",
            "c. O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I",
            "d. Nc1c(Cl)cc(Cl)cc1Cl"
        ],
        "answer": "d",
        "answer_smiles": "Nc1c(Cl)cc(Cl)cc1Cl",
        "domain": "DILT",
        "id": 285
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. CC=C1NC(=O)C2CSSCCC=CC(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(C(C)C)NC1=O",
            "b. Cc1cc(=O)oc2cc(O)ccc12",
            "c. C=CCN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5",
            "d. CNC(=O)c1cnn(-c2nc(N)c3ncn(C4OC(CO)C(O)C4O)c3n2)c1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(=O)oc2cc(O)ccc12",
        "domain": "DILT",
        "id": 286
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1",
            "b. CCC(N)Cc1c[nH]c2ccccc12",
            "c. C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12",
            "d. Oc1ccc(CCCCNCC(O)c2ccc(O)c(O)c2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1",
        "domain": "DILT",
        "id": 287
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O",
            "b. CCN(CC)c1ccc(N)cc1",
            "c. Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12",
            "d. CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(N)=O)C(O)C5(CC)C=CCN6CCC43C65)C2)C1"
        ],
        "answer": "b",
        "answer_smiles": "CCN(CC)c1ccc(N)cc1",
        "domain": "DILT",
        "id": 288
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. Clc1ccc(Oc2c(Cl)ccc(Cl)c2Cl)c(Cl)c1Cl",
            "b. O=[N+]([O-])[O-]",
            "c. CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1",
            "d. CNCC(O)c1cccc(O)c1"
        ],
        "answer": "a",
        "answer_smiles": "Clc1ccc(Oc2c(Cl)ccc(Cl)c2Cl)c(Cl)c1Cl",
        "domain": "DILT",
        "id": 289
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced liver toxicity based on the public experimental data?",
        "options": [
            "a. NC(N)=NCCCC(N)C(=O)O",
            "b. c1ccc(Oc2ccccc2)cc1",
            "c. Cc1cc(=O)n(-c2ccccc2)n1C",
            "d. CC(C)c1ccc(NC(=O)CN(CC(=O)O)CC(=O)O)cc1"
        ],
        "answer": "b",
        "answer_smiles": "c1ccc(Oc2ccccc2)cc1",
        "domain": "DILT",
        "id": 290
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=N[C@H]1O",
            "b. C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1",
            "c. CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@H]12",
            "d. O=P(O)(O)C(Cc1ccc(Cl)cc1)P(=O)(O)O"
        ],
        "answer": "a",
        "answer_smiles": "O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=N[C@H]1O",
        "domain": "HIA",
        "id": 291
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21",
            "b. CC(=O)NCCCS(=O)(=O)O",
            "c. O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O",
            "d. NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@H](O[C@@H]2O[C@@H](CN)[C@@H](O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H]1O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](N)[C@@H]1O"
        ],
        "answer": "a",
        "answer_smiles": "CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21",
        "domain": "HIA",
        "id": 292
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@H]1NC(=N)N",
            "b. COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC",
            "c. COc1cc2c(cc1OC)[C@H](Cc1cc(OC)c(OC)c(OC)c1)[N@+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2",
            "d. C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@H](O)[C@H](O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@@H](O)[C@@H](O)[C@@H]1N[C@@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC",
        "domain": "HIA",
        "id": 293
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1",
            "b. CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I",
            "c. CCC[C@@H]1O[C@@H]2C[C@@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1",
            "d. COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3[N+](C)(C)CC2)CC[N+]1(C)C"
        ],
        "answer": "c",
        "answer_smiles": "CCC[C@@H]1O[C@@H]2C[C@@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1",
        "domain": "HIA",
        "id": 294
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. NCCC(O)(P(=O)(O)O)P(=O)(O)O",
            "b. CC(C)[N+]1(C)[C@@H]2CC[C@@H]1CC(OC(=O)[C@@H](CO)c1ccccc1)C2",
            "c. CN(N=O)C(=O)N[C@@H]1[C@H](O)[C@H](O)[C@H](CO)O[C@@H]1O",
            "d. COc1c(N2CCN[C@@H](C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12"
        ],
        "answer": "d",
        "answer_smiles": "COc1c(N2CCN[C@@H](C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12",
        "domain": "HIA",
        "id": 295
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1",
            "b. C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1",
            "c. O=P(O)(O)C(Cc1ccc(Cl)cc1)P(=O)(O)O",
            "d. CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@H]12"
        ],
        "answer": "a",
        "answer_smiles": "CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1",
        "domain": "HIA",
        "id": 296
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. CC(=O)NC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](N)[C@@H]3O)[C@@H](N)C[C@@H]2N)[C@@H](O)[C@@H](O)[C@@H]1O",
            "b. C[C@@]12CCC(=O)C=C1CC[C@H]1[C@H]2[C@H](O)C[C@]2(C)[C@@H]1CC[C@@]2(O)C(=O)CO",
            "c. NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@H](O[C@@H]2O[C@@H](CN)CC[C@@H]2N)[C@H](O)[C@@H]1O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](N)[C@@H]1O",
            "d. CC1(C)[C@H](C(=O)O)N2C(=O)C[C@@H]2S1(=O)=O"
        ],
        "answer": "b",
        "answer_smiles": "C[C@@]12CCC(=O)C=C1CC[C@H]1[C@H]2[C@H](O)C[C@]2(C)[C@@H]1CC[C@@]2(O)C(=O)CO",
        "domain": "HIA",
        "id": 297
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. NC[C@@H]1O[C@@H](O[C@@H]2[C@H](O[C@@H]3O[C@H](CO)[C@H](OC[C@@H]4O[C@@H](CN)[C@@H](O)[C@@H](O)[C@@H]4N)[C@H]3O)[C@@H](O)[C@@H](N)C[C@@H]2N)[C@@H](N)[C@H](O)[C@@H]1O",
            "b. Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2",
            "c. CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@@H]1C(=O)O",
            "d. CC(O)(P(=O)(O)O)P(=O)(O)O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2",
        "domain": "HIA",
        "id": 298
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. CC1(C)S[C@H]2[C@@H](NC(=O)[C@@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@@H]1C(=O)O",
            "b. CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C",
            "c. NC[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](N)[C@@H]3O)[C@@H](N)C[C@@H]2N)[C@@H](N)C[C@@H]1O",
            "d. COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1"
        ],
        "answer": "d",
        "answer_smiles": "COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1",
        "domain": "HIA",
        "id": 299
    },
    {
        "question": "Which of the following four compounds is most likely to be well absorbed in the human intestine (%FA>=30%) based on the public experimental data?",
        "options": [
            "a. Clc1ccccc1CN1CCc2sccc2C1",
            "b. CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1",
            "c. CC(=O)O[C@@H]1[C@H]([N+]2(C)CCCCC2)C[C@@H]2[C@@H]3CC[C@@H]4C[C@@H](OC(C)=O)[C@@H](N5CCCCC5)C[C@]4(C)[C@@H]3CC[C@]21C",
            "d. C[N+]1(C)CC[C@H](OC(=O)[C@@](O)(c2ccccc2)C2CCCC2)C1"
        ],
        "answer": "a",
        "answer_smiles": "Clc1ccccc1CN1CCc2sccc2C1",
        "domain": "HIA",
        "id": 300
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)cnc2I)cn1",
            "b. CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O",
            "c. CC1CN(c2ccc3c(n2)NC(=O)CO3)C(c2ccc(F)cc2)CO1",
            "d. Cc1cccc(C)c1CNc1cc(-c2c[nH]c(=O)[nH]c2=O)cn2c(C)c(C)nc12"
        ],
        "answer": "b",
        "answer_smiles": "CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O",
        "domain": "HMS",
        "id": 301
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(S(=O)(=O)N2C(=O)C(c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCCC3C(=O)N(C)C)c3cc(Cl)ccc32)cc1",
            "b. CC(C)(C)CC1NC(C(=O)Nc2ccn(CC(C)(C)O)n2)C(c2cccc(Cl)c2F)C1(C#N)c1ccc(Cl)cc1F",
            "c. CCc1ccc(-c2ccc(C(=O)N(C)C3CCN(C(=O)N4CCC(NC5CCOCC5)C4)C3)cc2)cc1",
            "d. Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(C#N)cc1"
        ],
        "answer": "a",
        "answer_smiles": "COc1ccc(S(=O)(=O)N2C(=O)C(c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCCC3C(=O)N(C)C)c3cc(Cl)ccc32)cc1",
        "domain": "HMS",
        "id": 302
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1ncnc2ccc(-c3cc(F)cc(NC(=O)CN4CCCC4)c3)cc12",
            "b. NC(=O)c1sc(-c2ccc(Cl)cc2)cc1N",
            "c. N=C(N)NC(=O)c1nc(Cl)c(N)nc1N",
            "d. N#Cc1ccc(NC2CCC(n3cnc4cnc5[nH]ccc5c43)CC2)nc1"
        ],
        "answer": "b",
        "answer_smiles": "NC(=O)c1sc(-c2ccc(Cl)cc2)cc1N",
        "domain": "HMS",
        "id": 303
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COC(=O)C1=C(CN2CCOCC2C(=O)O)NC(c2nccn2C)=NC1c1ccc(F)cc1Cl",
            "b. c1ccc(CNc2nnc(-c3c[nH]c4ncccc34)o2)cc1",
            "c. CC(Nc1nccc(Nc2cc(C3CC3)[nH]n2)n1)c1nc2cc[nH]c2cc1F",
            "d. Cc1cc(C)c2cc(C(=O)NC3CN(c4cc(Cl)ncc4Cl)C3)ccc2n1"
        ],
        "answer": "b",
        "answer_smiles": "c1ccc(CNc2nnc(-c3c[nH]c4ncccc34)o2)cc1",
        "domain": "HMS",
        "id": 304
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(F)(F)CN1CCOc2c(nn(-c3ccccc3Cl)c2-c2ccc(Cl)cc2)C1=O",
            "b. c1ccc(CN2C3CCC2CC(n2cnc4cnc5[nH]ccc5c42)C3)cc1",
            "c. C=CCC(NC(=O)COC)C(O)CNC1CC2(CCC2)Oc2ncc(C(F)(F)C(C)(C)C)cc21",
            "d. Cc1ccc2c(N3CCN(CCc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1"
        ],
        "answer": "c",
        "answer_smiles": "C=CCC(NC(=O)COC)C(O)CNC1CC2(CCC2)Oc2ncc(C(F)(F)C(C)(C)C)cc21",
        "domain": "HMS",
        "id": 305
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(NC(=O)N1CCc2cnc(NC3CCOCC3)nc2C1)c1ccc(Cl)c(F)c1",
            "b. CCC(C)C1C(=O)NC(C2Cc3ccccc3C2)C(=O)N1C(C(=O)N1CCOCC1)c1coc(C)n1",
            "c. CCOC(=O)C1=C(CN2CCOCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)cc1Br",
            "d. CCc1nn2c(-c3cc(OC)c(OC)cc3OC)cccc2c1N(CC1CCOCC1)CC1CC1"
        ],
        "answer": "d",
        "answer_smiles": "CCc1nn2c(-c3cc(OC)c(OC)cc3OC)cccc2c1N(CC1CCOCC1)CC1CC1",
        "domain": "HMS",
        "id": 306
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=c1ccc(-c2ccccc2)cn1-c1ccccc1",
            "b. COC(=O)NC1CCCOc2c1nn(-c1ccccc1Cl)c2-c1ccc(Cl)cc1",
            "c. COc1ccc(OC)c(Sc2ccc3nnc(-c4cn(C)nc4C)n3n2)c1",
            "d. CC1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C"
        ],
        "answer": "d",
        "answer_smiles": "CC1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C",
        "domain": "HMS",
        "id": 307
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1cc2nc(N3CCc4ncccc4C3)nc(N)c2c(-c2ncccn2)c1OC",
            "b. O=C(NCC12CC3CC(CC(C3)C1)C2)c1c(Cl)ccc2nc(N3CCCC(NCCc4nnn[nH]4)C3)ccc12",
            "c. Cc1ccc(S(=O)(=O)Nc2c(C(=O)NC(C)C(C)(C)C)c(C)nn2C2CCS(=O)(=O)CC2)cc1",
            "d. CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12"
        ],
        "answer": "b",
        "answer_smiles": "O=C(NCC12CC3CC(CC(C3)C1)C2)c1c(Cl)ccc2nc(N3CCCC(NCCc4nnn[nH]4)C3)ccc12",
        "domain": "HMS",
        "id": 308
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(Nc1cc(-c2ccncc2)n[nH]1)C(Cc1ccccc1)NCc1cncs1",
            "b. CC(C)(C)Cc1nc2cc(S(=O)(=O)C3CN(C(N)=O)C3)ccc2n1CC1(O)CCOCC1",
            "c. CC(Oc1cc(-c2ccc3cnn(C)c3c2)cc2ncccc12)C1CNC(=O)C1",
            "d. CCOC(=O)C1=C(CN2CCOCC2C(=O)O)NC(c2nccs2)=NC1c1ccc(F)c(F)c1F"
        ],
        "answer": "a",
        "answer_smiles": "O=C(Nc1cc(-c2ccncc2)n[nH]1)C(Cc1ccccc1)NCc1cncs1",
        "domain": "HMS",
        "id": 309
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a human microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1",
            "b. Cc1noc(Cc2cccc3c2CCC3c2ncc[nH]2)n1",
            "c. CN(c1ncnc2[nH]ccc12)C1CC(NS(=O)(=O)N(C)CCC#N)C1",
            "d. CC(C)c1c(-c2cnn(C(C)(C)C)c2)[nH]c2c(C#N)cnn2c1=O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1noc(Cc2cccc3c2CCC3c2ncc[nH]2)n1",
        "domain": "HMS",
        "id": 310
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. CCOC(O)=C1C(C)=NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1",
            "b. CN1C(=O)CCC1c1cccnc1",
            "c. C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1",
            "d. CN1CCN2c3ccccc3Cc3ccccc3C2C1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C(=O)CCC1c1cccnc1",
        "domain": "HOB",
        "id": 311
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21",
            "b. CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21",
            "c. NC(CCS)C(=O)O",
            "d. CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C"
        ],
        "answer": "c",
        "answer_smiles": "NC(CCS)C(=O)O",
        "domain": "HOB",
        "id": 312
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. CC1=NNC2=CN=C(c3ccccc3Cl)c3cc(Cl)ccc3N21",
            "b. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21",
            "c. CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)O",
            "d. CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21",
        "domain": "HOB",
        "id": 313
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3",
            "b. Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1",
            "c. CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21",
            "d. Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1"
        ],
        "answer": "b",
        "answer_smiles": "Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1",
        "domain": "HOB",
        "id": 314
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. Oc1ncc(F)c(O)n1",
            "b. CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2",
            "c. CC(C)(C)NCC(O)c1ccccc1Cl",
            "d. CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2",
        "domain": "HOB",
        "id": 315
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. Clc1ccc2nsnc2c1NC1=NCCN1",
            "b. COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341",
            "c. Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1",
            "d. CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1",
        "domain": "HOB",
        "id": 316
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1",
            "b. CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2",
            "c. CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21",
            "d. CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21"
        ],
        "answer": "c",
        "answer_smiles": "CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21",
        "domain": "HOB",
        "id": 317
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12",
            "b. O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21",
            "c. CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C",
            "d. CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21"
        ],
        "answer": "a",
        "answer_smiles": "NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12",
        "domain": "HOB",
        "id": 318
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1",
            "b. CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21",
            "c. COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1",
            "d. CCOC(=O)Nc1c[n+](N2CCOCC2)no1"
        ],
        "answer": "b",
        "answer_smiles": "CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21",
        "domain": "HOB",
        "id": 319
    },
    {
        "question": "Which of the following four compounds is most likely to have high human oral bioavailability (%F>=80%) based on the public experimental data?",
        "options": [
            "a. CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
            "b. CC[N+](C)(C)c1cccc(O)c1",
            "c. C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(O)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC",
            "d. COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C"
        ],
        "answer": "a",
        "answer_smiles": "CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
        "domain": "HOB",
        "id": 320
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. O=C1CCCN2C(=N1)Oc1cc(Cl)ccc12",
            "b. O=C1C(O)OCCN1CC(O)Cn1c([N+](=O)[O-])cnc1C(F)(F)F",
            "c. CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1C",
            "d. Brc1cncnc1-c1cccs1"
        ],
        "answer": "d",
        "answer_smiles": "Brc1cncnc1-c1cccs1",
        "domain": "LD50mice",
        "id": 321
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CCOC(=O)COc1ccc(NC(=O)COc2ccc(C=C3SC(=O)NC3=O)cc2)cc1",
            "b. [O]c1ccc(C(=N[N]c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])c2ccc([O])cc2)cc1",
            "c. O=C(O)c1cn(C2CC2)c2c(OC(F)F)c(N3CC4CCCNC4C3)c(F)cc2c1=O",
            "d. CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1",
        "domain": "LD50mice",
        "id": 322
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CCSC(=S)N(CC(O)C(O)C(O)C(O)CO)C(CCSC)C(=O)O",
            "b. COc1ccc(C=NNC(=O)Cn2c(-c3ccc(N(C)C)cc3)nc(-c3ccccc3)c2-c2ccccc2)cc1",
            "c. CSCCC(C(=O)O)N(CC(O)C(O)C(O)C(O)CO)C(=S)SCc1ccccc1",
            "d. CNC(CC(=O)O)C(=O)O"
        ],
        "answer": "d",
        "answer_smiles": "CNC(CC(=O)O)C(=O)O",
        "domain": "LD50mice",
        "id": 323
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CN(C)c1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)n2CC(=O)NN)cc1",
            "b. O=P(O)(O)CN1CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CC1",
            "c. [N]C([N])=NC([N])=N[C]c1ccc(Cl)c(Cl)c1",
            "d. CC(=O)CC1c2c(ccc3c2OCO3)C=C2c3cc4c(cc3CCN21)OCO4"
        ],
        "answer": "b",
        "answer_smiles": "O=P(O)(O)CN1CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CCN(CP(=O)(O)O)CC1",
        "domain": "LD50mice",
        "id": 324
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1N=C2",
            "b. CCc1ccc(CCOc2ccc(CC3SC(=O)N(CC(=O)c4ccc(-c5ccccc5)cc4)C3=O)cc2)nc1",
            "c. CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23",
            "d. Cc1c(C)c2c(c(C)c1N)CC(C)(CN1CCN(c3cccc(-n4ccnc4)c3)CC1)O2"
        ],
        "answer": "c",
        "answer_smiles": "CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23",
        "domain": "LD50mice",
        "id": 325
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. Fc1ccc(CNCCNc2ccnc3cc(Cl)ccc23)c(F)c1",
            "b. CC(C)(C)C(NC(=O)C(CC1CCCC1)CN(O)C=O)C(=O)N1CCC2(CC1)CNc1cc(F)ccc12",
            "c. CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(NCCN)NC(=O)C2C(O)CCN2C(=O)C(C(O)CCN)NC(=O)C(C(O)C(O)c2ccc(O)cc2)NC(=O)C2CC(O)CN2C(=O)C(C(C)O)NC1=O",
            "d. CCCCSCCNCCN"
        ],
        "answer": "c",
        "answer_smiles": "CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(NCCN)NC(=O)C2C(O)CCN2C(=O)C(C(O)CCN)NC(=O)C(C(O)C(O)c2ccc(O)cc2)NC(=O)C2CC(O)CN2C(=O)C(C(C)O)NC1=O",
        "domain": "LD50mice",
        "id": 326
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CC(=O)Oc1cccc(C(=O)NCCCCC(NC(=O)c2cccc(OC(C)=O)c2OC(C)=O)C(=O)NC(CCC(=O)N(C)OC(=O)c2ccccc2)C(=O)NC(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c2ccccc2)c1OC(C)=O",
            "b. O=c1c2ccccc2[se]n1-c1cccnc1",
            "c. CCc1c(C(=O)Nc2cc(S(=O)(=O)N(CC)CC)ccc2O)[nH]c(C)c1C(C)=O",
            "d. CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)N1CCC(NC(=O)Cc2ccccc2)CC1)C(C)(C)C"
        ],
        "answer": "a",
        "answer_smiles": "CC(=O)Oc1cccc(C(=O)NCCCCC(NC(=O)c2cccc(OC(C)=O)c2OC(C)=O)C(=O)NC(CCC(=O)N(C)OC(=O)c2ccccc2)C(=O)NC(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c2ccccc2)c1OC(C)=O",
        "domain": "LD50mice",
        "id": 327
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(OC(=O)C(F)CCN(C)C)C(NC(=O)OC(C)(C)C)c4ccccc4)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C",
            "b. CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc4ccsc34)CC2)CC1",
            "c. CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23",
            "d. CC(=CC(=O)c1ccccc1)NNC(=O)c1ccncc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(OC(=O)C(F)CCN(C)C)C(NC(=O)OC(C)(C)C)c4ccccc4)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C",
        "domain": "LD50mice",
        "id": 328
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21",
            "b. CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N",
            "c. COc1cc(C=CC(=O)OC2CCC3(C)C(=CCC4(O)C3CC(OC(=O)C=C(C)C(C)C)C3(C)C(O)(C(C)=O)CCC43O)C2)cc(OC)c1OC",
            "d. O=c1oc2ccccc2c(O)c1C1=NN(c2ccccc2)C(c2cccnc2)C1"
        ],
        "answer": "a",
        "answer_smiles": "CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21",
        "domain": "LD50mice",
        "id": 329
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in mice based on the public experimental data?",
        "options": [
            "a. CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc4sccc34)CC2)CC1",
            "b. O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1",
            "c. COc1ccc(CN=Cc2ccccc2OP2(Oc3ccccc3C=NCc3ccc(OC)cc3)=NP3(=NP4(=N2)Oc2ccccc2-c2ccccc2O4)Oc2ccccc2-c2ccccc2O3)cc1",
            "d. O=C1CCCN2C(=N1)Sc1cc(Cl)ccc12"
        ],
        "answer": "b",
        "answer_smiles": "O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1",
        "domain": "LD50mice",
        "id": 330
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. O=C(O)CCCC(=O)Nc1ccc(O)c(C(=O)O)c1",
            "b. O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O",
            "c. Cc1c(C(N)=O)sc2c1c(=O)n(Cc1ccccc1)c1n[nH]c(=O)n21",
            "d. COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(=N)c1ccc(F)c(F)c1)CC2"
        ],
        "answer": "c",
        "answer_smiles": "Cc1c(C(N)=O)sc2c1c(=O)n(Cc1ccccc1)c1n[nH]c(=O)n21",
        "domain": "LD50rat",
        "id": 331
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. COc1cc(CC(=O)Nc2ccncc2)cc(OC)c1OC",
            "b. CC(=O)c1nn(-c2ccc(Cl)cc2)c2nc3nc4onc(-c5ccccc5)c4c(-c4ccc(Cl)cc4)c3c(=O)n12",
            "c. CN(C)c1ccc(C=CC(=O)c2c(O)ccc3c(-c4ccccc4)cc(=O)oc23)cc1",
            "d. O=C(NN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(NC(=O)c1cc(O)nc(O)c1)C3=O)c1cc(O)nc(O)c1"
        ],
        "answer": "c",
        "answer_smiles": "CN(C)c1ccc(C=CC(=O)c2c(O)ccc3c(-c4ccccc4)cc(=O)oc23)cc1",
        "domain": "LD50rat",
        "id": 332
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. CCN1c2ncc(C)nc2C(N)=NS1(=O)=O",
            "b. CC(CO)NC(=O)OCc1ccccc1",
            "c. COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(=N)c1cccc(F)c1)CC2",
            "d. O=C(CCc1ccc(O)c(O)c1)CC(CCc1ccc(O)c(O)c1)OC1OCC(O)C(O)C1O"
        ],
        "answer": "b",
        "answer_smiles": "CC(CO)NC(=O)OCc1ccccc1",
        "domain": "LD50rat",
        "id": 333
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC",
            "b. COc1cc(CC(=O)Nc2ccncc2)cc(OC)c1OC",
            "c. CC(C=Cc1ccccc1)=NOC(C)C(N)=O",
            "d. CCN(CC)CCOC(=O)c1ccccc1OC(C)=O"
        ],
        "answer": "a",
        "answer_smiles": "COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC",
        "domain": "LD50rat",
        "id": 334
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. O=P(O)(O)Oc1cc(-c2ccccc2F)nc2cc3c(cc12)OCO3",
            "b. COc1c(N2CC(N)C3(CC3)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3F)c12",
            "c. c1ccc2[nH]c(-c3cscn3)nc2c1",
            "d. Cc1ccc2oc(=O)c3c(C)nc4c5ccccc5oc4c3c2c1"
        ],
        "answer": "b",
        "answer_smiles": "COc1c(N2CC(N)C3(CC3)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3F)c12",
        "domain": "LD50rat",
        "id": 335
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. CCCCSc1ccc2nc(NC(=O)OC)cn2c1",
            "b. NC(=O)c1cc[n+](CC=CC[n+]2ccc(C=NO)c(F)c2)cc1",
            "c. COc1ccc(C=NNC(N)=S)cc1OC",
            "d. CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O"
        ],
        "answer": "d",
        "answer_smiles": "CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O",
        "domain": "LD50rat",
        "id": 336
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. O=C(CNc1ccc(Cl)cc1)NN=Cc1cccc(Br)c1",
            "b. Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1",
            "c. NC(=O)c1cc[n+](CCC[n+]2ccc(C=NO)cc2)cc1",
            "d. NC(=O)c1ccc[n+](CC=CC[n+]2ccc(C=NO)cc2)c1"
        ],
        "answer": "d",
        "answer_smiles": "NC(=O)c1ccc[n+](CC=CC[n+]2ccc(C=NO)cc2)c1",
        "domain": "LD50rat",
        "id": 337
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. O=C1c2c(Br)c(Br)c(Br)c(Br)c2C(=O)N1Cc1ccccn1",
            "b. N=c1c2c3c(sc2nc(S)n1C(=O)c1ccccc1)CCCC3",
            "c. COc1cccc(N2CCN(C(=O)c3c(-c4cccc(F)c4)noc3C)CC2)c1",
            "d. NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O"
        ],
        "answer": "b",
        "answer_smiles": "N=c1c2c3c(sc2nc(S)n1C(=O)c1ccccc1)CCCC3",
        "domain": "LD50rat",
        "id": 338
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. CC1CN(Cc2cccc3c2ccn3-c2ccccc2-c2nnn[nH]2)CC(C)O1",
            "b. CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc([S+](C)[O-])cc1",
            "c. CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1",
            "d. O=C(NCCO)c1ccc(Cl)cn1"
        ],
        "answer": "b",
        "answer_smiles": "CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc([S+](C)[O-])cc1",
        "domain": "LD50rat",
        "id": 339
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit an LD50 ≥500 mg/kg in rats based on the public experimental data?",
        "options": [
            "a. COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(=N)c1cccc(C)c1)CC2",
            "b. CC1CCCCN1C1=C([O-])C(O)C(C)(N2CCCCC2C)C1",
            "c. CN1CCC(c2c(O)cc(O)c3c(=O)cc(C=Cc4c(Cl)cccc4Cl)oc23)C(O)C1",
            "d. O=C(CCc1ccc(O)c(O)c1)CC(CCc1ccc(O)c(O)c1)OC1OCC(O)C(O)C1O"
        ],
        "answer": "b",
        "answer_smiles": "CC1CCCCN1C1=C([O-])C(O)C(C)(N2CCCCC2C)C1",
        "domain": "LD50rat",
        "id": 340
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1",
            "b. CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1",
            "c. CC=C1C2C=C(C)CC1(N)c1ccc(O)nc1C2",
            "d. Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1",
        "domain": "MATE1i",
        "id": 341
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1",
            "b. CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21",
            "c. CC(N)C1CCC(C(=O)Nc2ccncc2)CC1",
            "d. COc1ccc2cc(C(C)C(=O)O)ccc2c1"
        ],
        "answer": "a",
        "answer_smiles": "CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1",
        "domain": "MATE1i",
        "id": 342
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)C1(NC(=O)C2CC3c4cccc5[nH]cc(c45)CC3N(C)C2)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O",
            "b. CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)C1C(=O)OC",
            "c. CN(N=O)C(=O)NC1C(O)OC(CO)C(O)C1O",
            "d. O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)C1(NC(=O)C2CC3c4cccc5[nH]cc(c45)CC3N(C)C2)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O",
        "domain": "MATE1i",
        "id": 343
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1",
            "b. CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21",
            "c. Oc1ncc(F)c(O)n1",
            "d. COc1c(Cl)cc2c(c1OC)N(C)C1N3C(=O)C4(C)SSC3(C(=O)N4C)C(O)C21O"
        ],
        "answer": "a",
        "answer_smiles": "O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1",
        "domain": "MATE1i",
        "id": 344
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ncc([N+](=O)[O-])n1CC(C)O",
            "b. CC(C(=O)O)c1cccc(Oc2ccccc2)c1",
            "c. CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1",
            "d. Nc1c2ccccc2nc2ccccc12"
        ],
        "answer": "c",
        "answer_smiles": "CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1",
        "domain": "MATE1i",
        "id": 345
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(cc(OCC(=O)O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C",
            "b. CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2",
            "c. C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C",
            "d. CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2",
        "domain": "MATE1i",
        "id": 346
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1",
            "b. CN(C)CCOC(c1ccccc1)c1ccccc1",
            "c. CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12",
            "d. CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12",
        "domain": "MATE1i",
        "id": 347
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1",
            "b. CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(N)=O)C(O)C5(CC)C=CCN6CCC43C65)C2)C1",
            "c. COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1OC",
            "d. Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl"
        ],
        "answer": "c",
        "answer_smiles": "COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1OC",
        "domain": "MATE1i",
        "id": 348
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1nc2ccc(OC(F)(F)F)cc2s1",
            "b. C#CC1(O)CCC2C3CCC4=Cc5oncc5CC4(C)C3CCC21C",
            "c. CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1",
            "d. CC(=O)Nc1ccc(O)cc1"
        ],
        "answer": "b",
        "answer_smiles": "C#CC1(O)CCC2C3CCC4=Cc5oncc5CC4(C)C3CCC21C",
        "domain": "MATE1i",
        "id": 349
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the MATE1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(O)=C3C(=O)c4c(O)cccc4C(C)(O)C3CC12",
            "b. CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O",
            "c. CN(C)CCCN1c2ccccc2CCc2ccccc21",
            "d. CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1"
        ],
        "answer": "d",
        "answer_smiles": "CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1",
        "domain": "MATE1i",
        "id": 350
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1nn(C)c(C)c1N(C)S(=O)(=O)c1ccc(-c2ccnc(N3CCNCC3)c2)cc1",
            "b. CC(O)(Cn1ccc2cc([N+](=O)[O-])ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1",
            "c. COc1ccc2c(c1)C(c1ccc(Cl)cc1)=NC(COS(=O)(=O)C1CC1)c1nnc(C)n1-2",
            "d. Cc1nnc2n1-c1ccc(-c3cnn(CC(N)=O)c3)cc1C(c1ccc(Cl)cc1)=NC2COS(C)(=O)=O"
        ],
        "answer": "b",
        "answer_smiles": "CC(O)(Cn1ccc2cc([N+](=O)[O-])ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1",
        "domain": "MMS",
        "id": 351
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1nc2ccc(OC3CCOC3)nc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl",
            "b. CC(C)OC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1(C)c1ccc(F)cc1",
            "c. Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(C2CC2)cc1",
            "d. CC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1"
        ],
        "answer": "a",
        "answer_smiles": "Nc1nc2ccc(OC3CCOC3)nc2n1CC(O)c1ccc(C(F)(F)F)cc1Cl",
        "domain": "MMS",
        "id": 352
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1cc(NC(=O)Cc2ccc(F)c(Cl)c2)n(C2CCCCC2)n1",
            "b. Cc1c(Cc2cccc(NS(=O)(=O)N3CCN(C)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12",
            "c. CC(Nc1nccc(Nc2cc(C3CC3)[nH]n2)n1)c1cc2cc[nH]c2cn1",
            "d. CC1(c2ccc(F)cc2)N=C(c2nccs2)NC(CN2CCOCC2)=C1c1ncco1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1c(Cc2cccc(NS(=O)(=O)N3CCN(C)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12",
        "domain": "MMS",
        "id": 353
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(F)(F)F)nc2n1",
            "b. O=C(CN1CCN(c2ccc(C(F)(F)F)cn2)CC1)NC1C2CC3CC1CC(O)(C3)C2",
            "c. Cc1c(Cc2cccc(NS(=O)(=O)NCCC#N)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12",
            "d. O=C(Nc1ccc(O)c(C(=O)O)c1)c1ccc(NC(=O)c2ccco2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1c(Cc2cccc(NS(=O)(=O)NCCC#N)c2)c(=O)oc2cc(OC(=O)N(C)C)c(Cl)cc12",
        "domain": "MMS",
        "id": 354
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)n1ncnc1-c1cn2c(n1)-c1ccc(-c3cnn(CCO)c3)cc1OCC2",
            "b. CCC(F)(F)c1nc2nc(C)cc(Nc3ccc(S(F)(F)(F)(F)F)cc3)n2n1",
            "c. CCn1ccc2cc(NC(=O)Nc3ccc(OC(CCN(C)C)c4ccccc4)cc3)ccc21",
            "d. CC(NC1CCN(c2ccc(-c3nn[nH]n3)cc2)C1)c1cccc2ccccc12"
        ],
        "answer": "d",
        "answer_smiles": "CC(NC1CCN(c2ccc(-c3nn[nH]n3)cc2)C1)c1cccc2ccccc12",
        "domain": "MMS",
        "id": 355
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(OCc4ccccc4)nc3)cc2)cc1",
            "b. CN(Cc1nnc(-c2ccco2)o1)Cc1c(F)cccc1Cl",
            "c. CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1",
            "d. CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2ccccc2-c2c(C)noc21"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(OCc4ccccc4)nc3)cc2)cc1",
        "domain": "MMS",
        "id": 356
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(O)(CN1CCc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1",
            "b. COc1cc(C(=O)Nc2cc(OC(F)(F)F)ccc2-n2cncn2)ccc1OC1CC1",
            "c. CCCc1nc(Nc2cc(NCCN)nnc2C(N)=O)ccc1OC",
            "d. CCC(C)(C)C(=O)NCc1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(O)(CN1CCc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1",
        "domain": "MMS",
        "id": 357
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1ncnc2c1sc1cc(-c3cccc(-c4nn[nH]n4)c3)ccc12",
            "b. COC(=O)C1=C(CN2CC3CC2CO3)NC(c2nccs2)=NC1(C)c1ccc(F)cc1",
            "c. CNC(=O)C1Cc2ccccc2N1C(=O)Cc1ccc(C(C)C)cc1",
            "d. COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
        "domain": "MMS",
        "id": 358
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Nc1ncc(C(=O)NC2CN(C(=O)C3CC3)C2)c2ccc(-c3cccc(F)c3)nc12",
            "b. COCCOc1cnc2ccn(C(C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)c(=O)c2c1",
            "c. O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3ccncc3)cc1)CC2",
            "d. O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3cn[nH]c3)cc1)CC2"
        ],
        "answer": "b",
        "answer_smiles": "COCCOc1cnc2ccn(C(C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)c(=O)c2c1",
        "domain": "MMS",
        "id": 359
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a mice microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1ccc(C=CC(=O)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1",
            "b. Cc1cc2oc(=O)cc(-c3cccc(N)c3)c2c(C)c1-c1ccc(CN2CCOCC2)cc1",
            "c. COc1ccc(-c2noc(C(Cc3ccc(-n4ncc(C(=O)O)c4N)cc3)c3ccc(F)cc3)n2)cc1",
            "d. CC(C)(C)NS(=O)(=O)c1cncc(-c2cc(F)n3nc(N)nc3c2)c1"
        ],
        "answer": "a",
        "answer_smiles": "COc1ccc(C=CC(=O)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1",
        "domain": "MMS",
        "id": 360
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CCSSCCC",
            "b. c1ccc2sc(SN(C3CCCCC3)C3CCCCC3)nc2c1",
            "c. CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C",
            "d. C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1"
        ],
        "answer": "c",
        "answer_smiles": "CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C",
        "domain": "NR-AR-LBD",
        "id": 361
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cc(CCC(=O)OCCOCCOCCOC(=O)CCc2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O",
            "b. CCCCCOC(=O)c1ccccc1C(=O)OCCCCC",
            "c. CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13",
            "d. CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O",
        "domain": "NR-AR-LBD",
        "id": 362
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. NNC(N)=S",
            "b. CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1",
            "c. C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C",
            "d. C=CCON/C(CCC)=C1\\C(=O)CC(C)(C)C(C(=O)OC)=C1O"
        ],
        "answer": "c",
        "answer_smiles": "C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C",
        "domain": "NR-AR-LBD",
        "id": 363
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1",
            "b. Clc1ccc2ccccc2c1",
            "c. CCCCCCCCCCCC",
            "d. C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO"
        ],
        "answer": "d",
        "answer_smiles": "C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",
        "domain": "NR-AR-LBD",
        "id": 364
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cccc(Oc2ccccc2)c1",
            "b. [N-]=[N+]=C1C=Cc2c(cccc2S(=O)(=O)O)C1=O",
            "c. c1cc2ccc3ccc4ccc5cccc6c(c1)c2c3c4c56",
            "d. C[C@H](C(=O)O)c1cccc(Oc2ccccc2)c1"
        ],
        "answer": "c",
        "answer_smiles": "c1cc2ccc3ccc4ccc5cccc6c(c1)c2c3c4c56",
        "domain": "NR-AR-LBD",
        "id": 365
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC",
            "b. CCCCNCC",
            "c. OC12N=C(c3ccccc3)SC1Cc1cc(Cl)ccc12",
            "d. C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O"
        ],
        "answer": "d",
        "answer_smiles": "C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O",
        "domain": "NR-AR-LBD",
        "id": 366
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. OC[C@H]1O[C@H](O[C@@]2(CO)O[C@@H](O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O",
            "b. C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",
            "c. CC(C)CCCC(C)CC=O",
            "d. COC(=O)c1ccc(C(=O)O)cc1"
        ],
        "answer": "b",
        "answer_smiles": "C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO",
        "domain": "NR-AR-LBD",
        "id": 367
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. FC(F)(F)c1ccccc1",
            "b. O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F",
            "c. O=C(CCl)C(Cl)Cl",
            "d. CCCCCCCC/C=C\\CCCCCCCC(=O)OCCOC(=O)CCCCCCC/C=C\\CCCCCCCC"
        ],
        "answer": "c",
        "answer_smiles": "O=C(CCl)C(Cl)Cl",
        "domain": "NR-AR-LBD",
        "id": 368
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(COc1ccccc1)N(CCCl)Cc1ccccc1",
            "b. CCCCOC(=O)CCCCCCCCC(=O)OCCCC",
            "c. CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C",
            "d. CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C",
        "domain": "NR-AR-LBD",
        "id": 369
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor androgen receptor ligand-binding domain (AR LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc(C[C@H](C)N)c(OC)cc1Br",
            "b. O=C(O)c1cccc(Cl)n1",
            "c. COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1",
            "d. COC(=O)C1=C(C)NC(COC(N)=O)=C(C(=O)OC(C)C)C1c1cccc(Cl)c1Cl"
        ],
        "answer": "d",
        "answer_smiles": "COC(=O)C1=C(C)NC(COC(N)=O)=C(C(=O)OC(C)C)C1c1cccc(Cl)c1Cl",
        "domain": "NR-AR-LBD",
        "id": 370
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)Nc1c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c(I)c(N(C)C(C)=O)c1I",
            "b. CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C",
            "c. Nc1cccc2c(O)nnc(O)c12",
            "d. O=C(O)CCC/C=C\\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O"
        ],
        "answer": "b",
        "answer_smiles": "CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C",
        "domain": "NR-AR",
        "id": 371
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCNCC",
            "b. C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12",
            "c. OC12N=C(c3ccccc3)SC1Cc1cc(Cl)ccc12",
            "d. CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC"
        ],
        "answer": "b",
        "answer_smiles": "C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12",
        "domain": "NR-AR",
        "id": 372
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)NCC(O)COc1cccc2[nH]ccc12",
            "b. CCCCCCCC(=O)Oc1c(Br)cc(C#N)cc1Br",
            "c. CCCNC(C)C(=O)Nc1ccccc1C",
            "d. CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21"
        ],
        "answer": "d",
        "answer_smiles": "CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21",
        "domain": "NR-AR",
        "id": 373
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1c(Cl)cccc1[N+](=O)[O-]",
            "b. COc1ccc(C(=O)/C(Br)=C\\C(=O)O)cc1",
            "c. COC(=O)c1ccccc1S(=O)(=O)NC(=O)N(C)c1nc(C)nc(OC)n1",
            "d. C=C1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O"
        ],
        "answer": "d",
        "answer_smiles": "C=C1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O",
        "domain": "NR-AR",
        "id": 374
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. NC(=O)CCCCC1CCSS1",
            "b. C=C(CC(=O)O)C(=O)O",
            "c. C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O",
            "d. C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1"
        ],
        "answer": "c",
        "answer_smiles": "C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O",
        "domain": "NR-AR",
        "id": 375
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ccc(Cl)cc1N",
            "b. Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1",
            "c. CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Br)Br",
            "d. CC(=O)Nc1nnc(S(N)(=O)=O)s1"
        ],
        "answer": "a",
        "answer_smiles": "Nc1ccc(Cl)cc1N",
        "domain": "NR-AR",
        "id": 376
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O",
            "b. CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1",
            "c. CCCCCCCCC1CCC(=O)O1",
            "d. FCOC(C(F)(F)F)C(F)(F)F"
        ],
        "answer": "c",
        "answer_smiles": "CCCCCCCCC1CCC(=O)O1",
        "domain": "NR-AR",
        "id": 377
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(C)(C)C",
            "b. CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C",
            "c. O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1ccc([N+](=O)[O-])cc1",
            "d. NCC1(Cc2noc(=O)[nH]2)CCCCC1"
        ],
        "answer": "b",
        "answer_smiles": "CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C",
        "domain": "NR-AR",
        "id": 378
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1",
            "b. c1csc(-c2ccc(-c3cccs3)s2)c1",
            "c. COc1cc(-c2nc(NC(=O)c3cc4cc(C)cc(C)c4n3CC(=O)O)sc2CCC2CCCCC2)c(OC)cc1Cl",
            "d. O=P(O)(O)OC(CO)CO"
        ],
        "answer": "b",
        "answer_smiles": "c1csc(-c2ccc(-c3cccs3)s2)c1",
        "domain": "NR-AR",
        "id": 379
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the androgen receptor (AR) nuclear receptor (<=10uM) based on the public experimental data?",
        "options": [
            "a. OCCCBr",
            "b. CO[Si](CCCOCC1CO1)(OC)OC",
            "c. CC(=O)C=Cc1ccc2c(c1)OCO2",
            "d. NNc1ccc(C(=O)O)cc1"
        ],
        "answer": "d",
        "answer_smiles": "NNc1ccc(C(=O)O)cc1",
        "domain": "NR-AR",
        "id": 380
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CCSSCCC",
            "b. N#Cc1cccnc1",
            "c. Nc1cccc(S(=O)(=O)c2cccc(N)c2)c1",
            "d. C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1"
        ],
        "answer": "b",
        "answer_smiles": "N#Cc1cccnc1",
        "domain": "NR-AhR",
        "id": 381
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. COP(=O)(OC)OC(Br)C(Cl)(Cl)Br",
            "b. C=CC(C)(O)CC/C=C(/C)CCC=C(C)C",
            "c. COP(=O)(OC)O/C(C)=C/C(=O)N(C)C",
            "d. CCOC(=O)C(C)Oc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CCOC(=O)C(C)Oc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1",
        "domain": "NR-AhR",
        "id": 382
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. OCC(c1ccc(Cl)cc1)c1ccc(Cl)cc1",
            "b. CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12",
            "c. Nc1ccc(-c2ccccc2)cc1",
            "d. Cc1ccc(C(=O)O)cc1"
        ],
        "answer": "c",
        "answer_smiles": "Nc1ccc(-c2ccccc2)cc1",
        "domain": "NR-AhR",
        "id": 383
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1cc(C)cc(OP(=O)(Oc2cc(C)cc(C)c2)Oc2cc(C)cc(C)c2)c1",
            "b. C=C(C#N)C(=O)OCC",
            "c. CCN(Cc1cccc(S(=O)(=O)O)c1)c1ccc(C(=C2C=CC(=[N+](CC)Cc3cccc(S(=O)(=O)O)c3)C=C2)c2ccc(O)cc2S(=O)(=O)O)cc1",
            "d. CCCCC(CC)COC(=O)OOC(C)(C)C"
        ],
        "answer": "a",
        "answer_smiles": "Cc1cc(C)cc(OP(=O)(Oc2cc(C)cc(C)c2)Oc2cc(C)cc(C)c2)c1",
        "domain": "NR-AhR",
        "id": 384
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCCCC(=O)Oc1c(Br)cc(C#N)cc1Br",
            "b. C=Cc1ccccc1C=C",
            "c. O=C(CS)Nc1ccccc1",
            "d. CCCNC(C)C(=O)Nc1ccccc1C"
        ],
        "answer": "c",
        "answer_smiles": "O=C(CS)Nc1ccccc1",
        "domain": "NR-AhR",
        "id": 385
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O",
            "b. CN1C(=O)/C(=N/NC(N)=S)c2ccccc21",
            "c. O=C(O)c1ccc(Cl)cc1",
            "d. O=S(=O)(O)CCN1CCN(CCO)CC1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C(=O)/C(=N/NC(N)=S)c2ccccc21",
        "domain": "NR-AhR",
        "id": 386
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O",
            "b. O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12",
            "c. NC(Cc1ccccc1)C(=O)O",
            "d. COC(=O)CC(C)=O"
        ],
        "answer": "b",
        "answer_smiles": "O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12",
        "domain": "NR-AhR",
        "id": 387
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1",
            "b. CCN(Cc1c(F)cccc1Cl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-]",
            "c. O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12",
            "d. CC(C)COC(=O)c1ccccc1C(=O)OCC(C)C"
        ],
        "answer": "a",
        "answer_smiles": "CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1",
        "domain": "NR-AhR",
        "id": 388
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H]1CCN(C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c2cccc3c2NC[C@H](C)C3)[C@@H](C(=O)O)C1",
            "b. O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Nc1ncc(C(F)(F)F)cc1Cl",
            "c. CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21",
            "d. Cc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCC3)c1"
        ],
        "answer": "b",
        "answer_smiles": "O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Nc1ncc(C(F)(F)F)cc1Cl",
        "domain": "NR-AhR",
        "id": 389
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor AhR (aryl hydrocarbon receptor) (<=10uM) based on the public experimental data?",
        "options": [
            "a. NS(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1",
            "b. COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1",
            "c. CC(C)CC(C)N",
            "d. Nc1ccc(/N=N/c2ccccc2)cc1"
        ],
        "answer": "d",
        "answer_smiles": "Nc1ccc(/N=N/c2ccccc2)cc1",
        "domain": "NR-AhR",
        "id": 390
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1",
            "b. CCC(=O)OCCOc1ccccc1",
            "c. CCCCCCCCCCCC(=O)O",
            "d. O=C(Cc1ccccc1)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1",
        "domain": "NR-Aromatase",
        "id": 391
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCCCCCCl",
            "b. CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O",
            "c. c1ccc(C[n+]2cccc3ccccc32)cc1",
            "d. Nc1ccc(Oc2ccc(Cl)cc2)cc1"
        ],
        "answer": "d",
        "answer_smiles": "Nc1ccc(Oc2ccc(Cl)cc2)cc1",
        "domain": "NR-Aromatase",
        "id": 392
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(c1ccc(O)cc1O)c1ccc(O)cc1O",
            "b. CCCCOC(=O)CCCCC(=O)OCCCC",
            "c. O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12",
            "d. CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C"
        ],
        "answer": "c",
        "answer_smiles": "O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12",
        "domain": "NR-Aromatase",
        "id": 393
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOC(=O)c1ccccc1C(=O)OCC",
            "b. CCOc1ccc2nc3cc(N)ccc3c(N)c2c1",
            "c. CC/C=C\\CCOC(=O)c1ccccc1O",
            "d. CCOC(=O)COC(=O)c1ccccc1C(=O)OCC"
        ],
        "answer": "b",
        "answer_smiles": "CCOc1ccc2nc3cc(N)ccc3c(N)c2c1",
        "domain": "NR-Aromatase",
        "id": 394
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1",
            "b. O=S(=O)(Oc1ccc(Cl)cc1Cl)c1ccccc1",
            "c. COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2",
            "d. CCOC(=O)Nc1ccc2c(c1)N(C(=O)CN(C)C)c1ccccc1CC2"
        ],
        "answer": "a",
        "answer_smiles": "C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1",
        "domain": "NR-Aromatase",
        "id": 395
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(O)c1ccccc1C(=O)O",
            "b. CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC",
            "c. CC1(C)[C@@H]2CC[C@@]1(C)[C@H](OC(=O)CSC#N)C2",
            "d. O=c1cccccc1O"
        ],
        "answer": "d",
        "answer_smiles": "O=c1cccccc1O",
        "domain": "NR-Aromatase",
        "id": 396
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ccc2cc(S(=O)(=O)O)ccc2c1",
            "b. CC(C)(C)c1ccc(N)cc1",
            "c. C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl",
            "d. CN(C)CCc1c[nH]c2ccccc12"
        ],
        "answer": "c",
        "answer_smiles": "C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl",
        "domain": "NR-Aromatase",
        "id": 397
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=P(O)(OCc1ccccc1)OCc1ccccc1",
            "b. CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3",
            "c. CCN(Cc1cccc(S(=O)(=O)O)c1)c1ccccc1",
            "d. CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32"
        ],
        "answer": "d",
        "answer_smiles": "CC[C@]12CCCN3CCc4c(n(c5ccccc45)C(=O)C1)[C@@H]32",
        "domain": "NR-Aromatase",
        "id": 398
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1",
            "b. OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1cccnc1",
            "c. CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1",
            "d. CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O"
        ],
        "answer": "b",
        "answer_smiles": "OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1cccnc1",
        "domain": "NR-Aromatase",
        "id": 399
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor Aromatase (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12",
            "b. C=CC(C)(CCC=C(C)C)OC=O",
            "c. C=CCCCCCCCC",
            "d. CCSC(=O)Cl"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12",
        "domain": "NR-Aromatase",
        "id": 400
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CN(N=O)c1ccccc1",
            "b. NCCc1ccc(O)cc1",
            "c. O=C(O)c1c(Cl)cccc1Cl",
            "d. CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1"
        ],
        "answer": "d",
        "answer_smiles": "CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1",
        "domain": "NR-ER-LBD",
        "id": 401
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2",
            "b. CC(C)(C#N)/N=N/C(C)(C)C#N",
            "c. CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1",
            "d. C[N+](C)(C)CCOC(N)=O"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1",
        "domain": "NR-ER-LBD",
        "id": 402
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O",
            "b. C[n+]1ccccc1/C=N/O",
            "c. CSC(C)(C)/C=N\\O",
            "d. CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C",
        "domain": "NR-ER-LBD",
        "id": 403
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",
            "b. NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1",
            "c. C#C[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C",
            "d. O=C(CN1CCNCC1)NC1CCCCC1"
        ],
        "answer": "c",
        "answer_smiles": "C#C[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C",
        "domain": "NR-ER-LBD",
        "id": 404
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. Clc1cccc(Cl)c1",
            "b. Cc1ccc(C)o1",
            "c. N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O",
            "d. CN(C)c1ccc(C2(c3ccc(N(C)C)cc3)OC(=O)c3cc(N(C)C)ccc32)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CN(C)c1ccc(C2(c3ccc(N(C)C)cc3)OC(=O)c3cc(N(C)C)ccc32)cc1",
        "domain": "NR-ER-LBD",
        "id": 405
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12",
            "b. CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O",
            "c. Clc1cc(Cl)c(Cl)nc1Cl",
            "d. C1CCCCCCCCCCC1"
        ],
        "answer": "b",
        "answer_smiles": "CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O",
        "domain": "NR-ER-LBD",
        "id": 406
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1",
            "b. CCC(C)C1CCCCC1=O",
            "c. O=C(c1ccccc1)c1ccc(O)cc1O",
            "d. C[C@]12C(=O)OC(=O)[C@H]1[C@H]1C=C[C@@H]2C1"
        ],
        "answer": "c",
        "answer_smiles": "O=C(c1ccccc1)c1ccc(O)cc1O",
        "domain": "NR-ER-LBD",
        "id": 407
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1",
            "b. O=C1CCCCCCCCCCCN1",
            "c. O=C1CCN(c2ccccc2)N1",
            "d. CC(=O)OC1CCCCC1C(C)(C)C"
        ],
        "answer": "a",
        "answer_smiles": "C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1",
        "domain": "NR-ER-LBD",
        "id": 408
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. N#Cc1ccccn1",
            "b. CCC1(C)CC(=O)NC1=O",
            "c. C/C=C1\\NC(=O)[C@H]2CSSCCC=C[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O",
            "d. CCCO"
        ],
        "answer": "c",
        "answer_smiles": "C/C=C1\\NC(=O)[C@H]2CSSCCC=C[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O",
        "domain": "NR-ER-LBD",
        "id": 409
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear receptor estrogen receptor ligand-binding domain (ER LBD) (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C(Cl)Cl",
            "b. N#CSCSC#N",
            "c. CC(=O)OCC=Cc1ccccc1",
            "d. CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1"
        ],
        "answer": "b",
        "answer_smiles": "N#CSCSC#N",
        "domain": "NR-ER-LBD",
        "id": 410
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2",
            "b. CC(C)(C#N)/N=N/C(C)(C)C#N",
            "c. CC(C)COP(=O)(OCC(C)C)OCC(C)C",
            "d. N#CCCl"
        ],
        "answer": "d",
        "answer_smiles": "N#CCCl",
        "domain": "NR-ER",
        "id": 411
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. O=C(CS)Nc1ccccc1",
            "b. Cc1c(-c2cccnc2)c2ccccc2n1CCCCC(=O)O",
            "c. NC(=O)NC1NC(=O)NC1=O",
            "d. N[Pt](N)(Cl)Cl"
        ],
        "answer": "a",
        "answer_smiles": "O=C(CS)Nc1ccccc1",
        "domain": "NR-ER",
        "id": 412
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. FC(F)(F)c1ccccc1",
            "b. O=C(O)CNC(=O)c1ccc([N+](=O)[O-])cc1",
            "c. O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F",
            "d. O=CO"
        ],
        "answer": "b",
        "answer_smiles": "O=C(O)CNC(=O)c1ccc([N+](=O)[O-])cc1",
        "domain": "NR-ER",
        "id": 413
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. CCCCOC(O)CC",
            "b. C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O",
            "c. CC[N+](C)(C)c1cccc(O)c1",
            "d. Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O"
        ],
        "answer": "d",
        "answer_smiles": "Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O",
        "domain": "NR-ER",
        "id": 414
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. CCCC[N+](C)(CCCC)CCCC",
            "b. BrCc1cccc(Oc2ccccc2)c1",
            "c. COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC",
            "d. C[N+](C)(C)Cc1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "BrCc1cccc(Oc2ccccc2)c1",
        "domain": "NR-ER",
        "id": 415
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. C(=C/c1ccccc1)\\c1ccccc1",
            "b. O=C(c1ccccc1)C1CCC1",
            "c. CCCCC(CC)COC(=O)c1ccccc1",
            "d. CC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C"
        ],
        "answer": "a",
        "answer_smiles": "C(=C/c1ccccc1)\\c1ccccc1",
        "domain": "NR-ER",
        "id": 416
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. NC[C@H](O)c1ccc(O)c(O)c1",
            "b. c1ccc([Bi](c2ccccc2)c2ccccc2)cc1",
            "c. CCCCCCCCCCCCCCCCCCOCC(O)CO",
            "d. CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C"
        ],
        "answer": "b",
        "answer_smiles": "c1ccc([Bi](c2ccccc2)c2ccccc2)cc1",
        "domain": "NR-ER",
        "id": 417
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. O=C(O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O",
            "b. NNC(=S)NN",
            "c. CC(C)(C)CC(C)(C)c1ccccc1O",
            "d. CCCCN(CCCCO)N=O"
        ],
        "answer": "c",
        "answer_smiles": "CC(C)(C)CC(C)(C)c1ccccc1O",
        "domain": "NR-ER",
        "id": 418
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. CC[C@@]1(c2ccccc2)NC(=O)N(C)C1=O",
            "b. Cc1ccc(N=Nc2c(O)ccc(N=Nc3ccc(S(=O)(=O)O)cc3)c2O)c(C)c1",
            "c. CCCCCCCCC=O",
            "d. CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN"
        ],
        "answer": "d",
        "answer_smiles": "CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN",
        "domain": "NR-ER",
        "id": 419
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the nuclear estrogen receptor (ER) (<=10uM) based on its molecular structure based on the public experimental data?",
        "options": [
            "a. C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC",
            "b. Brc1c(Br)c(Br)c(Br)c(Br)c1Br",
            "c. CN1C(=O)/C(=N/NC(N)=S)c2ccccc21",
            "d. C=CCOCC(CO)(COCC=C)COCC=C"
        ],
        "answer": "a",
        "answer_smiles": "C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC",
        "domain": "NR-ER",
        "id": 420
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)c1ccc(N)cc1",
            "b. CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O",
            "c. Cc1ccccc1CO[C@H]1C[C@]2(C(C)C)CC[C@@]1(C)O2",
            "d. NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O"
        ],
        "answer": "b",
        "answer_smiles": "CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O",
        "domain": "NR-PPARg",
        "id": 421
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. C1CCCC1",
            "b. CCCCCCC(O)CCCCCCCCCCC(=O)O",
            "c. Cc1cc(C)c(C)c(O)c1",
            "d. Oc1ncnc2[nH]ncc12"
        ],
        "answer": "b",
        "answer_smiles": "CCCCCCC(O)CCCCCCCCCCC(=O)O",
        "domain": "NR-PPARg",
        "id": 422
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CC(C)(CCC=C(C)C)OC=O",
            "b. CCCOC/C(=N\\c1ccc(Cl)cc1C(F)(F)F)n1ccnc1",
            "c. C=CCCCCCCCC",
            "d. CCSC(=O)Cl"
        ],
        "answer": "b",
        "answer_smiles": "CCCOC/C(=N\\c1ccc(Cl)cc1C(F)(F)F)n1ccnc1",
        "domain": "NR-PPARg",
        "id": 423
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CC(=C)CCC=C(C)C",
            "b. CCN(CC)CCSC(=O)C(c1ccccc1)c1ccccc1",
            "c. CCCCCCC/C=C/C=O",
            "d. CN(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CCN(CC)CCSC(=O)C(c1ccccc1)c1ccccc1",
        "domain": "NR-PPARg",
        "id": 424
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc(/C=C/C(=O)O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@H](C)CCC=C(C)C)CC[C@@]3(C)[C@@H]5CC[C@H]4C2(C)C)ccc1O",
            "b. C=CCOC(=O)CCC1CCCCC1",
            "c. O=C(O)c1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1",
            "d. O=C1CCCCO1"
        ],
        "answer": "a",
        "answer_smiles": "COc1cc(/C=C/C(=O)O[C@H]2CC[C@]34C[C@]35CC[C@]3(C)[C@@H]([C@H](C)CCC=C(C)C)CC[C@@]3(C)[C@@H]5CC[C@H]4C2(C)C)ccc1O",
        "domain": "NR-PPARg",
        "id": 425
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCCCCCCCCc1ccccc1O",
            "b. CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-]",
            "c. CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC",
            "d. O=[N+]([O-])c1cc(Cl)c(Cl)cc1Cl"
        ],
        "answer": "a",
        "answer_smiles": "CCCCCCCCCCCCc1ccccc1O",
        "domain": "NR-PPARg",
        "id": 426
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC",
            "b. CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@]1(C)O[C@@H]1CC=C(C)C",
            "c. CN[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)O[C@H]2C[C@@H](N)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N)C[C@@H]3N)O[C@@H]2[C@@H]1O",
            "d. CC(CO)(CO)CO"
        ],
        "answer": "b",
        "answer_smiles": "CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@]1(C)O[C@@H]1CC=C(C)C",
        "domain": "NR-PPARg",
        "id": 427
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1",
            "b. O=C(O)c1cccc(Cl)n1",
            "c. O=[N+]([O-])C(Cl)(Cl)Cl",
            "d. CC(C)(C)NCCO"
        ],
        "answer": "a",
        "answer_smiles": "CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1",
        "domain": "NR-PPARg",
        "id": 428
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(OCc1ccccc1)c1cccnc1",
            "b. O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21",
            "c. CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O",
            "d. CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1"
        ],
        "answer": "b",
        "answer_smiles": "O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21",
        "domain": "NR-PPARg",
        "id": 429
    },
    {
        "question": "Which of the following four compounds is most likely to interact with an agonist or ligand for the nuclear receptor PPAR纬 (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCOCCC",
            "b. CC(C)(C)c1csc(-c2cc3cc(OCc4ccccc4CC(=O)O)ccc3o2)n1",
            "c. OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1",
            "d. COC(C)(C)OC"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)(C)c1csc(-c2cc3cc(OCc4ccccc4CC(=O)O)ccc3o2)n1",
        "domain": "NR-PPARg",
        "id": 430
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O",
            "b. COc1cc([C@@H]2c3cc4c(cc3[C@@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O",
            "c. COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1",
            "d. CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1",
        "domain": "OATP1b1i",
        "id": 431
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12",
            "b. COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC",
            "c. O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12",
            "d. CC(=O)O[C@H]1C[C@@H](OC(C)=O)C(C)(C)[C@@H]2C[C@@H](O)[C@@]3(C)[C@H](CC[C@]4(C)[C@@H](c5ccoc5)OC(=O)[C@H]5O[C@@]534)[C@@]12C"
        ],
        "answer": "c",
        "answer_smiles": "O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12",
        "domain": "OATP1b1i",
        "id": 432
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2[C@H](C)[C@H](CC1)O[C@]1(CC[C@H](C)[C@H](C[C@@H](C)O)O1)[C@H]2C",
            "b. CC(=O)O[C@]1(C)CC[C@@]23C[C@H]1C(C)(C)[C@@H]2CC[C@H]3C",
            "c. COC(=O)[C@@H]1OC(=O)[C@H]2O[C@]23[C@@]2(C)[C@H](CC[C@@]13C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@H]2OC(C)=O",
            "d. COc1c(CC(=O)c2cc3c(cc2O)OC(C)(C)C(O)C3)ccc2c1C=CC(C)(C)O2"
        ],
        "answer": "b",
        "answer_smiles": "CC(=O)O[C@]1(C)CC[C@@]23C[C@H]1C(C)(C)[C@@H]2CC[C@H]3C",
        "domain": "OATP1b1i",
        "id": 433
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1",
            "b. CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12",
            "c. COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CC[C@@H]3[C@@]1(C)C2=O",
            "d. CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C"
        ],
        "answer": "a",
        "answer_smiles": "OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1",
        "domain": "OATP1b1i",
        "id": 434
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O",
            "b. CC1=CC(=O)C2=C(C)C[C@H](O)[C@@H]3[C@H](OC(=O)[C@H]3C)[C@H]12",
            "c. Cc1[nH]c2ccccc2c1CN(C)C",
            "d. COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3=C4C=C(OC)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O"
        ],
        "answer": "b",
        "answer_smiles": "CC1=CC(=O)C2=C(C)C[C@H](O)[C@@H]3[C@H](OC(=O)[C@H]3C)[C@H]12",
        "domain": "OATP1b1i",
        "id": 435
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)O[C@@H]1CC[C@]2(C)[C@H](C[C@@H](OC(C)=O)[C@]3(C)C4=CC(=O)O[C@H](c5ccoc5)[C@@]4(C)CC[C@@H]23)C1(C)C",
            "b. CC(=O)[C@H]1CC[C@H]2[C@@H]3CC(=O)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",
            "c. CC(=O)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C4=CC(=O)OC4)[C@@H](OC(C)=O)C[C@]32O)C1",
            "d. C=CC1=C(C)c2cc3nc(cc4[nH]c(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4CCC(=O)O)C(CCC(=O)O)=C3C"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)O[C@H]1CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C4=CC(=O)OC4)[C@@H](OC(C)=O)C[C@]32O)C1",
        "domain": "OATP1b1i",
        "id": 436
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)C[C@H]1C2(C)CC34OC5(C)O[C@@]6([C@H](OC(C)=O)C(OC(C)=O)[C@]7(C)C(/C(=C(/O)C(C)C)C(=O)O[C@H]7c7ccoc7)[C@@]6(O5)[C@H](OC(C)=O)[C@@]3(O)C2OC(=O)C(C)C)[C@]14C",
            "b. CC(=O)O[C@@H]1C[C@@H]2C(C)(C)[C@H](O)C=C[C@@]2(C)[C@@H]2CC[C@@]3(C)C(=CC(=O)O[C@@H]3c3ccoc3)[C@@]12C",
            "c. C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O",
            "d. CC1(C)C2CC(=O)O[C@@]3(C)C4=CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]2(C)C=C[C@H]1O"
        ],
        "answer": "c",
        "answer_smiles": "C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O",
        "domain": "OATP1b1i",
        "id": 437
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)CCCC1(C)C=Cc2c(O)c3c(c(CCC(C)C)c2O1)OC12C(CC4CC1C(C)(C)OC2(CCC(C)C(=O)O)C4O)C3=O",
            "b. COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3",
            "c. Cc1c(C(=O)O)c(O)cc2c1C(=O)c1c(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c(O)c1C2=O",
            "d. C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1"
        ],
        "answer": "d",
        "answer_smiles": "C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1",
        "domain": "OATP1b1i",
        "id": 438
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)[C@H]3CC[C@]4(C)[C@@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]3(C)[C@H](O)C[C@@H]12",
            "b. CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1",
            "c. O=c1ccc2cc(O)c(O)cc2o1",
            "d. CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1"
        ],
        "answer": "c",
        "answer_smiles": "O=c1ccc2cc(O)c(O)cc2o1",
        "domain": "OATP1b1i",
        "id": 439
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1",
            "b. C=C[C@@](C)(O)CC[C@H]1C(=C)C[C@H](O)[C@H]2C(C)(C)CCC[C@]12C",
            "c. CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\\CCC=C(C)C)C(=O)O",
            "d. COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1",
        "domain": "OATP1b1i",
        "id": 440
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)O[C@H]1C[C@@H](OC(C)=O)C(C)(C)[C@@H]2C[C@@H](OC(C)=O)[C@]3(C)[C@H]([C@H](OC(C)=O)C[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@@]534)[C@@]12C",
            "b. CCC(C)C(=O)O[C@@H]1C[C@@]2(C)[C@H](c3ccoc3)OC(=O)CC23OC2(C)O[C@]14[C@]1(C)[C@@H](CC(=O)OC)C5(C)CC1(O)[C@](O)(C5OC(=O)C1(C)OC1C)[C@@H](OC(C)=O)[C@]34O2",
            "c. O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12",
            "d. O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(=O)c2c(O)c(O)cc([C@H]3Oc4cc(O)cc(O)c4C[C@H]3OC(=O)c3cc(O)c(O)c(O)c3)c2c1)c1cc(O)c(O)c(O)c1"
        ],
        "answer": "c",
        "answer_smiles": "O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12",
        "domain": "OATP1b3i",
        "id": 441
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2C)c(O)c1C=O",
            "b. COc1cc2c(cc1OC)[C@@H]1C(=O)c3ccc4oc(C(C)C)cc4c3O[C@@H]1CO2",
            "c. COC(=O)c1c(C)c2c(c(C)c1O)OC(=O)c1c(C)c(Cl)c(O)c(Cl)c1O2",
            "d. O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc2c(cc1OC)[C@@H]1C(=O)c3ccc4oc(C(C)C)cc4c3O[C@@H]1CO2",
        "domain": "OATP1b3i",
        "id": 442
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C",
            "b. C=C1[C@@H]2CC[C@@]3(C)[C@H](c4ccoc4)OC(=O)C[C@]13O[C@H]1CC(=O)C(C)(C)[C@H](CC(=O)OC)[C@]12C",
            "c. CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1",
            "d. CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1"
        ],
        "answer": "d",
        "answer_smiles": "CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1",
        "domain": "OATP1b3i",
        "id": 443
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc(C/C=C/c2ccccc2)c(OC)cc1O",
            "b. CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12",
            "c. CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C",
            "d. Cc1cc(O)c(C=O)c2c1C(=O)Oc1c(C)c(O)c3c(c1O2)C(O)OC3=O"
        ],
        "answer": "b",
        "answer_smiles": "CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12",
        "domain": "OATP1b3i",
        "id": 444
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1",
            "b. CC[C@H]1/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]2[C@H](C)[C@H](CC1)O[C@]1(CC[C@H](C)[C@H](C[C@@H](C)O)O1)[C@H]2C",
            "c. CC(C)=CCC[C@]1(C)C=Cc2c(O)c3c(c(CC=C(C)C)c2O1)O[C@]12C(C[C@@H]4C[C@H]1C(C)(C)O[C@@]2(C/C=C(/C)C(=O)O)C4O)C3=O",
            "d. C=C(C)C1(O)OC(=O)C=C1OC"
        ],
        "answer": "d",
        "answer_smiles": "C=C(C)C1(O)OC(=O)C=C1OC",
        "domain": "OATP1b3i",
        "id": 445
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC",
            "b. O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21",
            "c. C=C1[C@@H]2CC[C@@]3(C)[C@H](c4ccoc4)OC(=O)C[C@]13O[C@H]1C[C@H](O)C(C)(C)[C@H](CC(=O)OC)[C@]12C",
            "d. O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1"
        ],
        "answer": "a",
        "answer_smiles": "CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC",
        "domain": "OATP1b3i",
        "id": 446
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CNC[C@H](O)c1cccc(O)c1",
            "b. COC(=O)c1c(OC)cc2c(c1C)Oc1c(Cl)c(O)c(Cl)c(C)c1C(=O)O2",
            "c. CCC(C)C(=O)O[C@@H]1C[C@]2(C)[C@H](c3ccoc3)OC(=O)CC23OC2(C)OC34[C@H](OC(=O)C(C)C)[C@@]3(O)[C@@H](OC(=O)[C@]5(C)O[C@H]5C)[C@]5(C)C[C@@]3(O)[C@@](C)([C@H]5CC(=O)OC)C14O2",
            "d. CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O"
        ],
        "answer": "a",
        "answer_smiles": "CNC[C@H](O)c1cccc(O)c1",
        "domain": "OATP1b3i",
        "id": 447
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C",
            "b. O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O",
            "c. OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
            "d. COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12",
        "domain": "OATP1b3i",
        "id": 448
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1",
            "b. CC(=O)O[C@H]1CC[C@]2(C)C3=C(CC[C@H]2C1(C)C)[C@@]1(C)CC[C@H]([C@H](C)CCC=C(C)C)[C@]1(C)CC3",
            "c. COC(=O)C[C@H]1C(C)(C)C2(O)OC34CC2C(=O)[C@]1(C)C3CC[C@]1(C)C4=CC(=O)O[C@H]1c1ccoc1",
            "d. C=N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "C=N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccccc1",
        "domain": "OATP1b3i",
        "id": 449
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP1b3 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H]1C[C@H](O)[C@@]2(O)[C@]13CC(=O)OC[C@]2(C)[C@@](C)(O)C(=O)C3",
            "b. CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1",
            "c. COC(=O)C[C@H]1C2(C)CC34OC5(C)O[C@@]6([C@H](OC)C(OC(=O)C(C)C)[C@]7(C)C(/C(=C(/OC)C(C)C)C(=O)O[C@H]7c7ccoc7)[C@@]6(O5)[C@H](OC)[C@@]3(OC)C2OC(C)=O)[C@]14C",
            "d. CC(=O)Oc1cc2c(c(C)c1OC(C)=O)CC=C1[C@]2(C)CC[C@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@@]12C"
        ],
        "answer": "a",
        "answer_smiles": "C[C@@H]1C[C@H](O)[C@@]2(O)[C@]13CC(=O)OC[C@]2(C)[C@@](C)(O)C(=O)C3",
        "domain": "OATP1b3i",
        "id": 450
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3",
            "b. CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C",
            "c. CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1",
            "d. CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2cc(C(=O)O)ccc21"
        ],
        "answer": "b",
        "answer_smiles": "CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C",
        "domain": "OATP2b1i",
        "id": 451
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C(C)C1CCC2=CC(=O)CC(C)C2(C)C1",
            "b. CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O",
            "c. COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1",
            "d. CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C"
        ],
        "answer": "d",
        "answer_smiles": "CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C",
        "domain": "OATP2b1i",
        "id": 452
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1",
            "b. CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O",
            "c. CC12CCC3c4ccc(OS(=O)(=O)O)cc4CCC3C1CCC2=O",
            "d. CNCCC(Oc1ccccc1C)c1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O",
        "domain": "OATP2b1i",
        "id": 453
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(O)=C1C(C)=NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12",
            "b. Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O",
            "c. CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1",
            "d. COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O",
        "domain": "OATP2b1i",
        "id": 454
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN1CCCC1c1cccnc1",
            "b. CC(C)NCC(O)COc1cccc2ccccc12",
            "c. CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O",
            "d. CCCC(CCC)C(=O)O"
        ],
        "answer": "d",
        "answer_smiles": "CCCC(CCC)C(=O)O",
        "domain": "OATP2b1i",
        "id": 455
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2",
            "b. Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)C(NC(=O)C(O)c3ccccc3)C2SC1",
            "c. CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C",
            "d. CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1"
        ],
        "answer": "c",
        "answer_smiles": "CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C",
        "domain": "OATP2b1i",
        "id": 456
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(O)c5cccc(OC)c5nc34)cc1)CC2",
            "b. O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1",
            "c. COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1",
            "d. CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21"
        ],
        "answer": "a",
        "answer_smiles": "COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(O)c5cccc(OC)c5nc34)cc1)CC2",
        "domain": "OATP2b1i",
        "id": 457
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)Cc1ccc(C(C)C(=O)O)cc1",
            "b. CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1",
            "c. Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2",
            "d. CC[N+](CC)(CC)CC"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1",
        "domain": "OATP2b1i",
        "id": 458
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C",
            "b. NNC(=O)c1ccncc1",
            "c. Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1",
            "d. CCC(=C(CC)c1ccc(O)cc1)c1ccc(O)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CCC(=C(CC)c1ccc(O)cc1)c1ccc(O)cc1",
        "domain": "OATP2b1i",
        "id": 459
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the OATP2b1 transporter (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23",
            "b. CCOc1ccc(NC(C)=O)cc1",
            "c. Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2",
            "d. CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)=C(O)O1"
        ],
        "answer": "d",
        "answer_smiles": "CCCC1(CCc2ccccc2)CC(=O)C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)=C(O)O1",
        "domain": "OATP2b1i",
        "id": 460
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)Cc1ccc(C(C)C(=O)O)cc1",
            "b. CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12",
            "c. N=C(N)NCCCCNC(=N)N",
            "d. COc1ccc(CCNCC(O)c2ccc(O)cc2)cc1OC"
        ],
        "answer": "d",
        "answer_smiles": "COc1ccc(CCNCC(O)c2ccc(O)cc2)cc1OC",
        "domain": "OCT1I",
        "id": 461
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)CC(c1ccccc1)c1c(O)oc2ccccc2c1=O",
            "b. COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
            "c. CC(F)(F)c1cc2c(cc1S(N)(=O)=O)S(=O)(=O)NC(Cc1ccccc1)N2",
            "d. CNCC(O)c1ccc(O)c(O)c1"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
        "domain": "OCT1I",
        "id": 462
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)NC1C(NC(=N)N)C=C(C(=O)O)OC1C(O)C(O)CO",
            "b. CN1CC(=O)N=C1N",
            "c. COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC",
            "d. O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC",
        "domain": "OCT1I",
        "id": 463
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1",
            "b. CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C",
            "c. NCCCC(N)(C(=O)O)C(F)F",
            "d. CCC1(c2ccccc2)C(=O)NC(=O)NC1=O"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1",
        "domain": "OCT1I",
        "id": 464
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1",
            "b. CC12CCC3c4ccc(O)cc4CCC3C1CCC2O",
            "c. CNC(=O)c1cccnc1",
            "d. CC(=O)Nc1ccc(O)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CC12CCC3c4ccc(O)cc4CCC3C1CCC2O",
        "domain": "OCT1I",
        "id": 465
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O",
            "b. CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O",
            "c. CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O",
            "d. Oc1ncc(F)c(O)n1"
        ],
        "answer": "b",
        "answer_smiles": "CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O",
        "domain": "OCT1I",
        "id": 466
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1nc(O)c2nc(CNc3ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc3)cnc2n1",
            "b. COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC",
            "c. CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1",
            "d. CC(N)(Cc1ccc(O)c(O)c1)C(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC",
        "domain": "OCT1I",
        "id": 467
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1",
            "b. C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12",
            "c. C[N+](C)(C)CCO",
            "d. NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O"
        ],
        "answer": "b",
        "answer_smiles": "C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12",
        "domain": "OCT1I",
        "id": 468
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Clc1cccc(Cl)c1NC1=NCCN1",
            "b. CN1CCN2c3ccccc3Cc3ccccc3C2C1",
            "c. CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O",
            "d. Oc1ncc(F)c(O)n1"
        ],
        "answer": "a",
        "answer_smiles": "Clc1cccc(Cl)c1NC1=NCCN1",
        "domain": "OCT1I",
        "id": 469
    },
    {
        "question": "Which of the following four compounds is most likely to inhibit the organic cation transporter 1 (OCT1) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O",
            "b. Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1",
            "c. O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O",
            "d. Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2"
        ],
        "answer": "a",
        "answer_smiles": "CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O",
        "domain": "OCT1I",
        "id": 470
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1",
            "b. CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O",
            "c. C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O",
            "d. CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1"
        ],
        "answer": "a",
        "answer_smiles": "COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1",
        "domain": "OCT2I",
        "id": 471
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C",
            "b. CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1",
            "c. Clc1ccccc1CN1CCc2sccc2C1",
            "d. Oc1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C",
        "domain": "OCT2I",
        "id": 472
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21",
            "b. CCCOC(=O)c1ccc(O)cc1",
            "c. CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12",
            "d. O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O"
        ],
        "answer": "a",
        "answer_smiles": "CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21",
        "domain": "OCT2I",
        "id": 473
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1",
            "b. Brc1c(NC2=NCCN2)ccc2nccnc12",
            "c. CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CSC21",
            "d. NC(=O)N1c2ccccc2CC(=O)c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "Brc1c(NC2=NCCN2)ccc2nccnc12",
        "domain": "OCT2I",
        "id": 474
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1c(Cl)cccc1Nc1ccccc1C(=O)O",
            "b. Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1",
            "c. CCN(CC)C(=O)N1CCN(C)CC1",
            "d. CNCCc1ccccn1"
        ],
        "answer": "b",
        "answer_smiles": "Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1",
        "domain": "OCT2I",
        "id": 475
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1",
            "b. Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl",
            "c. CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1",
            "d. Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1",
        "domain": "OCT2I",
        "id": 476
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)NNC(=O)c1ccncc1",
            "b. CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1",
            "c. COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1",
            "d. CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1"
        ],
        "answer": "c",
        "answer_smiles": "COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1",
        "domain": "OCT2I",
        "id": 477
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl",
            "b. CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
            "c. CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1",
            "d. COc1c2occc2cc2ccc(=O)oc12"
        ],
        "answer": "b",
        "answer_smiles": "CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
        "domain": "OCT2I",
        "id": 478
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl",
            "b. COc1ccc(C(=O)c2ccccc2)c(O)c1",
            "c. N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O",
            "d. N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1"
        ],
        "answer": "d",
        "answer_smiles": "N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1",
        "domain": "OCT2I",
        "id": 479
    },
    {
        "question": "Which of the following four chemical structures is most likely to inhibit organic cation transporter 2 (OCT2) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nn1nnc2ccccc21",
            "b. OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1",
            "c. O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I",
            "d. Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1",
        "domain": "OCT2I",
        "id": 480
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. COc1ccc(-c2cc(CS(=O)(=O)c3ccccc3)on2)cc1",
            "b. CCc1nc2oc3ccccc3c(=O)c2cc1C(=O)OC",
            "c. CC1CN(C(=O)Nc2ccc(F)cc2F)CC(C)O1",
            "d. COc1ccc(C(C)=NNc2cccc(C(=O)O)c2)cc1OC"
        ],
        "answer": "c",
        "answer_smiles": "CC1CN(C(=O)Nc2ccc(F)cc2F)CC(C)O1",
        "domain": "PBS74",
        "id": 481
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. NNC(=S)NC1CCCCCCCCCCC1",
            "b. CCOC(=O)C1CCN(Cc2cc(=O)oc3cc(C)ccc23)CC1",
            "c. CCOC(=O)c1nnn2c1nc(N(CC)CC)c1ccccc12",
            "d. CC(C)CCNC(=O)c1cc2c(=O)[nH]c3ccccc3c2s1"
        ],
        "answer": "b",
        "answer_smiles": "CCOC(=O)C1CCN(Cc2cc(=O)oc3cc(C)ccc23)CC1",
        "domain": "PBS74",
        "id": 482
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. CC(=O)C1=C(O)C(=O)N(c2ccccn2)C1c1ccc(Cl)cc1",
            "b. Cc1cc2oc(=O)cc(CN3CCC(C)CC3)c2cc1C",
            "c. COc1ccc(C2CC(c3cccs3)Nc3nnnn32)cc1",
            "d. COc1ccc(NC(=O)Nc2nnc(Cc3ccc(OC)c(OC)c3)s2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CC(=O)C1=C(O)C(=O)N(c2ccccn2)C1c1ccc(Cl)cc1",
        "domain": "PBS74",
        "id": 483
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. Cc1ccc(NC(=O)c2cc3c(=O)oc4ccc(C)cc4c3s2)nc1",
            "b. Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(Cl)cc(Cl)c1",
            "c. O=C(NNS(=O)(=O)c1ccc([N+](=O)[O-])cc1)c1ccc2ccccc2c1O",
            "d. O=C(Nc1ccccc1Cc1ccccc1)c1ccccc1F"
        ],
        "answer": "c",
        "answer_smiles": "O=C(NNS(=O)(=O)c1ccc([N+](=O)[O-])cc1)c1ccc2ccccc2c1O",
        "domain": "PBS74",
        "id": 484
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. c1ccc2c(CN3CCSCC3)cccc2c1",
            "b. Cc1cccc(NC(=O)OC2CN3CCC2CC3)c1",
            "c. CC(C)c1ccc(C=CC(=O)NC(=S)NN2CCOCC2)cc1",
            "d. CCOc1ccccc1CN1C(=O)C2(OCCO2)c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cccc(NC(=O)OC2CN3CCC2CC3)c1",
        "domain": "PBS74",
        "id": 485
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. Cc1ccc2[nH]c(C(=O)NN=Cc3ccccc3O)c(C)c2c1",
            "b. Cn1c(=O)c2c(nc3n2CC(CO)O3)n(C)c1=O",
            "c. CC(=O)c1c(C)[nH]c(C(=O)COC(=O)c2ccc(Cl)nc2)c1C",
            "d. COc1ccccc1C=NNC(=O)c1ccccc1OCCOc1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "Cn1c(=O)c2c(nc3n2CC(CO)O3)n(C)c1=O",
        "domain": "PBS74",
        "id": 486
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. Cc1ccc(C=NNC(=S)NC2CCCCC2)o1",
            "b. CCc1nc2sc(C(C)=O)c(N)c2c2c1CCCC2",
            "c. Cc1ccc(N2CC(C)Cn3c2nc2c3c(=O)[nH]c(=O)n2C)cc1",
            "d. NC(=O)CSc1nnc(-c2ccccn2)n1Cc1ccco1"
        ],
        "answer": "d",
        "answer_smiles": "NC(=O)CSc1nnc(-c2ccccn2)n1Cc1ccco1",
        "domain": "PBS74",
        "id": 487
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. O=C(COC(=O)CCc1ccc(S(=O)(=O)N2CCOCC2)cc1)Nc1ccccc1OC(F)F",
            "b. CC(C)c1ccccc1NC(=S)NC(=O)C1CCCCC1",
            "c. CCc1nc(SCC(=O)Nc2cccc3ccccc23)[nH]c(=O)c1C",
            "d. Cc1cccc(NC(=O)c2ccc([N+](=O)[O-])s2)n1"
        ],
        "answer": "a",
        "answer_smiles": "O=C(COC(=O)CCc1ccc(S(=O)(=O)N2CCOCC2)cc1)Nc1ccccc1OC(F)F",
        "domain": "PBS74",
        "id": 488
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. Cc1nc(-c2ccc([N+](=O)[O-])cc2)nc2[nH]ccc(=O)c12",
            "b. S=C(Nc1ccccc1)Nc1ccccc1-n1cccc1",
            "c. O=C(Nc1ccno1)Nc1ccc(Cl)cc1Cl",
            "d. CCCOc1ccccc1C=C1SC(N)=NC1=O"
        ],
        "answer": "b",
        "answer_smiles": "S=C(Nc1ccccc1)Nc1ccccc1-n1cccc1",
        "domain": "PBS74",
        "id": 489
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high aqueous solubility (≥10 μg/mL) in PBS (pH 7.4) based on their chemical structures and their public experimental data?",
        "options": [
            "a. Cc1nc2ccccc2c(=O)n1N=Cc1ccc(C(C)(C)C)cc1",
            "b. O=c1[nH]nc(-c2ccc(F)cc2)cc1Cc1ccccc1",
            "c. Cc1cccc(NC(=O)c2ccc(S(=O)(=O)N3CCCC3)cc2)c1C",
            "d. CC(C)(C)C(=O)C(C#N)=Cc1cccs1"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)(C)C(=O)C(C#N)=Cc1cccs1",
        "domain": "PBS74",
        "id": 490
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1",
            "b. COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC",
            "c. CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1",
            "d. CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12"
        ],
        "answer": "d",
        "answer_smiles": "CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12",
        "domain": "PLD",
        "id": 491
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. O=c1cc[nH]c(=S)[nH]1",
            "b. CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O",
            "c. CN(C)CCCN(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC21C",
            "d. CC(C)CC(N)C(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "CN(C)CCCN(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC21C",
        "domain": "PLD",
        "id": 492
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O",
            "b. O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O",
            "c. O=C(Oc1ccccc1C(=O)O)c1ccccc1O",
            "d. CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1"
        ],
        "answer": "a",
        "answer_smiles": "CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O",
        "domain": "PLD",
        "id": 493
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1",
            "b. COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1",
            "c. CN(C)CCCn1c2c(c3ccccc31)CCCCCC2",
            "d. O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1"
        ],
        "answer": "c",
        "answer_smiles": "CN(C)CCCn1c2c(c3ccccc31)CCCCCC2",
        "domain": "PLD",
        "id": 494
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. C#CC1(OC(C)=O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C",
            "b. CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21",
            "c. CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1",
            "d. C=CCC1(O)CCC2C3CCC4=CCCCC4C3CCC21C"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21",
        "domain": "PLD",
        "id": 495
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. N#Cc1ccc(NC(=O)NC(=N)N)cc1Cl",
            "b. CCC1C(=O)OCC1Cc1cncn1C",
            "c. C[N+](C)(C)CC(O)CC(=O)[O-]",
            "d. CC(Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4nccs4)c3)c12)C(=O)N1CCOCC1"
        ],
        "answer": "a",
        "answer_smiles": "N#Cc1ccc(NC(=O)NC(=N)N)cc1Cl",
        "domain": "PLD",
        "id": 496
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. Cc1cn(C2C=CC(CO)O2)c(=O)[nH]c1=O",
            "b. CC(=O)OCC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C",
            "c. OC(CN1CCCCC1)c1ccc(C=C2c3ccccc3-c3ccccc32)cc1",
            "d. CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C"
        ],
        "answer": "c",
        "answer_smiles": "OC(CN1CCCCC1)c1ccc(C=C2c3ccccc3-c3ccccc32)cc1",
        "domain": "PLD",
        "id": 497
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. CCOC(=O)c1cncn1C(C)c1ccccc1",
            "b. NC(=O)NC(=O)Cc1ccccc1",
            "c. CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(OC)c(OC)cc21",
            "d. C=C1CC1CC(N)C(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(OC)c(OC)cc21",
        "domain": "PLD",
        "id": 498
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
            "b. CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O",
            "c. COC(=O)c1ccc(O)cc1",
            "d. CC1c2cccc(O)c2C(=O)C2=C(O)C3(O)C(=O)C(C(N)=O)=C(O)C(N(C)C)C3C(O)C21"
        ],
        "answer": "a",
        "answer_smiles": "CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
        "domain": "PLD",
        "id": 499
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit drug-induced phospholipidosis based on the public experimental data?",
        "options": [
            "a. O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O",
            "b. CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1",
            "c. CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)CCC4(C)C3CCC21C",
            "d. CC(=O)Nc1c(I)c(C(=O)O)c(I)c(N(C)C(C)=O)c1I"
        ],
        "answer": "b",
        "answer_smiles": "CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1",
        "domain": "PLD",
        "id": 500
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(S(=O)(=O)N(C)C)cc1C#Cc1cc(Cl)ccc1OCC(=O)O",
            "b. Cc1c(-c2ccc(N3CC[C@@H](F)C3)cc2)[nH]c2cc(F)cc(F)c2c1=O",
            "c. NC(=O)c1cncc(-c2ccc(C3CCC(CCO)CC3)cc2)n1",
            "d. CN(C)Cc1nccn1-c1ccc(N2CCC(NS(=O)(=O)c3ccc4cc(Cl)ccc4c3)C2=O)c(F)c1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1c(-c2ccc(N3CC[C@@H](F)C3)cc2)[nH]c2cc(F)cc(F)c2c1=O",
        "domain": "PPBhuman",
        "id": 501
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. Nc1cccc(-c2ccc(Cn3cc(C(=O)O)c(=O)c4cccc(F)c43)cn2)c1",
            "b. Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Br)n[nH]1",
            "c. CCC(C(=O)NC(C=CC(=O)OC1CCC1)CC1CCNC1=O)n1cccc(NC(=O)c2cc(C)on2)c1=O",
            "d. CC(C(=O)OC1C[N+]2(Cc3nc(-c4ccccc4)no3)CCC1CC2)(c1ccccc1)N1CCCCC1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Br)n[nH]1",
        "domain": "PPBhuman",
        "id": 502
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC(C)(NS(=O)(=O)c1ccc2c(Cl)cnc(N=C(N)N)c2c1)C(=O)O",
            "b. CCc1c(CCN2CCC(C(=O)O)CC2)cccc1-c1nsc(-c2ccc(OC(C)C)c(Cl)c2)n1",
            "c. Nc1noc2ccc(-n3nc(C(F)(F)F)c4c3C(=O)N(c3ccc(-c5ccccc5CN5CCCC5)cc3F)CC4)cc12",
            "d. O=C(NCC1(CO)CCCC1)c1nc(N2CCOCC2)n2ccccc12"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)(NS(=O)(=O)c1ccc2c(Cl)cnc(N=C(N)N)c2c1)C(=O)O",
        "domain": "PPBhuman",
        "id": 503
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CN(C)Cc1cccc(-c2ccc(Cn3cc(C(=O)O)c(=O)c4cccc(F)c43)cc2)c1",
            "b. Nc1ccn(C2CSC(CO)O2)c(=O)n1",
            "c. C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3ccncc3)CCC1CC2)(c1ccccc1)N1CCCCC1",
            "d. CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C"
        ],
        "answer": "b",
        "answer_smiles": "Nc1ccn(C2CSC(CO)O2)c(=O)n1",
        "domain": "PPBhuman",
        "id": 504
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CCCCCCC(=O)N1CC(=O)C(=C(O)CC(C)CC(C)(C)C)C1=O",
            "b. CC1Cc2c(ccc3[nH]ncc23)C(c2ncc(NC3CN(CCCF)C3)cc2F)N1CC1(F)CC1",
            "c. Cc1cnc(-c2cc(NC(=O)c3ccc(C(F)(F)F)nc3C)ccc2Cl)[nH]1",
            "d. CC(C)=CCCC(C)(OC1OC(COC2OC(CO)C(O)C2O)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C"
        ],
        "answer": "c",
        "answer_smiles": "Cc1cnc(-c2cc(NC(=O)c3ccc(C(F)(F)F)nc3C)ccc2Cl)[nH]1",
        "domain": "PPBhuman",
        "id": 505
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC1(C)NCC(c2cc(F)cc(F)c2)N(CC(=O)Nc2ccc3c(c2)CC2(C3)C(=O)Nc3ncccc32)C1=O",
            "b. Cc1cn([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C2)c(=O)[nH]c1=O",
            "c. Cc1ccc(-n2nc(C)cc2C)c(O)c1",
            "d. COc1c(N2CC3(CC3)[C@](C)(N)C2)c(F)cc2c(=O)c(C(=O)O)cn([C@@H]3C[C@@H]3F)c12"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cn([C@H]2CCCN(Cc3ccc(C(=O)O)c(Oc4cccc(Br)c4)c3)C2)c(=O)[nH]c1=O",
        "domain": "PPBhuman",
        "id": 506
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. O=C1CC(c2cc(F)c(F)c(F)c2)CN1Cc1ccncc1F",
            "b. COC(=O)c1cccc(-n2sc3ccccc3c2=O)c1",
            "c. COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccc(NCCCc3ccccc3-c3sc4c(c3C(=O)O)CC(C)(C)CC4)cc2)NC(=O)OC2COC3(C)OCCC23)cc1",
            "d. Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F"
        ],
        "answer": "d",
        "answer_smiles": "Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F",
        "domain": "PPBhuman",
        "id": 507
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC(Nc1ncnc(N)c1C#N)c1nc2ccc(F)cc2n1-c1cccnc1",
            "b. O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12",
            "c. N=C(N)NCCCC(NC(=O)CN1CCN(S(=O)(=O)c2ccc3c(Cl)cccc3c2)CC1=O)C(=O)c1nccs1",
            "d. O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)CC4c4cccc(Cl)c4)CC3)cn2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "O=c1cc(N2CCOCC2)nc2n(Cc3cccc(Cl)c3Cl)ccn12",
        "domain": "PPBhuman",
        "id": 508
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC1Cc2c(ccc3[nH]ncc23)C(c2ccc(OCCN3CC(CF)C3)cn2)N1CC(F)(F)F",
            "b. CC1N=C(N)N=C(N)N1c1ccc(Cl)cc1",
            "c. O=C1COCCN1c1ccc(CO[C@@H]2COc3nc([N+](=O)[O-])cn3C2)cn1",
            "d. CN(C)CCCN1c2ccccc2CCc2ccccc21"
        ],
        "answer": "d",
        "answer_smiles": "CN(C)CCCN1c2ccccc2CCc2ccccc21",
        "domain": "PPBhuman",
        "id": 509
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit high human plasma protein binding (PPB) (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. Nc1ncnc2c1C(=O)N(c1ccc(-c3ncccc3Cl)cc1)CCO2",
            "b. COC(=O)N[C@@H](C)C#Cc1cnc(Oc2ccc(OC(C)C)cc2)s1",
            "c. COc1cc2c(cc1OC)C1CC(O)C(CC(C)C)CN1CC2",
            "d. Cc1cnc(N)nc1OCC(C)(C)CO"
        ],
        "answer": "b",
        "answer_smiles": "COC(=O)N[C@@H](C)C#Cc1cnc(Oc2ccc(OC(C)C)cc2)s1",
        "domain": "PPBhuman",
        "id": 510
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. Cc1ccn2c(C(=O)NCc3ccc(Oc4ccc(Cl)cc4)cc3)c(C)nc2c1",
            "b. O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1",
            "c. Cc1cc2nc(NCCCO)n(CC(=O)c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)c2cc1C",
            "d. CC(CO)Nc1nc(SCc2ccco2)nc2nc(N)sc12"
        ],
        "answer": "d",
        "answer_smiles": "CC(CO)Nc1nc(SCc2ccco2)nc2nc(N)sc12",
        "domain": "PPBmouse",
        "id": 511
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CS(=O)(=O)N(CCO)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12",
            "b. N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1",
            "c. CC1OCCC2Oc3ccc(-c4cccnc4F)cc3C3(N=C(N)N(C)C3=O)C12",
            "d. O=c1[nH]c2ccc(-c3c(Cl)cccc3OC(F)(F)F)cc2[nH]1"
        ],
        "answer": "b",
        "answer_smiles": "N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1",
        "domain": "PPBmouse",
        "id": 512
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC(CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12",
            "b. FCCCOc1ccc2nc(Nc3ccncc3)ccc2c1",
            "c. CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1",
            "d. CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1"
        ],
        "answer": "a",
        "answer_smiles": "CC(CO)Nc1nc(SCc2ccccc2)nc2nc(N)sc12",
        "domain": "PPBmouse",
        "id": 513
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC",
            "b. CCS(=O)(=O)Nc1cnc2c(c1)-c1cn(C)c(=O)cc1OCCCCc1cc(F)cc(F)c1O2",
            "c. Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O",
            "d. COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C"
        ],
        "answer": "c",
        "answer_smiles": "Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O",
        "domain": "PPBmouse",
        "id": 514
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1cnc(C(=O)Nc2ccc(F)c(C3(C)N=C(N)COC3C(F)F)c2)cn1",
            "b. Cn1cc(C2CC3CSC(N)=NC3(c3ccc(F)cc3F)CO2)cn1",
            "c. COc1cc(OC)c2c(c1Cl)OC1(C2=O)C(NCc2ccc(C)cc2)=CC(=O)CC1C",
            "d. O=C(Cc1cccs1)NC1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CSC12"
        ],
        "answer": "d",
        "answer_smiles": "O=C(Cc1cccs1)NC1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CSC12",
        "domain": "PPBmouse",
        "id": 515
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC(CC(=O)O)c1cccc(-n2c(C(N)=O)cc3ccc(OC(F)(F)F)cc32)n1",
            "b. Cc1cc(C2CCN(C(=O)C3CN(C(C)(C)C)CC3c3ccc(F)cc3F)CC2)n(-c2ccc(F)c(Cl)c2)n1",
            "c. c1cn(-c2cc(NC3=NCC4(CN5CCC4CC5)O3)ncn2)cn1",
            "d. CC1(N)CC(C(=O)N2CCC(c3ccnn3-c3ccc(F)c(Cl)c3)CC2)C(c2ccc(F)cc2F)C1"
        ],
        "answer": "c",
        "answer_smiles": "c1cn(-c2cc(NC3=NCC4(CN5CCC4CC5)O3)ncn2)cn1",
        "domain": "PPBmouse",
        "id": 516
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC",
            "b. Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2",
            "c. Cc1cccc(C=NNc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1",
            "d. O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1cccc(C=NNc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1",
        "domain": "PPBmouse",
        "id": 517
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CNCc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1",
            "b. CCc1cc(C(=O)NC2CC(C(N)=O)N(C(=O)c3coc4ccccc34)C2)n(CC)n1",
            "c. CC1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)N=C(N)COC1F",
            "d. N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2"
        ],
        "answer": "d",
        "answer_smiles": "N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2",
        "domain": "PPBmouse",
        "id": 518
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC1NC(NCC(F)F)=Nc2cccc(Cl)c21",
            "b. COC1CN(c2nc(-c3ncn(C)n3)c(C(=O)O)s2)CCC1NC(=O)c1[nH]c(C)c(Cl)c1Br",
            "c. Cc1cccnc1C1CCCC(c2nc3cccc(N4CCN(C)CC4)n3c2Cl)N1C",
            "d. CCCS(=O)(=O)Nc1ccc(F)c(NC(=O)c2cccc3c(N)ncnc23)c1F"
        ],
        "answer": "b",
        "answer_smiles": "COC1CN(c2nc(-c3ncn(C)n3)c(C(=O)O)s2)CCC1NC(=O)c1[nH]c(C)c(Cl)c1Br",
        "domain": "PPBmouse",
        "id": 519
    },
    {
        "question": "Which of the following four compounds is most likely to show strong binding to mouse plasma proteins (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1cnc2c(NCc3nnc4ccc(-c5cc(F)cc(F)c5)nn34)ccnc2c1",
            "b. COc1ccc(Cn2cnc3cc4c(cc32)COC4)cc1C",
            "c. COc1ccc(NC(=O)N2CCN(c3nc(N)nc4c3ncn4C)C(C)C2)c(C)c1",
            "d. CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(Cn2cnc3cc4c(cc32)COC4)cc1C",
        "domain": "PPBmouse",
        "id": 520
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1",
            "b. OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1",
            "c. CC(Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4nccs4)c3)c12)C(=O)N1CCOCC1",
            "d. CC1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21"
        ],
        "answer": "b",
        "answer_smiles": "OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1",
        "domain": "PPBrat",
        "id": 521
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CCCSc1nc(N)c2nnn(C3CC(OCCO)C(O)C3O)c2n1",
            "b. O=C(C1CCCN(c2ccc3nc(C4(n5cc(Cl)cn5)CC4)[nH]c3n2)C1)N1CCCC1",
            "c. O=C(C1CCOC1)N1CC2C(CNc3nc(-c4ccccn4)cs3)C2C1",
            "d. COc1cc(NC(=O)c2nccs2)ccc1NC(=O)c1ccccc1Cl"
        ],
        "answer": "d",
        "answer_smiles": "COc1cc(NC(=O)c2nccs2)ccc1NC(=O)c1ccccc1Cl",
        "domain": "PPBrat",
        "id": 522
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC1=CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CC(N3CCCC3)C2)c1O",
            "b. C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1",
            "c. CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2",
            "d. OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCCCCOC1CCCCCC1"
        ],
        "answer": "c",
        "answer_smiles": "CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2",
        "domain": "PPBrat",
        "id": 523
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3C)c12",
            "b. CC(C)(ON=C(C(=O)NC1C(=O)N(OS(=O)(=O)O)C1COC(=O)CNC(=O)c1cc(=O)c(O)cn1O)c1csc(N)n1)C(=O)O",
            "c. CO[C@H]1CC[C@]2(CC1)Cc1ccc(-c3cncc(Br)c3)cc1C21N=C(C)C(N)=N1",
            "d. Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(F)cc3)C2)n1C"
        ],
        "answer": "c",
        "answer_smiles": "CO[C@H]1CC[C@]2(CC1)Cc1ccc(-c3cncc(Br)c3)cc1C21N=C(C)C(N)=N1",
        "domain": "PPBrat",
        "id": 524
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1",
            "b. CCC1CCCCN1C(=O)CCC1(c2ccc(Cl)cc2)c2ccccc2-c2nccn21",
            "c. O=C1CC(c2c(Cl)cccc2Cl)CC(O)=C1Sc1ccccc1Cl",
            "d. CCc1cc(-c2nc(-c3cc(C)c(OCC(O)CNC(=O)CO)c(CC)c3)no2)ccc1CN(C)C"
        ],
        "answer": "a",
        "answer_smiles": "O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1",
        "domain": "PPBrat",
        "id": 525
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. Cc1noc(-c2nnc3n2CCN(C(=O)c2ccc(-c4cccs4)cc2)C3C)n1",
            "b. COc1ccc(S(=O)(=O)N(CC(C)C)CC(O)C(Cc2ccc(N3CC(Oc4ccccc4-c4sc5c(c4C(=O)O)CC(C)(C)CC5)C3)cc2)NC(=O)OC2COC3(C)OCCC23)cc1",
            "c. O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1",
            "d. CCS(=O)(=O)c1ccc(CC(=O)Nc2ccc(C(C)(C)C(=O)Nc3ccc(F)cc3)c(F)c2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1",
        "domain": "PPBrat",
        "id": 526
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1",
            "b. CCCCCCCC1(CC)C(=O)NC(=O)NC1=O",
            "c. Cc1nc2c(s1)CCC2C(=O)Nc1ccc(CC2CCC(C(O)c3cccnc3)N2)cc1",
            "d. CCCC1(C(=O)c2ccc(N)c(Cl)c2)CCCN1"
        ],
        "answer": "a",
        "answer_smiles": "C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1",
        "domain": "PPBrat",
        "id": 527
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F",
            "b. CC1(C)CN(Cc2ccc3c(c2)c(=O)c(C(N)=O)cn3-c2ccc(F)cc2)CCO1",
            "c. CCCN(CCCNc1nc(N)n2nc(-c3ccco3)nc2n1)CCc1cccc2c1CC(=O)N2",
            "d. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21"
        ],
        "answer": "d",
        "answer_smiles": "CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21",
        "domain": "PPBrat",
        "id": 528
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CN1CCOCC1C(=O)N1CCC(O)(c2ccccc2)C2CCCCC21",
            "b. CCCOCCn1c(=O)c(N2CCNCC2)nc2cnc(-c3ccc(OC)nc3)cc21",
            "c. Cc1ccccc1NC(=O)Nc1ccc(CC(=O)N2CC(F)CC2COc2ccc(C(=O)O)cc2)cc1Cl",
            "d. COc1cc(F)cc2c1nnc1c2c(-c2ccncc2C)nn1C"
        ],
        "answer": "b",
        "answer_smiles": "CCCOCCn1c(=O)c(N2CCNCC2)nc2cnc(-c3ccc(OC)nc3)cc21",
        "domain": "PPBrat",
        "id": 529
    },
    {
        "question": "Which of the following four compounds is most likely to show high rat plasma protein binding (%fb>=70%) based on the public experimental data?",
        "options": [
            "a. CC1=CCCC1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CC(N(C)C)C2)c1O",
            "b. CCC1(CC)OCC(c2cc(F)cc(F)c2)N(CC(=O)Nc2ccc3c(c2)CC2(C3)C(=O)Nc3ncccc32)C1=O",
            "c. CC(C)CNCc1c(C(=O)NC2CCCC(O)C2)noc1-c1ccc(C(F)(F)F)cc1",
            "d. CSc1ccc(-c2ccccc2[C@@H]2CCC(F)(F)C[C@H]2C(=O)NCC#N)cc1"
        ],
        "answer": "d",
        "answer_smiles": "CSc1ccc(-c2ccccc2[C@@H]2CCC(F)(F)C[C@H]2C(=O)NCC#N)cc1",
        "domain": "PPBrat",
        "id": 530
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1",
            "b. c1ccc2nc(N3CCNCC3)ccc2c1",
            "c. COC(=O)C1=COC(C)C2CN3CCc4c([nH]c5ccccc45)C3CC12",
            "d. CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C"
        ],
        "answer": "d",
        "answer_smiles": "CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C",
        "domain": "PgpI",
        "id": 531
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)NCC(O)COc1ccc(CC(N)=O)cc1",
            "b. COc1ccc(C2CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2)cc1O",
            "c. CC(=C(OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1",
            "d. OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1"
        ],
        "answer": "d",
        "answer_smiles": "OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1",
        "domain": "PgpI",
        "id": 532
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CNC1C(OC2C(OC3C(O)C(O)C(N=C(N)N)C(O)C3N=C(N)N)OC(C)C2(O)CO)OC(CO)C(O)C1O",
            "b. CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)oc2ccccc2c1=O",
            "c. CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OCCC(C)C)cc12",
            "d. C=CCOc1ccccc1OCC(O)CNC(C)C"
        ],
        "answer": "c",
        "answer_smiles": "CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OCCC(C)C)cc12",
        "domain": "PgpI",
        "id": 533
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1",
            "b. OCCN(CCO)c1nc(N2CCCc3ccccc32)c2nc(N(CCO)CCO)nc(N3CCCc4ccccc43)c2n1",
            "c. O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21",
            "d. OC(Cn1ccnc1)c1ccc(CCc2ccccc2)cc1"
        ],
        "answer": "b",
        "answer_smiles": "OCCN(CCO)c1nc(N2CCCc3ccccc32)c2nc(N(CCO)CCO)nc(N3CCCc4ccccc43)c2n1",
        "domain": "PgpI",
        "id": 534
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cccc(CCc2ccccc2OCCCCCN2CCc3ccccc3C2)c1",
            "b. Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1",
            "c. NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(O)C(O)C1O",
            "d. CN1C(CC(=O)c2ccccc2)CCCC1CC(O)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "COc1cccc(CCc2ccccc2OCCCCCN2CCc3ccccc3C2)c1",
        "domain": "PgpI",
        "id": 535
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC12CCC3C(CCC4(O)CC(O)CCC34C=O)C1(O)CCC2C1=CC(=O)OC1",
            "b. CN1CCC23c4ccccc4NC1C21CCN(C)C3Nc2ccccc21",
            "c. Cc1ccc(-c2n[nH]c3c2C(c2ccc(N(C)C)cc2)C(C#N)=C(N)O3)cc1",
            "d. O=C1NCCO1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc(-c2n[nH]c3c2C(c2ccc(N(C)C)cc2)C(C#N)=C(N)O3)cc1",
        "domain": "PgpI",
        "id": 536
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COCOC1CC(=O)OCC(C)C(=O)OC(C(C)C)C(=O)N(C)C1Cc1ccccc1",
            "b. O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12",
            "c. COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C",
            "d. C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl"
        ],
        "answer": "a",
        "answer_smiles": "COCOC1CC(=O)OCC(C)C(=O)OC(C(C)C)C(=O)N(C)C1Cc1ccccc1",
        "domain": "PgpI",
        "id": 537
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(C(=O)OCCCN1CCN(CCCOC(=O)C(CC)c2ccccc2)CC1)c1ccccc1",
            "b. COCCc1ccc(OCC(O)CNC(C)C)cc1",
            "c. COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1OCC(=O)N1CCN(Cc2ccc(OC)c(OC)c2OC)CC1",
            "d. C=C1C(OC(=O)c2ccccc2)C(OC(C)=O)C(OC(C)=O)C(C)(C)C=CC(C)C(=O)C2(O)CC(C)C(O)C2C1OC(=O)C(C)CC"
        ],
        "answer": "d",
        "answer_smiles": "C=C1C(OC(=O)c2ccccc2)C(OC(C)=O)C(OC(C)=O)C(C)(C)C=CC(C)C(=O)C2(O)CC(C)C(O)C2C1OC(=O)C(C)CC",
        "domain": "PgpI",
        "id": 538
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC",
            "b. CC(C)NC1CCC(c2ccccc2)(c2ccccc2)CC1",
            "c. O=C(C=CC=Cc1ccc2c(c1)OCO2)N1CCCCC1",
            "d. CCCNCC(O)Cn1c(C)c(C(=O)c2cccs2)c(=O)n1-c1ccccc1"
        ],
        "answer": "c",
        "answer_smiles": "O=C(C=CC=Cc1ccc2c(c1)OCO2)N1CCCCC1",
        "domain": "PgpI",
        "id": 539
    },
    {
        "question": "Which of the following four compounds is most likely to act as an inhibitor of P-glycoprotein (P-gp) (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN(CC)CCOC(=O)c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1",
            "b. OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F",
            "c. Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1",
            "d. O=C(NCc1ccccc1)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "CCN(CC)CCOC(=O)c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1",
        "domain": "PgpI",
        "id": 540
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)N1N=C(c2cc(F)ccc2F)CC1c1cccc(O)c1",
            "b. CCCC(C)(COC(N)=O)COC(=O)NC(C)C",
            "c. CCCCCCCCCCCCCC=CC(O)C(N)COP(=O)(O)O",
            "d. CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12"
        ],
        "answer": "d",
        "answer_smiles": "CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12",
        "domain": "PgpS",
        "id": 541
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21",
            "b. O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O",
            "c. CCOCC=Cc1ccc(-c2nc(-c3ccc(NC(C)C)cc3)c(-c3ccc(NC(C)C)cc3)[nH]2)cc1",
            "d. OC1COC(n2c3ccc(Br)cc3c3ccc4c5ccccc5[nH]c4c32)C(O)C1O"
        ],
        "answer": "a",
        "answer_smiles": "CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21",
        "domain": "PgpS",
        "id": 542
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=[N+]([O-])c1ccc(Oc2c(Cl)cc(S(=O)(=O)NC(=NO)Nc3ccc(Cl)cc3)cc2Cl)c(Cl)c1",
            "b. Cc1cccc(NC(=O)CCc2ccc(N3C(N)=NC(N)=NC3(C)C)cc2)c1",
            "c. CC(O)c1cc2c(s1)C(=O)c1scc(C(C)O)c1C2=O",
            "d. COc1cccc(C(=O)c2cc3cc(OC)ccc3[nH]2)c1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cccc(NC(=O)CCc2ccc(N3C(N)=NC(N)=NC3(C)C)cc2)c1",
        "domain": "PgpS",
        "id": 543
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1",
            "b. Clc1ccc(-c2cn(-c3ccccc3)c(-c3ccccc3)n2)c(Cl)c1",
            "c. Oc1ccc(Br)cc1C=Nc1cccc(C(F)(F)F)c1",
            "d. COc1ccc(CNCCN(CC=C(C)CCC=C(C)CCC=C(C)C)Cc2ccc(OC)c(OC)c2)cc1OC"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1",
        "domain": "PgpS",
        "id": 544
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(=O)O",
            "b. CCOP(=S)(OCC)SC(CCl)N1C(=O)c2ccccc2C1=O",
            "c. CCCCNP1(NCCCC)=NP(NCCCC)(NCCCC)=NP(NCCCC)(NCCCC)=NP(NCCCC)(NCCCC)=N1",
            "d. CC(C)N1CCC(N(C(=O)Cc2ccccc2)c2ccc(Cl)cc2)CC1"
        ],
        "answer": "c",
        "answer_smiles": "CCCCNP1(NCCCC)=NP(NCCCC)(NCCCC)=NP(NCCCC)(NCCCC)=NP(NCCCC)(NCCCC)=N1",
        "domain": "PgpS",
        "id": 545
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC1(C)CC(=O)NC1=O",
            "b. COC1=CC23CCCN2CCc2cc4c(cc2C3C1O)OCO4",
            "c. C=C(C)C1(Sc2ccc(OC)cc2)CC1",
            "d. Cc1nc(-c2c(F)cccc2-c2ccc(C(C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1"
        ],
        "answer": "d",
        "answer_smiles": "Cc1nc(-c2c(F)cccc2-c2ccc(C(C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1",
        "domain": "PgpS",
        "id": 546
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1OC(OCC(Br)=C(Br)COC2OC(=O)C(Cl)=C2Cl)C(Cl)=C1Cl",
            "b. CC1(C)N=C(N)N=C(N)N1c1ccc(CCCCCCc2ccc(S(=O)(=O)F)cc2)cc1",
            "c. CN(C)CCCCN1CCc2c(n(C)c3ccccc23)C1=O",
            "d. Cn1c2ccccc2c(=NNc2ccc(S(N)(=O)=O)cc2)c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "CC1(C)N=C(N)N=C(N)N1c1ccc(CCCCCCc2ccc(S(=O)(=O)F)cc2)cc1",
        "domain": "PgpS",
        "id": 547
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1NC(C2CCC(Cl)CN2)C(=O)NC1C1CCC(Cl)CN1",
            "b. O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1",
            "c. CC=CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C23OC(=O)OC2C(OC(=O)C(O)C(C=C(C)C)NC(=O)OC(C)(C)C)C(C)=C1C3(C)C",
            "d. CCN(CC)CCCC(C)Nc1ccnc(C=Cc2ccc(Cl)cc2)c1"
        ],
        "answer": "c",
        "answer_smiles": "CC=CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C23OC(=O)OC2C(OC(=O)C(O)C(C=C(C)C)NC(=O)OC(C)(C)C)C(C)=C1C3(C)C",
        "domain": "PgpS",
        "id": 548
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CCc1[nH]c2c(OCc3ccccc3)cc(N(CC=C)C(C)=O)cc2c1C",
            "b. COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC",
            "c. CCCCCCCCCCCCP(=O)(O)OCC(N)C(=O)O",
            "d. O=C1C(Cl)=C(Nc2ccc3c[nH]nc3c2)C(=O)c2ccccc21"
        ],
        "answer": "b",
        "answer_smiles": "COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC",
        "domain": "PgpS",
        "id": 549
    },
    {
        "question": "Which of the following four compounds is most likely to act as a substrate for P-glycoprotein (P-gp) (EC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C1C(Cl)=C(N2CCN(C3=C(Cl)C(=O)c4ccccc4C3=O)CC2)C(=O)c2ccccc21",
            "b. CN(C)CCN1C(=O)Nc2c3cc(O)ccc3nc3c([N+](=O)[O-])ccc1c23",
            "c. CCCC(=O)Nc1cc(C=CC(=O)N2CC(CCl)c3c2cc(OCc2ccccc2)c2[nH]cc(C)c32)n(C)c1",
            "d. Cc1ccc(N=C2C=C(O)C(=O)c3ccccc32)c(C)c1"
        ],
        "answer": "b",
        "answer_smiles": "CN(C)CCN1C(=O)Nc2c3cc(O)ccc3nc3c([N+](=O)[O-])ccc1c23",
        "domain": "PgpS",
        "id": 550
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. COc1nc2cccnc2n1-c1ccc(Nc2ccc(C)cn2)cc1",
            "b. CC(=O)NC(CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1",
            "c. CCC(CC)C1C(=O)NC(C2Cc3ccccc3C2)C(=O)N1C(C(=O)N1CCOCC1)c1ccc(C)nc1",
            "d. CC1CN(Cc2ccc(-c3cccnc3C(=O)N3CCC(Nc4ccc(F)c(F)c4)CC3)cc2)CC(C)N1"
        ],
        "answer": "a",
        "answer_smiles": "COc1nc2cccnc2n1-c1ccc(Nc2ccc(C)cn2)cc1",
        "domain": "RMS",
        "id": 551
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#Cc1ccnc(N2C(=O)CCC2C(=O)N(c2cccc(F)c2)C2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1",
            "b. O=C(Cc1ccc(Cl)cc1)NC(Cc1ccc(Cl)cc1)C(=O)NC1CCNCC1",
            "c. Nc1ccnc(Nc2ccc(Oc3ccc(F)cc3)cc2)n1",
            "d. CNC(C)(C)c1ccc(-n2cc3cccc(C(N)=O)c3n2)cc1"
        ],
        "answer": "c",
        "answer_smiles": "Nc1ccnc(Nc2ccc(Oc3ccc(F)cc3)cc2)n1",
        "domain": "RMS",
        "id": 552
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1",
            "b. O=C1NCC2c3c(cccc31)CCN2C(=O)Cc1cccnc1",
            "c. COCCN1CCN(c2ccc3nc(Nc4cnc(OC)c(F)c4)c(-c4nc(C)nc(N)n4)n3c2)CC1",
            "d. Fc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1"
        ],
        "answer": "d",
        "answer_smiles": "Fc1ccc2nc(-c3cccnc3)n(C3CC3)c2c1",
        "domain": "RMS",
        "id": 553
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC(=O)O)c(Cl)c1)C2",
            "b. Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2OC(C)C(F)(F)F)C3)ccn1",
            "c. Nc1ccnc(Nc2ccc(Oc3ccncc3)cc2)n1",
            "d. O=c1[nH]cc(-c2ccccc2)cc1-c1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(-n2cc3c(n2)CN(C(=O)c2cc(C#N)ccc2OC(C)C(F)(F)F)C3)ccn1",
        "domain": "RMS",
        "id": 554
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. N#Cc1cc(N)ncc1-c1cc(N2CCOCC2)nc(N2CCOCC2)n1",
            "b. N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1",
            "c. C=C1CC1NC1CCN(c2ccc(NC(=O)C(C)(C)c3ccccc3)cc2Cl)CC1",
            "d. CC(C)c1nc(-c2ccc(F)c(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1"
        ],
        "answer": "b",
        "answer_smiles": "N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1",
        "domain": "RMS",
        "id": 555
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1nn(Cc2ccccc2)c(C)c1CC(=O)NCc1ccc(F)cc1Cl",
            "b. Clc1cccc(-c2ccc(N3CCOCC3)nc2)c1Cl",
            "c. Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5)CC3)cccc2n1",
            "d. CC(C)(C(=O)Nc1ccc(N2CCC3(CCN(CC4CC4)C3)CC2)c(Cl)c1)c1nccc(C(F)(F)F)n1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1nn(Cc2ccccc2)c(C)c1CC(=O)NCc1ccc(F)cc1Cl",
        "domain": "RMS",
        "id": 556
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1nn(-c2ccc(C(N)=O)cc2)c(C)c1CC(=O)NCc1ccc(F)cc1Cl",
            "b. Cc1cc(Nc2cncc(NC(C)c3ncc(F)cn3)n2)n[nH]1",
            "c. Cc1c(-c2cccc(S(C)(=O)=O)c2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12",
            "d. Cn1ccc2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c21"
        ],
        "answer": "c",
        "answer_smiles": "Cc1c(-c2cccc(S(C)(=O)=O)c2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12",
        "domain": "RMS",
        "id": 557
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. NC1=NC2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c2cc(-c2cccnc2)nc1F",
            "b. CC1C(N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12",
            "c. CC(C)Cc1cc(O)c(-c2ccccc2)c(=O)[nH]1",
            "d. CCC(C)C1C(=O)NC(C2Cc3ccccc3C2)C(=O)N1C(C(=O)N1CCOCC1)c1ccc(C)nc1"
        ],
        "answer": "b",
        "answer_smiles": "CC1C(N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12",
        "domain": "RMS",
        "id": 558
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. Cc1nn(CCN(C)C)c(C)c1CC(=O)NCc1ccc(F)cc1Cl",
            "b. CCC(C)CN1C(=O)c2ccccc2C(C(=O)O)C1c1cc2ccccc2o1",
            "c. NC1CCCN(c2c(Br)cccc2C=C2SC(=O)NC2=O)C1",
            "d. COc1n[nH]c2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(C)(C)C#N)c4)ccc3F)cc12"
        ],
        "answer": "d",
        "answer_smiles": "COc1n[nH]c2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(C)(C)C#N)c4)ccc3F)cc12",
        "domain": "RMS",
        "id": 559
    },
    {
        "question": "Which of the following four compounds is most likely to be cleared in a rat microsome assay, with measured clearance ≥30% of hepatic blood flow, based on public experimental data?",
        "options": [
            "a. CC(C)CN1CC2C(CNc3nc(-c4ccccn4)cs3)C2C1",
            "b. O=C(O)c1ccc(OC2CCN(C(=O)NC3CC3c3ccccc3)CC2)c(Cl)c1",
            "c. CN1C(=O)Cc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(N)nc4)CC3)ccc21",
            "d. c1cc2c(cc1OCC1CCNCC1)CCN(C1CCC1)CC2"
        ],
        "answer": "c",
        "answer_smiles": "CN1C(=O)Cc2cc(-c3cc(C(O)(C(F)(F)F)C(F)(F)F)cnc3N3CCN(S(=O)(=O)c4ccc(N)nc4)CC3)ccc21",
        "domain": "RMS",
        "id": 560
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. O=C(O)CN(CC(=O)O)CC(=O)O",
            "b. CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1",
            "c. O=Cc1ccc(F)cc1",
            "d. Clc1sc(Cl)c(Cl)c1Cl"
        ],
        "answer": "a",
        "answer_smiles": "O=C(O)CN(CC(=O)O)CC(=O)O",
        "domain": "SR-ARE",
        "id": 561
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. CC(C)OC(=O)Nc1cccc(Cl)c1",
            "b. c1ccc(CNc2ncnc3c2ncn3C2CCCCO2)cc1",
            "c. CCOc1cc(C=O)ccc1O",
            "d. COCC(C)N(C(=O)CCl)c1c(C)csc1C"
        ],
        "answer": "d",
        "answer_smiles": "COCC(C)N(C(=O)CCl)c1c(C)csc1C",
        "domain": "SR-ARE",
        "id": 562
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. Brc1c(NC2=NCCN2)ccc2nccnc12",
            "b. O=C1c2cccc(O)c2C(=O)c2c(O)cccc21",
            "c. Cc1ccn2nc(S(=O)(=O)Nc3c(F)cccc3F)nc2n1",
            "d. CCC(C)COC(=O)CC(C)C"
        ],
        "answer": "b",
        "answer_smiles": "O=C1c2cccc(O)c2C(=O)c2c(O)cccc21",
        "domain": "SR-ARE",
        "id": 563
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. COc1ccccc1OC(=O)Oc1ccccc1OC",
            "b. NC(=O)c1cccc([N+](=O)[O-])c1",
            "c. N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O",
            "d. CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O"
        ],
        "answer": "d",
        "answer_smiles": "CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O",
        "domain": "SR-ARE",
        "id": 564
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. c1cnccn1",
            "b. COC(C)OC",
            "c. CC(=O)OC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C",
            "d. ClC=CCl"
        ],
        "answer": "c",
        "answer_smiles": "CC(=O)OC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C",
        "domain": "SR-ARE",
        "id": 565
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. CCOP(=S)(OCC)SC(CCl)N1C(=O)c2ccccc2C1=O",
            "b. CC(C)COC(=O)c1ccccc1",
            "c. CCCCCCCCCCCCCCCCN(C)C",
            "d. CC(C)CCCCCCOC(=O)CCCCC(=O)OCCCCCCC(C)C"
        ],
        "answer": "a",
        "answer_smiles": "CCOP(=S)(OCC)SC(CCl)N1C(=O)c2ccccc2C1=O",
        "domain": "SR-ARE",
        "id": 566
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. CCOC(=O)C(Cl)C(C)=O",
            "b. CC(=O)Nc1ncc([N+](=O)[O-])s1",
            "c. CC(C)CCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCC(C)C",
            "d. CCCOC/C(=N\\c1ccc(Cl)cc1C(F)(F)F)n1ccnc1"
        ],
        "answer": "d",
        "answer_smiles": "CCCOC/C(=N\\c1ccc(Cl)cc1C(F)(F)F)n1ccnc1",
        "domain": "SR-ARE",
        "id": 567
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. CCCCN1C=CN(C)C1",
            "b. COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2",
            "c. COC(=O)CCSCCC(=O)OC",
            "d. C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2",
        "domain": "SR-ARE",
        "id": 568
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. C=C(C)CCC[C@H](C)CCO",
            "b. CC(Cc1ccc2c(c1)OCO2)NO",
            "c. CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O",
            "d. N[C@@H]1CONC1=O"
        ],
        "answer": "c",
        "answer_smiles": "CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O",
        "domain": "SR-ARE",
        "id": 569
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the antioxidant response element (ARE) (<=10uM) in a stress response assay based on the public experimental data?",
        "options": [
            "a. O=C(NN1CCCC1)NS(=O)(=O)c1ccc(Cl)cc1",
            "b. Nc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl",
            "c. CCC1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1",
            "d. C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C=C"
        ],
        "answer": "d",
        "answer_smiles": "C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C=C",
        "domain": "SR-ARE",
        "id": 570
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=Cc1ccc(Cl)c([N+](=O)[O-])c1",
            "b. CCCCCCCCNC",
            "c. Cc1cc2nc(N)sc2cc1C",
            "d. Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1cc2nc(N)sc2cc1C",
        "domain": "SR-ATAD5",
        "id": 571
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)c1ccc(CBr)cc1",
            "b. CC(=O)OCC(=O)Nc1cc(C#N)cc(NC(=O)COC(C)=O)c1Cl",
            "c. CCOC(=O)c1ccccc1C(=O)OCC",
            "d. O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl"
        ],
        "answer": "a",
        "answer_smiles": "COC(=O)c1ccc(CBr)cc1",
        "domain": "SR-ATAD5",
        "id": 572
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=NN(c1ccccc1)c1ccccc1",
            "b. O=C(N[C@@H]1N=C(c2ccccc2F)c2cccc3c2N(CC3)C1=O)c1cc2ccccc2[nH]1",
            "c. Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O",
            "d. CNC(=O)Oc1cccc2ccccc12"
        ],
        "answer": "b",
        "answer_smiles": "O=C(N[C@@H]1N=C(c2ccccc2F)c2cccc3c2N(CC3)C1=O)c1cc2ccccc2[nH]1",
        "domain": "SR-ATAD5",
        "id": 573
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCCC(O)CCOC(C)=O",
            "b. CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1",
            "c. Cc1cccc(/N=N/c2ccc(N(C)C)cc2)c1",
            "d. CCCCC(CC)COC(=O)/C=C\\C(=O)OCC(CC)CCCC"
        ],
        "answer": "c",
        "answer_smiles": "Cc1cccc(/N=N/c2ccc(N(C)C)cc2)c1",
        "domain": "SR-ATAD5",
        "id": 574
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@]12C(=O)OC(=O)[C@H]1[C@H]1C=C[C@@H]2C1",
            "b. CCC(C)C1CCCCC1=O",
            "c. CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21",
            "d. CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1"
        ],
        "answer": "c",
        "answer_smiles": "CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21",
        "domain": "SR-ATAD5",
        "id": 575
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1ccccc1",
            "b. CSc1ccc(Cl)cc1",
            "c. Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C",
            "d. Cc1ccc(Cl)cc1Cl"
        ],
        "answer": "a",
        "answer_smiles": "O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1ccccc1",
        "domain": "SR-ATAD5",
        "id": 576
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOc1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-]",
            "b. Cc1ncc([N+](=O)[O-])n1CCO",
            "c. CCC(C)(c1ccc(O)cc1)c1ccc(O)cc1",
            "d. Nc1ccc(Oc2ccc(N)c(N)c2)cc1"
        ],
        "answer": "d",
        "answer_smiles": "Nc1ccc(Oc2ccc(N)c(N)c2)cc1",
        "domain": "SR-ATAD5",
        "id": 577
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1nc2cc(Cl)ccc2o1",
            "b. CSc1nc(NC(C)C)nc(NC(C)C)n1",
            "c. CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1",
            "d. ClC(Cl)=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1"
        ],
        "answer": "c",
        "answer_smiles": "CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1",
        "domain": "SR-ATAD5",
        "id": 578
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(CCl)C(=O)Cl",
            "b. ClCCl",
            "c. CC(C)CCOC(=O)c1ccccc1",
            "d. C=CC(=O)OCCOCCOCCOCCOC(=O)C=C"
        ],
        "answer": "d",
        "answer_smiles": "C=CC(=O)OCCOCCOCCOCCOC(=O)C=C",
        "domain": "SR-ATAD5",
        "id": 579
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the ATAD5-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=C(C)C(=O)OCCOCCOC(=O)C(=C)C",
            "b. NC(=O)Nc1nc2ccccc2[nH]1",
            "c. Cc1ccc2nc(-c3ccc(N)cc3)sc2c1S(=O)(=O)O",
            "d. CCC(C)(C)C1CCC(OC)CC1"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc2nc(-c3ccc(N)cc3)sc2c1S(=O)(=O)O",
        "domain": "SR-ATAD5",
        "id": 580
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=CC(=O)NC(C)C",
            "b. O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O",
            "c. O=C(O)C1C2CCC(O2)C1C(=O)O",
            "d. CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O"
        ],
        "answer": "d",
        "answer_smiles": "CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O",
        "domain": "SR-HSE",
        "id": 581
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1ccc([N+](=O)[O-])c2c1O[Hg]2",
            "b. COc1ccc(C)cc1N",
            "c. O=C1O[C@H]([C@@H](O)CO)C(O)=C1O",
            "d. O=[N+]([O-])c1cc[n+]([O-])cc1"
        ],
        "answer": "a",
        "answer_smiles": "Cc1ccc([N+](=O)[O-])c2c1O[Hg]2",
        "domain": "SR-HSE",
        "id": 582
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. C=Cc1ccccc1C=C",
            "b. Nc1ccc(S(=O)(=O)Nc2nccs2)cc1",
            "c. O=C1c2ccccc2C(=O)C1c1ccc(Br)cc1",
            "d. CCCCCCCC(=O)Oc1c(Br)cc(C#N)cc1Br"
        ],
        "answer": "b",
        "answer_smiles": "Nc1ccc(S(=O)(=O)Nc2nccs2)cc1",
        "domain": "SR-HSE",
        "id": 583
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. c1ccc(CNc2[nH]cnc3ncnc2-3)cc1",
            "b. NC(CS)C(=O)O",
            "c. CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1",
            "d. Nc1cc(Cl)c(-c2cc(Cl)c(N)cc2Cl)cc1Cl"
        ],
        "answer": "d",
        "answer_smiles": "Nc1cc(Cl)c(-c2cc(Cl)c(N)cc2Cl)cc1Cl",
        "domain": "SR-HSE",
        "id": 584
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. N#Cc1ccc(N(CC(N)=O)CC(F)(F)F)cc1C(F)(F)F",
            "b. CCCCCCI",
            "c. CCCCNC(=N)NC(=N)N",
            "d. Cl[Sb](Cl)Cl"
        ],
        "answer": "d",
        "answer_smiles": "Cl[Sb](Cl)Cl",
        "domain": "SR-HSE",
        "id": 585
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCOC(=O)CC",
            "b. CNC(=O)ON=C(SC)C(=O)N(C)C",
            "c. O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1",
            "d. CCCCNC(=S)NCCCC"
        ],
        "answer": "d",
        "answer_smiles": "CCCCNC(=S)NCCCC",
        "domain": "SR-HSE",
        "id": 586
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1(C)C2CCC3(C2)[C@H]1C(=O)CCC3(C)C",
            "b. CCCCCCCO",
            "c. O=C(O)CC(O)(CC(=O)O)C(=O)O",
            "d. C[C@H]1[C@H](NC(=O)C(=NOC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "O=C(O)CC(O)(CC(=O)O)C(=O)O",
        "domain": "SR-HSE",
        "id": 587
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)=CC1C(C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C",
            "b. C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C",
            "c. CCN(CC)C(C)C(=O)c1ccccc1",
            "d. N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)=CC1C(C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C",
        "domain": "SR-HSE",
        "id": 588
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOC(=O)Cc1cccc2ccccc12",
            "b. CCCCCCCCCCCCCBr",
            "c. CC1(C)CON(Cc2ccccc2Cl)C1=O",
            "d. CC(C)=CC1C(C(=O)OCc2coc(Cc3ccccc3)c2)C1(C)C"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)=CC1C(C(=O)OCc2coc(Cc3ccccc3)c2)C1(C)C",
        "domain": "SR-HSE",
        "id": 589
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the heat shock element (HSE) stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1",
            "b. CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1",
            "c. C1CCCCCCCCCCC1",
            "d. CC(C)CCCCCCCOC(=O)c1ccc(C(=O)OCCCCCCCC(C)C)c(C(=O)OCCCCCCCC(C)C)c1"
        ],
        "answer": "d",
        "answer_smiles": "CC(C)CCCCCCCOC(=O)c1ccc(C(=O)OCCCCCCCC(C)C)c(C(=O)OCCCCCCCC(C)C)c1",
        "domain": "SR-HSE",
        "id": 590
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC(Cl)[N+](=O)[O-]",
            "b. N#CC(C#N)=Cc1ccc(O)c(O)c1",
            "c. CC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C",
            "d. CCC(C)O"
        ],
        "answer": "b",
        "answer_smiles": "N#CC(C#N)=Cc1ccc(O)c(O)c1",
        "domain": "SR-MMP",
        "id": 591
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)CC(C)(O)C#CC(C)(O)CC(C)C",
            "b. O=C(C=Cc1ccccc1)OCC=Cc1ccccc1",
            "c. Cc1cc(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1Br",
            "d. O=C(O)C1O[Sb]2OC(=O)C(O2)C(C(=O)O)O[Sb]2OC(=O)C1O2"
        ],
        "answer": "a",
        "answer_smiles": "CC(C)CC(C)(O)C#CC(C)(O)CC(C)C",
        "domain": "SR-MMP",
        "id": 592
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=c1nn[nH]c2ccccc12",
            "b. Cc1cc(O)c(Cl)c(C)c1Cl",
            "c. O=C1c2ccccc2CN2C(=O)c3ccccc3CN12",
            "d. CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(O)c(Cl)c(C)c1Cl",
        "domain": "SR-MMP",
        "id": 593
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCOC(=O)C(C)Oc1ccc(Oc2ccc(C(F)(F)F)cn2)cc1",
            "b. c1ccc(CNc2ncnc3c2ncn3C2CCCCO2)cc1",
            "c. COC(C)(C)CCCC(C)C/C=C/C(C)=C/C(=O)OC(C)C",
            "d. C=CC(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "COC(C)(C)CCCC(C)C/C=C/C(C)=C/C(=O)OC(C)C",
        "domain": "SR-MMP",
        "id": 594
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. NC(=O)c1ccccc1O",
            "b. C[N+](C)(C)CC(O)CC(=O)O",
            "c. CN1CC(O)C2=C/C(=N/NC(N)=O)C(=O)C=C21",
            "d. Cc1cc(=O)oc2cc(O)cc(O)c12"
        ],
        "answer": "d",
        "answer_smiles": "Cc1cc(=O)oc2cc(O)cc(O)c12",
        "domain": "SR-MMP",
        "id": 595
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=P(O)(O)OC[C@H](O)CO",
            "b. NCCS(=O)(=O)O",
            "c. COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1",
            "d. CCCCCCCCCCCCCCCCCCOS(=O)(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "NCCS(=O)(=O)O",
        "domain": "SR-MMP",
        "id": 596
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. BrCCCCCCBr",
            "b. COC(=O)C1CC(=O)C(C(=O)OC)CC1=O",
            "c. CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO",
            "d. Oc1ccc(Cl)cc1Cc1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "Oc1ccc(Cl)cc1Cc1ccccc1",
        "domain": "SR-MMP",
        "id": 597
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. COC(=O)C(C)(C)C",
            "b. COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-]",
            "c. O=C(Cc1ccccc1)OCCc1ccccc1",
            "d. COC(=O)c1sccc1S(N)(=O)=O"
        ],
        "answer": "b",
        "answer_smiles": "COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-]",
        "domain": "SR-MMP",
        "id": 598
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCc1cc(C2=C(C(=O)O)N(c3ccccc3C(F)(F)F)S(=O)(=O)c3ccccc32)cc2c1OCO2",
            "b. N[C@@H]1CONC1=O",
            "c. C=C(C)CCC[C@H](C)CCO",
            "d. CCCCNC(C)(C)[PH](=O)O"
        ],
        "answer": "a",
        "answer_smiles": "CCc1cc(C2=C(C(=O)O)N(c3ccccc3C(F)(F)F)S(=O)(=O)c3ccccc32)cc2c1OCO2",
        "domain": "SR-MMP",
        "id": 599
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the Matrix Metalloproteinase (MMP) mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(=O)O[C@@H]1C(=O)O[C@@H]2[C@H]1OC(=O)[C@@H]2OC(C)=O",
            "b. CCC(=O)OCc1ccccc1",
            "c. O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1",
            "d. N#CC(O)c1ccccc1"
        ],
        "answer": "c",
        "answer_smiles": "O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1",
        "domain": "SR-MMP",
        "id": 600
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1cncn1",
            "b. O=C1c2ccccc2C(=O)C1c1ccc2cc(S(=O)(=O)O)cc(S(=O)(=O)O)c2n1",
            "c. Nc1ccccc1S(=O)(=O)c1ccccc1",
            "d. CCN1C(=CC=Cc2ccc3ccccc3[n+]2CC)C=Cc2ccccc21"
        ],
        "answer": "d",
        "answer_smiles": "CCN1C(=CC=Cc2ccc3ccccc3[n+]2CC)C=Cc2ccccc21",
        "domain": "SR-p53",
        "id": 601
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. Cn1c(=N)[nH]c2[nH]cnc2c1=O",
            "b. CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1",
            "c. CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I",
            "d. N=C1NC(=N)c2ccccc21"
        ],
        "answer": "d",
        "answer_smiles": "N=C1NC(=N)c2ccccc21",
        "domain": "SR-p53",
        "id": 602
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(CO)CO",
            "b. C[C@@H]1[C@@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2CCc1ccccc1",
            "c. O=C(Cl)c1cc(C(=O)Cl)cc(C(=O)Cl)c1",
            "d. Cc1ccccc1S(=O)(=O)O"
        ],
        "answer": "c",
        "answer_smiles": "O=C(Cl)c1cc(C(=O)Cl)cc(C(=O)Cl)c1",
        "domain": "SR-p53",
        "id": 603
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCOc1cc(-c2nccc3cc(OC)c(OC)cc23)cc(OCC)c1OCC",
            "b. Oc1ccc(-c2ccc(O)cc2)cc1",
            "c. CCCCCCCCCCCC(=O)O",
            "d. CCC(=O)OCCOc1ccccc1"
        ],
        "answer": "b",
        "answer_smiles": "Oc1ccc(-c2ccc(O)cc2)cc1",
        "domain": "SR-p53",
        "id": 604
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\\CCCC(=O)OC(C)C)[C@@H](O)C[C@H]1O",
            "b. CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1",
            "c. CC1CC(=O)CC(C)(C)C1",
            "d. CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O"
        ],
        "answer": "a",
        "answer_smiles": "CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\\CCCC(=O)OC(C)C)[C@@H](O)C[C@H]1O",
        "domain": "SR-p53",
        "id": 605
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O",
            "b. COC(COC(N)=O)C1=C(N2CC2)C(=O)C(C)=C(N2CC2)C1=O",
            "c. COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O",
            "d. CC(C)C[C@@H](N)C(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "COC(COC(N)=O)C1=C(N2CC2)C(=O)C(C)=C(N2CC2)C1=O",
        "domain": "SR-p53",
        "id": 606
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CCC1CO1",
            "b. COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1",
            "c. O=C(CC(=O)C(F)(F)F)c1ccccc1",
            "d. Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1",
        "domain": "SR-p53",
        "id": 607
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)=CCOC(=O)c1ccccc1",
            "b. O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Br)cc(Br)c1O",
            "c. CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I",
            "d. CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1"
        ],
        "answer": "b",
        "answer_smiles": "O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Br)cc(Br)c1O",
        "domain": "SR-p53",
        "id": 608
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. C[C@H]1CNCCc2ccc(Cl)cc21",
            "b. Cc1cc(Br)ccc1NC(=O)CCl",
            "c. O=C(O)C(=O)O",
            "d. ClCc1cccnc1"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(Br)ccc1NC(=O)CCl",
        "domain": "SR-p53",
        "id": 609
    },
    {
        "question": "Which of the following four compounds is most likely to interact with the p53-mediated stress response pathway (<=10uM) based on the public experimental data?",
        "options": [
            "a. NC(=O)n1c(O)c(C(=O)c2cccs2)c2cc(Cl)ccc21",
            "b. NCc1cccnc1",
            "c. CC1=C(C=O)C(C)(C)CC=C1",
            "d. CC(C)(C)OC=O"
        ],
        "answer": "a",
        "answer_smiles": "NC(=O)n1c(O)c(C(=O)c2cccs2)c2cc(Cl)ccc21",
        "domain": "SR-p53",
        "id": 610
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CNCCc1cn(S(=O)(=O)c2cccc3c2CCO3)c2cccnc12",
            "b. CC(C)(C)NC(=O)CN1CC2CN(CC(=O)NCc3ccc(C#N)cc3)CC(C1)O2",
            "c. O=C1OC2(CCC(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1F",
            "d. N#Cc1ccc(OCCN2C[C@H]3CN(CCNS(=O)(=O)c4ccc(F)cc4)C[C@@H](C2)O3)c(F)c1"
        ],
        "answer": "a",
        "answer_smiles": "CNCCc1cn(S(=O)(=O)c2cccc3c2CCO3)c2cccnc12",
        "domain": "hERG",
        "id": 611
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)Oc1nccnc1CN1CCC(C(=O)Cc2c(F)cccc2C(F)(F)F)CC1",
            "b. COc1cc(C2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1",
            "c. Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)OCCN6)n3C)cccc2n1",
            "d. CCOc1cccc(/C=C/c2nc3ccccc3c(=O)n2-c2c(C)cccc2C)c1O"
        ],
        "answer": "c",
        "answer_smiles": "Cc1ccc2c(-c3nnc(SCCCN4CCc5cc6c(cc5CC4)OCCN6)n3C)cccc2n1",
        "domain": "hERG",
        "id": 612
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1",
            "b. CC(C)(C)c1ccc(CN2C[C@H]3CN(CCN(CCOc4ccc(C#N)cc4)S(C)(=O)=O)C[C@@H](C2)O3)cc1",
            "c. Cc1ccc(CN2CC[C@@H](N3CC[C@@H](c4ccc(O)cc4)[C@H](F)C3)C2=O)cc1",
            "d. CCC[C@@H](CCO)Nc1nc(N)nc(C)c1Cc1ccc(CN(C)CCO)cc1O"
        ],
        "answer": "a",
        "answer_smiles": "CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1",
        "domain": "hERG",
        "id": 613
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC1(C)CC(NC(=O)c2n[nH]c3c2CCC3)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2O1",
            "b. Cn1cnc(C(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)[C@H]2C[C@H]3CNC[C@H]3C2)c1",
            "c. Cc1ccc(N2CCN(C(=O)c3cccc(Cl)c3)CC2)cc1",
            "d. Cc1nc(N2CCN(C(=O)[C@@H]3CCCC[C@H]3C(=O)NC3(C#N)CC3)CC2)sc1C"
        ],
        "answer": "b",
        "answer_smiles": "Cn1cnc(C(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)[C@H]2C[C@H]3CNC[C@H]3C2)c1",
        "domain": "hERG",
        "id": 614
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Cc1nn(C2CCNCC2)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1",
            "b. Cc1ccc(S(N)(=O)=O)c(C)c1C(=O)N1CCC(CCN2C3CCC2CC(n2c(C)nc4ccccc42)C3)(c2cccc(F)c2)CC1",
            "c. CCC1(c2ccccc2)C(=O)N=C(O)NC1=O",
            "d. Cc1cc(C#Cc2cn(-c3ccc(F)cc3)c(C)n2)ccn1"
        ],
        "answer": "c",
        "answer_smiles": "CCC1(c2ccccc2)C(=O)N=C(O)NC1=O",
        "domain": "hERG",
        "id": 615
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. O=C(CCCCCCC(=O)Nc1ccccc1)NO",
            "b. CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl",
            "c. O=C(NC1CCN(Cc2ccn(-c3ccc(C(F)(F)F)cc3)c2)CC1)N[C@@H](CO)c1ccccc1",
            "d. CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@@H](n1c(C)nc3ccccc31)C2)c1ccccc1"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@@H](n1c(C)nc3ccccc31)C2)c1ccccc1",
        "domain": "hERG",
        "id": 616
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. Nc1ccc(-c2cnc3nc(N4CCC(N5CCCCC5)CC4)sc3c2)cn1",
            "b. COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1",
            "c. CCC[C@@H](CCO)Nc1nc(N)nc(C)c1Cc1ccc(CN2CCCC2)cc1OC",
            "d. NS(=O)(=O)c1ccc(CCNc2nc(Cl)nc3cccc(-c4ccccc4)c23)cc1"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1",
        "domain": "hERG",
        "id": 617
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CS(=O)(=O)N(CCOc1ccccc1)CCN1CC2CN(Cc3ccc(C#N)cc3)CC(C1)O2",
            "b. CC(C)CN(C(=O)c1cccc(C(F)(F)F)c1Cl)[C@H]1CCNC1",
            "c. COCCc1ccc(OCC(O)CNC(C)C)cc1",
            "d. O=C(NC[C@]1(O)CC[C@H](COCc2cccc(F)c2)CC1)c1ccc(O)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)CN(C(=O)c1cccc(C(F)(F)F)c1Cl)[C@H]1CCNC1",
        "domain": "hERG",
        "id": 618
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cc(O)ccc32)cc1",
            "b. N#Cc1ccc(OCCCN2CC3CN(CC(=O)NCCc4ccccc4)CC(C2)O3)cc1",
            "c. O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1",
            "d. Cc1nc(Oc2ccc(C(=O)N3CCOCC3)cc2)ccc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1"
        ],
        "answer": "c",
        "answer_smiles": "O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1",
        "domain": "hERG",
        "id": 619
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit hERG inhibition (IC50<=10uM) based on the public experimental data?",
        "options": [
            "a. CC(C)(C)Oc1nccnc1CCN1CCC(COc2ccccc2F)CC1",
            "b. CC1CN(c2ncc(CN[C@@H]3COC4=NC([N+](=O)[O-])CN4C3)cn2)CCN1c1ccc(OC(F)(F)F)cc1",
            "c. COC(=O)c1c(C)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1",
            "d. CC1(c2ccccc2)CCCN(C(=O)Nc2cccc(-c3ccccc3)c2)C1"
        ],
        "answer": "c",
        "answer_smiles": "COC(=O)c1c(C)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1",
        "domain": "hERG",
        "id": 620
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. CN1CCCC1c1cccnc1",
            "b. CCC(C)(C)c1ccc(CC(C)CN2CC(C)OC(C)C2)cc1",
            "c. O=c1[nH]c(=O)n(C2CCCO2)cc1F",
            "d. NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1"
        ],
        "answer": "d",
        "answer_smiles": "NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1",
        "domain": "nephrotox",
        "id": 621
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O",
            "b. Cc1cc(C)nc(NC(=O)NS(=O)(=O)c2ccccc2C(=O)OC2COC2)n1",
            "c. CC(CN1c2ccccc2Sc2ccccc21)N(C)C",
            "d. COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]"
        ],
        "answer": "b",
        "answer_smiles": "Cc1cc(C)nc(NC(=O)NS(=O)(=O)c2ccccc2C(=O)OC2COC2)n1",
        "domain": "nephrotox",
        "id": 622
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1",
            "b. COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1",
            "c. NCC1CCC(C(=O)O)CC1",
            "d. O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]"
        ],
        "answer": "b",
        "answer_smiles": "COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1",
        "domain": "nephrotox",
        "id": 623
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. Cl",
            "b. Nc1ccc(N=Nc2ccccc2)c(N)n1",
            "c. CC(=CC(=O)OCCCCCCCCC(=O)O)CC1OCC(CC2OC2C(C)C(C)O)C(O)C1O",
            "d. NCC(=O)O"
        ],
        "answer": "b",
        "answer_smiles": "Nc1ccc(N=Nc2ccccc2)c(N)n1",
        "domain": "nephrotox",
        "id": 624
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. O=C(O)CN1CCN(CC(=O)O)CCN(C(CO)C(O)CO)CCN(CC(=O)O)CC1",
            "b. COP(C)(=O)OC",
            "c. C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1",
            "d. N=C(N)c1ccc2cc(OC(=O)c3ccc(N=C(N)N)cc3)ccc2c1"
        ],
        "answer": "b",
        "answer_smiles": "COP(C)(=O)OC",
        "domain": "nephrotox",
        "id": 625
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CSC12)c1csc(N)n1",
            "b. CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C",
            "c. COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC",
            "d. CC(C)NCC(O)c1ccc(O)c(O)c1"
        ],
        "answer": "a",
        "answer_smiles": "CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CSC12)c1csc(N)n1",
        "domain": "nephrotox",
        "id": 626
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1",
            "b. CCC(CCC(C)C1CCC2C3CC=C4CC(OC5OC(CO)C(O)C(O)C5O)CCC4(C)C3CCC12C)C(C)C",
            "c. COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21",
            "d. NC(N)=NC(=O)c1nc(Cl)c(N)nc1N"
        ],
        "answer": "c",
        "answer_smiles": "COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21",
        "domain": "nephrotox",
        "id": 627
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O",
            "b. Cc1coc2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12",
            "c. CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1",
            "d. CC1=CC(=O)CC(C)(C)C1"
        ],
        "answer": "d",
        "answer_smiles": "CC1=CC(=O)CC(C)(C)C1",
        "domain": "nephrotox",
        "id": 628
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. CNc1cnn(-c2cccc(C(F)(F)F)c2)c(=O)c1Cl",
            "b. CCCCC(C)(C)C(O)C=CC1C(O)CC(=O)C1CCCCC=CC(=O)OC",
            "c. O=C1OC2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)OC2C(OC(=O)c2cc(O)c(O)c(O)c2)=C1OC(=O)c1cc(O)c(O)c(O)c1",
            "d. COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1"
        ],
        "answer": "a",
        "answer_smiles": "CNc1cnn(-c2cccc(C(F)(F)F)c2)c(=O)c1Cl",
        "domain": "nephrotox",
        "id": 629
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit nephrotoxicity based on the public experimental data?",
        "options": [
            "a. C=CCNCCCCCCCCCC",
            "b. CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO",
            "c. CC1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1",
            "d. O=C1C=CC=CC1=C1NC(=C2C=CC=CC2=O)N(c2ccc(C(=O)O)cc2)N1"
        ],
        "answer": "d",
        "answer_smiles": "O=C1C=CC=CC1=C1NC(=C2C=CC=CC2=O)N(c2ccc(C(=O)O)cc2)N1",
        "domain": "nephrotox",
        "id": 630
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. CNc1ccc(C=Cc2ccc(OCCOCCOCCF)nc2)cc1",
            "b. CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1",
            "c. CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1",
            "d. CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO"
        ],
        "answer": "d",
        "answer_smiles": "CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO",
        "domain": "reproductive",
        "id": 631
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)C1OCC(O)C1OC(=O)CCCCCCCCCCCCCCCCC",
            "b. C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C",
            "c. CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1",
            "d. N#CS"
        ],
        "answer": "d",
        "answer_smiles": "N#CS",
        "domain": "reproductive",
        "id": 632
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. CC(C)(C)C1=CC(=Cc2ccccc2)C=C(C(C)(C)C)C1=O",
            "b. CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1",
            "c. CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1",
            "d. O=C(CCS)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS"
        ],
        "answer": "b",
        "answer_smiles": "CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1",
        "domain": "reproductive",
        "id": 633
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. COc1cc(C2c3cc4c(cc3C(O)C(CO)C2C(=O)O)OCO4)cc(OC)c1OC",
            "b. O=C([O-])C(O)C(O)C(=O)[O-]",
            "c. C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1",
            "d. CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C",
        "domain": "reproductive",
        "id": 634
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1",
            "b. COc1cc(CNC(=O)CCCCC=CC(C)C)ccc1O",
            "c. COc1ccnc(C[S+]([O-])C2Nc3ccc(OC(F)F)cc3N2)c1OC",
            "d. CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C"
        ],
        "answer": "c",
        "answer_smiles": "COc1ccnc(C[S+]([O-])C2Nc3ccc(OC(F)F)cc3N2)c1OC",
        "domain": "reproductive",
        "id": 635
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. FC(F)OC(F)C(F)(F)F",
            "b. O=C(O)CCCc1ccccc1",
            "c. Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1",
            "d. COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1"
        ],
        "answer": "a",
        "answer_smiles": "FC(F)OC(F)C(F)(F)F",
        "domain": "reproductive",
        "id": 636
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. Nc1nc(N)nc(-c2ccccc2)n1",
            "b. O=C1C(O)=C(C2CCC(c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21",
            "c. CC(N)C(=O)NC(C)C(=O)NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC21",
            "d. CCC(=O)OC1(C(=O)SC)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C"
        ],
        "answer": "d",
        "answer_smiles": "CCC(=O)OC1(C(=O)SC)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C",
        "domain": "reproductive",
        "id": 637
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. CC(C)(O)C(=O)c1ccccc1",
            "b. NCCC(O)(P(=O)(O)O)P(=O)(O)O",
            "c. CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)CC(C)(C)C",
            "d. CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC"
        ],
        "answer": "c",
        "answer_smiles": "CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)CC(C)(C)C",
        "domain": "reproductive",
        "id": 638
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. COc1ccc(CN(CCN(C)C)c2ncccn2)cc1",
            "b. CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O",
            "c. O",
            "d. CCCCCCCCCCC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C"
        ],
        "answer": "d",
        "answer_smiles": "CCCCCCCCCCC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C",
        "domain": "reproductive",
        "id": 639
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit reproductive toxicity based on the public experimental data?",
        "options": [
            "a. C=CCCCCCCCCCCCCCCCCCCCCCCCCCC",
            "b. CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(=O)O",
            "c. NC1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1",
            "d. CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1"
        ],
        "answer": "b",
        "answer_smiles": "CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(=O)O",
        "domain": "reproductive",
        "id": 640
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1",
            "b. Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1",
            "c. OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1",
            "d. CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12"
        ],
        "answer": "c",
        "answer_smiles": "OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1",
        "domain": "teratogenicity",
        "id": 641
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13",
            "b. Cc1ccccc1C(OCCN(C)C)c1ccccc1",
            "c. CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1",
            "d. CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1"
        ],
        "answer": "d",
        "answer_smiles": "CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1",
        "domain": "teratogenicity",
        "id": 642
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21",
            "b. c1cnc2cc3c(cc2n1)C1CNCC3C1",
            "c. CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1",
            "d. S=P(N1CC1)(N1CC1)N1CC1"
        ],
        "answer": "d",
        "answer_smiles": "S=P(N1CC1)(N1CC1)N1CC1",
        "domain": "teratogenicity",
        "id": 643
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CC1C=CC=CC=CC=CC=CC=CC=CC(OC2OC(C)C(O)C(N)C2O)CC2OC(O)(CC(O)CC(O)C(O)CCC(O)CC(O)CC(=O)OC(C)C(C)C1O)CC(O)C2C(=O)O",
            "b. CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1",
            "c. CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COc1ccccc1",
            "d. CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1"
        ],
        "answer": "b",
        "answer_smiles": "CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1",
        "domain": "teratogenicity",
        "id": 644
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1",
            "b. Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1",
            "c. Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1",
            "d. COC1C(N(C)C(=O)c2ccccc2)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4"
        ],
        "answer": "d",
        "answer_smiles": "COC1C(N(C)C(=O)c2ccccc2)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4",
        "domain": "teratogenicity",
        "id": 645
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2",
            "b. CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1",
            "c. O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1",
            "d. COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3"
        ],
        "answer": "b",
        "answer_smiles": "CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1",
        "domain": "teratogenicity",
        "id": 646
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CCCN1CCCCC1C(=O)Nc1c(C)cccc1C",
            "b. CC(C)NCC(O)c1cc(O)cc(O)c1",
            "c. COC(=O)CCC(=O)CN",
            "d. CC(=O)NC1C(O)OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(CO)C(OC4OC(C(=O)O)C(O)C(O)C4OS(=O)(=O)O)C(OS(=O)(=O)O)C3NS(=O)(=O)O)C(O)C2OS(=O)(=O)O)C1O"
        ],
        "answer": "d",
        "answer_smiles": "CC(=O)NC1C(O)OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(CO)C(OC4OC(C(=O)O)C(O)C(O)C4OS(=O)(=O)O)C(OS(=O)(=O)O)C3NS(=O)(=O)O)C(O)C2OS(=O)(=O)O)C1O",
        "domain": "teratogenicity",
        "id": 647
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1",
            "b. CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C",
            "c. O=P(O)(O)C(Cl)(Cl)P(=O)(O)O",
            "d. CCC(c1cccc(O)c1)C(C)CN(C)C"
        ],
        "answer": "d",
        "answer_smiles": "CCC(c1cccc(O)c1)C(C)CN(C)C",
        "domain": "teratogenicity",
        "id": 648
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CSC12)c1nsc(NP(=O)(O)O)n1",
            "b. CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1",
            "c. CC(C)Cn1cnc2c(N)nc3ccccc3c21",
            "d. O=P1(NCCCl)OCCCN1CCCl"
        ],
        "answer": "d",
        "answer_smiles": "O=P1(NCCCl)OCCCN1CCCl",
        "domain": "teratogenicity",
        "id": 649
    },
    {
        "question": "Which of the following four compounds is most likely to exhibit teratogenicity based on the public experimental data?",
        "options": [
            "a. CN1CCC(CN2c3ccccc3Sc3ccccc32)C1",
            "b. FCOC(C(F)(F)F)C(F)(F)F",
            "c. CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O",
            "d. CC12CCC3c4ccc(O)cc4CC(CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)C3C1CCC2O"
        ],
        "answer": "d",
        "answer_smiles": "CC12CCC3c4ccc(O)cc4CC(CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)C3C1CCC2O",
        "domain": "teratogenicity",
        "id": 650
    }
]